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Summary 
 
  
 The early entry in human immunodeficiency virus type-1 (HIV-1) replication 
is well characterized. Numerous studies have contributed to the insights into early 
events but also influenced the perception of viruses as being metabolically inert and 
static in structure, which led to the assumption that they only remodel after the 
viruses have entered the host cells. This is mainly due to the focus of investigations 
on HIV infections of target cells and the lack of attention to cell-free virus particle 
alterations which can be difficult to detect. Recent advances in imaging techniques 
that are capable of reaching low nano-scale resolutions, almost achieving electron 
microscope ranges, have become an attractive tool to study such ultramicroscopic 
structures. 
 
 This thesis provides the first study of pre-entry cell-free alterations in HIV 
particles that also affect internal features, potentially following an ‘outside-in’ 
signaling concept. A reorganization of the viral architecture might lead to the 
observed expansion of HIV. However, the extend of the signaling mechanism within 
the core is unclear. For the first time, this study presents an infectious HIV particle 
that carries a functional, fluorescently-labelled capsid core that will help to assess 
such effects on core-internal features. Since the virus is incapable of synthesizing 
lipids and proteins autonomously, cellular proteins may be involved in this signaling 
process. We observed a variety of proteins that are involved in rearranging and 
organizing cellular networks within the target cell which might assist with CD4 
 ǆŝǀ
receptor-mediated restructuring of the virus particle and assuring cellular entry of 
HIV.  
 
 We demonstrate that, additionally to the expansion of the particle and capsid 
core, virion co-packaged cellular proteins are activated by phosphorylation upon 
CD4 receptor engagement. These events indicate that the structure of viruses is not 
static and that they seem to prime for subsequent entry steps. Although we did not 
find evidences which replication processes are potentially targeted and to what 
extend these particle alterations are involved in them, data hint to nominal influences 
of replication preparation at pre-entry.  
 
In conclusion, this thesis demonstrates that HIV is able to undergo 
reorganization processes, perhaps to prime for entry into the host cell. Hereby, it 
appears that cellular proteins may be involved in this process and that the CD4 
engagement could promote their phosphorylation leading to activation of co-
packaged human proteins to ensure cell access. An intrigue hypothesis for this event 
may be the stimulation of a signaling cascade.  
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1  General introduction 
 
The focus of this thesis is the dissection of the early stages in HIV-1 infection. In 
order to design novel and specific therapeutics, one approach is the interference with early 
replication phases. It is widely believed that viruses have a static structure prior to fusion but 
here we demonstrate that the virus encounters a CD4 receptor-induced expansion as detected 
in cryo-electron microscopy and single molecule fluorescence imaging. Furthermore, mass 
spectrometry analyses showed that cell-free HIV is capable of undergoing phosphorylation 
processes with CD4 engagement. To further broaden our knowledge about the sub-particle 
architecture of HIV during entry, we assessed super-resolution fluorescence imaging 
techniques capable of dissecting involved small structures, including viral Env, MA, CA, NC 
and RNA. This introduction will give a brief overview about our current knowledge in the 
field of HIV infection and knowledge gaps that are often restricted by technical limitations.        
 
1.1 Genomic structure of HIV-1 
 
Since the discovery of Human Immunodeficiency Virus 1 (HIV-1) in 1983 
(Barré-Sinoussi et al., 1983, Gallo et al., 1984), extensive research resulted in a 
comprehensive overview of the structural features of the virus. This included several 
major genes encoding for viral proteins that are shared between other retroviruses, 
containing group specific antigen (Gag), polymerase (Pol) and envelope (Env) as 
well as the regulatory elements, HIV-1 trans-activator (Tat) and the regulator of 
expression of virion proteins (Rev). Furthermore, some nonstructural (accessory) 
genes are unique to HIV-1 which comprise of the negative factor (Nef), lentivirus 
protein R (Vpr), the viral infectivity factor (Vif) and the virus protein U (Vpu) 
(Figure 1.1). 
 Ϯ
 
 
 
Figure 1.1 HIV-1 genome map. HIV-1 contains a complex, single stranded, positive sense RNA 
genome with a length of approximately 9 kb which encodes 3 major polyproteins (Gag, Pol and Env) 
and six accessory proteins (Rev, Tat, Nef, Vpr, Vpu and Vif). The Gag encodes MA, CA, NC and p6 
while Pol consists of genes for PR, RT, RNaseH and IN. Env encodes gp120 and gp41 subunits.  The 
proviral DNA is flanked by the long terminal repeats (LTR) regions on the 3’end and 5’end 
respectively. These LTR regions are created by duplication of the unique and repeat regions during 
reverse transcription. This figure is adapted from the 1998 sequence compendium gene map 
(http://www.hiv.lanl.gov) by Thomas Splettstoesser, 2014. 
 
1.1.1 Structure of HIV-1 particles 
 
Like other enveloped viruses, HIV-1 Gag molecules assembling by 
multimerization at the inner leaflet of the host cell plasma membrane (Gabelman et 
al., 1975, Richardson and Vance, 1976, Gelderblom et al., 1988, Gelderblom et al., 
1992) before budding and its release from the cell. This viral lipid membrane is 
studded with envelope proteins containing two non-covalently linked subunits, the 
outer glycoprotein 120 (gp120) and the virion-anchoring transmembrane protein 41 
(gp41). Cryo-electron tomography and crystal structure analyses identified the 
envelope structure as a trimer of three gp120-gp41 heterodimers (Zhu et al., 2006, 
Pancera et al., 2014) which holds crucial information for potential HIV external and 
internal interactions and therapeutics design. HIV-1 maturation occurs concomitant 
to budding and is catalyzed by the viral protease (PR) that cleaves the Gag precursor 
mainly into MA, CA, NC and p6 (Swanstrom and Wills, 1997, Vogt, 1997) resulting 
ĂƐĞƐ
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in the formation of the classical viral features. During maturation, a structural shell 
formed by the MA protein is associated with the inner viral lipid membrane (Hill et 
al., 1996) which seems to have the function of guiding the Env on the membrane 
surface. The classical view of the Env structure on the membrane surface considers a 
random distribution of the subunits but a recent study suggested the compact 
formation of the Env spikes on the surface of the viral membrane (Chojnacki et al., 
2012) . Therefore, the mature virion structure as shown in the classical model in 
Figure 1.2 may have to be revised accordingly. Within this sphere-like compartment, 
a distinctive cone-shaped core feature is configured, which was detected as a dense 
structure in Electron microscopy (EM) (Hockley et al., 1988, Goto et al., 1998). This 
capsid core encapsulates two copies of genomic RNA which forms a 
ribonucleoprotein complex (RNP) with the viral nucleocapsid (NC), reverse 
transcriptase (RT) and integrase (IN) whereas protease (PR) proteins are situated 
externally of the core. While the proteins Nef, Vif and Vpr are simultaneously 
packaged into the virion (Kappes et al., 1993, Camaur and Trono, 1996, Bukovsky et 
al., 1997, Bour and Strebel, 2000), Rev, Tat or Vpu seem not to be present in the 
viral particle (Figures 1.1 and 1.2). 
 
 
  
 ϰ
 
Figure 1.2 Schematic representation of immature and mature HIV-1 particle. The HIV-1 virion 
has roughly a spherical shape with defined external and internal regions. The immature particle 
consists of a different inner organization to the mature HIV-1 whereas Gag is arranged in a radial 
fashion with the N-terminal domain associated with the viral membrane and the C-terminus pointing 
towards the center of the particle. During the maturation process, proteolytic cleavage causes the 
formation of distinguishable compartments. The surface glycoprotein gp120 is exposed on the 
outskirts of the viral membrane and anchored via the gp41 transmembrane subunit in the lipid bilayer. 
Incorporated into the viral membrane are cellular membrane, obtained during the fusion process. On 
the inside is lined the matrix (MA) protein which protects the internal, characteristic cone shaped 
capsid (CA) structure. Within the CA core is packaged the single stranded RNA which is stabilized by 
nucleocapsid (NC). Simultaneously packaged is the viral enzymes protease (PR), reverse transcriptase 
(RT) and integrase (IN) as well as the accessory proteins Nef, Vpr, and Vif. The figure is adapted 
from PDB structural biology of HIV-1, obtained from the Swiss Institute of Bioinformatics 2015 
(http://viralzone.expasy.org). 
 
 
1.1.2 Gag gene coded proteins  
 
 The HIV-1 gag gene is initially synthesized as a 55 kDa precursor 
polyprotein containing matrix (MA, p17), capsid (CA, p24), nucleocapsid (NC, p7) 
and p6 structural proteins. In the immature virus the gag gene product provides the 
physical infrastructure whereas the polyprotein forms a concentric ring on the inner 
layer of the enveloped lipid membrane. The N-terminal region of the Gag is 
associated with the viral membrane while the C-terminal domain is pointing towards 
the center of the particle (Wilk et al., 2001, Fuller et al., 1997, Wright et al., 2007). 
During budding or short thereafter, the precursor polyprotein is cleaved by viral 
protease (PR) to obtain MA, CA, NC, p6 proteins and two spacer peptides, SP1 and 
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SP2. This proteolytic cleavage of the Gag polyprotein results in maturation and the 
rearrangement of virus internal structures to shape compartments with distinctive 
features that are required for infectious virion formation. For studying HIV 
structures, MA, CA and NC are a main focus for overall feature assessments which 
was also utilized in this study and consequently further referencing will emphasize 
on these structural proteins. MA, CA and NC are essential components in the 
assessment of imaging techniques aiming for structural characterizations on multiple 
levels. This includes imaging studies on early HIV entry, core internal arrangements 
during maturation and positioning investigations. 
  
1.1.3 Pol gene coded proteins 
 
 The pol gene encodes the viral enzymes of HIV-1 and during its cleavage 
viral protease (PR, p10), reverse transcriptase (RT, p51), RNase H (p15) and 
integrase (IN, p31) emerge. The C-terminus of the Gag and the N-terminus of the Pol 
are encoded by overlapping sequences. While gag contains an initiation and 
termination site, pol lacks an initiation sequence and is therefore synthesized as a 
GagPol fusion protein. This is mediated by an infrequent frame shift caused by a 
heptanucleotide slippery sequence followed by a short stem loop within the RNA 
genome (Jacks et al., 1988, Staple and Butcher, 2003). This ribosomal-derived shift 
occurs approximately 5% of the time to the pol reading frame and accounts for the 
Gag to GagPol ratio of about 20:1 (Jacks et al., 1988, Welker et al., 1996, Wilk et al., 
2001). This strict ratio of Gag to GagPol is essential for viral assembly and 
successful replication (Hung et al., 1998, Karacostas et al., 1993, Shehu-Xhilaga et 
al., 2001a). The pol genes encode for reverse transcription relevant proteins and 
 ϲ
enzymes that are important to study the process of reverse transcription. The frame 
shift in the pol gene can be utilized as a genetic characteristic important for HIV-1 
labelling assessments. 
 
1.1.4 Env gene coded proteins 
 
 The env gene encodes the envelope (Env) polyprotein (gp160) of HIV and is 
first synthesized in the endoplasmic reticulum. In order for successful infectivity the 
essential glycosylation commences during migration through the Golgi complex. The 
gp160 is subsequently cleaved to generate two subunits, the surface glycoprotein 
(SU, gp120) which is responsible for the engagement to the cellular CD4 receptor 
and the transmembrane glycoprotein (TM, gp41) that mediates fusion between the 
viral and cellular membranes (Willey et al., 1988). After cleavage of the gp160 
polyprotein, the subunits remain non-covalently associated to form the mature 
envelope glycoprotein complex (Veronese et al., 1985). The aforementioned Env 
distribution at a specific location on the viral membrane during maturation might be 
an important precursor for successful infection of HIV (Chojnacki et al., 2012). 
Imaging the positioning of the Env protein and studying its influence on internal 
compartments during HIV maturation might broaden our understanding of ‘outside-
in’ signaling cascades, as seen in other viruses (Meckes and Wills, 2008) which will 
be examined later. 
 
 
 
 
 ϳ
1.1.5 Regulatory and accessory gene coded proteins 
 
In addition to the three major polyproteins, HIV also encodes six accessory 
proteins; three regulatory proteins, trans-activator of transcription (Tat), regulator of 
virion expression (Rev) and negative factor Nef and three auxiliary proteins, viral 
infectivity factor (Vif), viral protein R (Vpr) and viral protein U (Vpu). Since some 
of the accessory proteins are important for aspects examined in this thesis, they are 
therefore introduced here. The Tat regulatory protein with its RNA binding 
properties has a role in replication by enhancing the efficiency of viral transcription 
(Vaishnav and Wong-Staal, 1991, Mujeeb et al., 1994) and is an important element 
which can assist with the assessment of infectivity (luciferase reporter assay 
recognizes Tat presence), important for Chapters 3 and 5. Rev is a transactivating 
protein that is essential for HIV protein expression regulation. It localizes to the 
nucleus where it is involved in the export of unspliced or incompletely spliced 
mRNAs (Bai et al., 2014). If the Rev of HIV is non-functional, it can assist with 
generating hybrids of fluorescently labelled and unlabelled particles that can be 
important for HIV infectivity rescue which is used in Chapter 5. Accessory protein 
Vpr plays an important role in nuclear import of the HIV pre-integration complex 
and is required for viral replication in non-dividing cells (Bukrinsky and Adzhubei, 
1999). It is extensively used in fluorescence microscopy as HIV particle internal 
fluorescently labelled protein that enables the tracking of viral virions or as reference 
for multiple fluorescence (used as mCherry-Vpr reference for cell infections and HIV 
particle localization). Nef and Vpu are important modulators in the regulation 
mechanisms of HIV to gain access to the cellular machinery. The expression of Nef 
early in the HIV replication cycle ensures T-cell activation and the establishment of a 
 ϴ
persistent state of infection (Abraham and Fackler, 2012). Vpu is involved in the 
degradation of the receptor molecule CD4 and the enhancement of the release of 
newly formed virions from the cell surface (Ruiz et al., 2010). 
 
1.2    HIV-1 replication cycle 
 
The HIV-1 replication cycle is generally divided into two major events, the 
early stages and the late stages which will be described in detail later in this section. 
Briefly, early stages of infection include engagement of the virus with the cell, 
fusion, reverse transcription and capsid core release and finally viral genome 
integration. Late replication stages comprise of virus protein transcription, 
translation, expression, particle production, budding and maturation.  
 
The initial contact of the virus with the host cell is mediated by the binding of 
viral Env to the cellular CD4 receptor which undergoes conformational changes to 
facilitate chemokine co-receptor binding, either to CCR5 or CXCR4. This results in 
the fusion of the viral membrane with the cell membrane and the internalization of 
the capsid core into the cellular cytoplasm. In order to deliver the viral genome to the 
nucleus, the encapsulated viral RNA (vRNA) is reverse transcribed into 
complementary DNA (cDNA) in preparation for integration. During that time the 
disassembly of the viral core (uncoating) occurs to release the proviral cDNA. Once 
integrated into the host cell genome within the nucleus, HIV-1 uses the cellular 
machinery to produce viral proteins. At the plasma membrane, the assembled viral 
proteins and the RNA bud as immature particles, and they are then released into the 
 ϵ
cellular surrounding for maturation before subsequent re-infection via cell-to-cell 
transmission (Figure 1.3) (Coffin, 1996).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 The HIV-1 replication cycle. Mature HIV-1 particles bind to the CD4 receptor on the 
cellular surface. This engagement causes conformational changes in the virion envelope protein which 
enables the attachment to either the CCR5 or CXCR4 co-receptor. Followed is this by the fusion 
process between the viral and cellular membranes, leading to the release of the capsid core into the 
cytosol for subsequent events. The entered core undergoes uncoating and reverse transcription (RT) 
processes with the RT complex formation that mediates the conversion of single stranded viral RNA 
into double stranded complementary DNA (cDNA) with the assistance of reverse transcriptase. The 
transcribed cDNA is transported into the nucleus where the viral genome is integrated into the 
genomic DNA of the cell to form the provirus. In order to transcribe the integrated provirus and 
translating into viral proteins, HIV-1 utilizes the cellular machinery. In the latent state of the virus the 
provirus remains transcriptionally silent within reservoirs but is capable of producing infectious virus 
when reactivated. Viral proteins and RNA that are transcribed, translocate to the plasma membrane 
where they are assembled into an immature virion. The release of the particles from the plasma 
membrane initiate the proteolytic cleavage by the viral protease enzyme and form mature particles, 
able to re-infect cells. The Figure is adapted from HIV-1 life cycle lecture by Dr Eric M. Verdin at 
Gladstone Institute of Virology and Immunology, University of California, San Francisco 
(http://slideplayer.com/slide/8964929/). 
 
 
 
 
 
 ϭϬ
1.2.1 Early entry and fusion 
 
The very initial contact between the virus and the host cell is achieved via 
unspecific or with minimized affinity related adhesion and fulfils the purpose of 
directed guidance to the binding target, CD4 receptor. Such attachment might occur 
with the direct interaction between HIV Env and negatively charged heparin sulfate 
proteoglycans (Saphire et al., 2001), α4β7 integrin (Arthos et al., 2008, Cicala et al., 
2009) or dendritic cell type-specific non-integrin (Geijtenbeek et al., 2000). These 
factors seem to escort the virus in close proximity to the CD4 receptor and co-
receptor and therefore assist with an increasing efficiency of infection success 
(Orloff et al., 1991). While these attachment factors are non-essential, the CD4 
receptor engagement and its specificity is crucial for the replication cycle. To 
enhance successful association with the cellular receptor, a model suggests that the 
Env trimers on the surface of the HIV-1 particle locate in close proximity (Chojnacki 
et al., 2012). This phenomenon is contrary to the assumption that viruses are static 
structures and only remodel after entering the target cell. With the binding of the 
viral Env to the receptor, it is believed that not only the gp120-gp41 Env per se but 
also the CD4 receptor undergoes conformational changes to induce subsequent 
fusion with the cell membrane (Blumenthal et al., 2012). This might trigger a 
signaling cascade to prepare internal compartments for subsequent steps in infection.   
 
Binding to the chemokine co-receptor (either CCR5 or CXCR4) exposes the 
fusion peptide that is inserted into the target cell plasma membrane (Moore and 
Doms, 2003). Consequently, this causes the conglomeration of the viral and cell 
membranes which leads to the opening of the lipid layer (Figure 1.4) and the 
 ϭϭ
formation of a fusion pore thereafter. Within this cavity the exposed capsid core is 
then released into the cytoplasm to facilitate further infection phases. 
 
 
Figure 1.4 A model for HIV-1 entry. Env is trimeric protein consisting of the gp120 subunit that 
interacts with cellular receptors on the cell membrane surface and the gp41 transmembrane protein 
which anchors the gp120 to the viral membrane (first panel). The interaction between Env and the 
CD4 receptor on the cell membrane induces conformational changes in gp120 (second panel) which 
results in the exposure and the participation of a conserved region in CCR5 or CXCR4 co-receptor 
binding (third panel). This complex formation results in the formation of a six-helix prebundle 
whereas the gp41 folds back, bringing the fusion peptides and the gp41 transmembrane domain in 
close proximity. It is likely that several Env trimers concentrated in one region are necessary to 
activate conformational changes and for the fusion pore (here are only two trimers are depicted). The 
figure is adapted from Moore and Doms, 2003.  
 
1.2.2 Entry via endocytosis 
 
Besides the CD4 receptor- and co-receptor-mediated entry of HIV-1 and 
other enveloped viruses, an alternative pathway is possible for viral internalization. 
Several types of endocytosis have been demonstrated, including the dynamin-
dependent, clathrin- (Sorkin, 2004) and caveolae-mediated (Lajoie and Nabi, 2010) 
endocytosis. In the case of HIV-1, the virus can productively enter via acidic 
endosomes by cell membrane fusion (Daecke et al., 2005, Marsh and Helenius, 2006, 
Miyauchi et al., 2009). Hereby, the large molecule clathrin forms a coated pit on the 
inner surface of the plasma membrane. These pits bud into the cell and create coated 
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vesicles, assisted by dynamin in the lipid raft and other cytoplasmic proteins. In the 
process components attached to the outside of the cell, such as HIV-1 virions, are 
engulfed.  
 
1.2.3 Virus disassembly, reverse transcription and integration 
         
This part of the HIV-1 replication cycle contains widely debated phases as it 
also involves simultaneously executed multiple processes that seem to be 
interdependent. It is widely agreed that the capsid core disassembly or uncoating 
occurs after fusion-dependent entry and before nuclear import and that the reverse 
transcription coincides with this process. Defined is the uncoating as the progressive 
partial or complete disassembly of the CA layers, probably immediately after its 
penetration to ensure release of the viral genome as well as associated proteins into 
the cytoplasm. However, the precise location and timing for this event remains 
unclear. A recent study hypothesized that the uncoating is a multi-phasic event 
allowing reverse transcription completion with cellular factors (Xu et al., 2013). This 
suggests that various viral and cellular factors are required for the uncoating and 
reverse transcription in a stepwise manner to ensure adequate selection of 
prerequisites for successful replication progression. This is supported by another 
recent investigation that indicated a rapid single core loss short after fusion, 
assigning for partial disassembly early on (Francis et al., 2016). However, another 
portion of cores remains intact for a long period, probably almost completely 
disassembling closer to the nuclear membrane. Core stability and reverse 
transcription initiation seem to be interdependent with this process. With the 
aforementioned initial disassembly, intermediate states might ensure the transfer of 
 ϭϯ
only selected packaged cellular factors into the core to accommodate precursor 
reverse transcription-related reactions by appropriate protection of the intra-viral 
genome. Whether the CD4 engagement already primes the core for subsequent 
uncoating steps or initiates reverse transcription at this early point to ensure rapid, 
partial core dismantling, once injected, is unclear.   
 
In this time frame, the reverse transcription has to commence, in order to 
facilitate the generation of integration products. Thus, the single-stranded positive 
HIV-1 RNA converts to double-stranded DNA (Telesnitsky and Goff, 1997, Basu et 
al., 2008) during this process. Despite the fact that the virions may contain all 
essential viral proteins and some packaged, necessary cellular factors, only restricted 
DNA synthesis seems to occur prior to infection (Lori et al., 1992, Trono, 1992). The 
completion of reverse transcription seems to occur well after the core release and is 
believed to take place in close proximity to the nucleus. In turn, the initiation of this 
event is thought to be triggered by the exposure of the incoming viral genome 
complex to deoxyribonucleotides (dNTP) in the cytoplasm. Incubation of intact 
virions or viral cores with dNTPs can induce reverse transcription, even without the 
use of mild detergents which is termed as natural endogenous reverse transcription 
(NERT) (Zhang et al., 1996, Zhang et al., 1998, Warrilow et al., 2007). Those 
reactions have indicated a substantial alteration in the core morphology (Zhang et al., 
2000) which suggests a reverse transcription-related interdependency to the 
uncoating process. Such response indicates that it could be part of intermediate states 
of the uncoating process whereas its initiation might occur at a very early point in 
infection. Proposed was that the reverse transcription initiation might destabilize the 
HIV-1 core (Francis et al., 2016) as one of the possible intermediate states before 
 ϭϰ
disassembly. Since the disassembly occurs rapidly, once the CA core has entered the 
cellular cytoplasm, the reverse transcription initiation might have happened earlier 
and caused prior destabilization of the core. However, there are hints that additional 
post-entry or cellular factors are required for subsequent stages in the reverse 
transcription process (Hooker and Harrich, 2003, Warrilow et al., 2008). Associated 
with the CA is the genomic viral RNA as well as viral RT, IN, MA, NC and Vpr 
proteins, depicting a complex (Bukrinsky et al., 1993, Heinzinger et al., 1994, 
Karageorgos et al., 1993, Nermut and Fassati, 2003). This complex has been shown 
to be associated with the cellular actin cytoskeleton (Bukrinskaya et al., 1998) and 
microtubule network (McDonald et al., 2002) and it is believed that they utilize the 
dynein-dynactin motors to move along microtubules. Consequently, this might assist 
with the delivery of the viral genome to the nucleus. 
 
In order to convert RNA into DNA, the reverse transcription is initiated by a 
tRNA primer which attaches to the HIV genome (Huang et al., 1998, Remy et al., 
1998, Cen et al., 1999, Cen et al., 2000). These tRNAs are selectively packaged via 
the interaction with the viral NC protein during assembly to allow specific primer 
association with HIV-1 RNA (De Rocquigny et al., 1992, Jiang et al., 1993). The 
reverse transcriptase enzyme catalyzes the RNA synthesis which results in a minus 
strand strong stop (-sssDNA) (Darlix et al., 1993, Darlix et al., 1995, Allain et al., 
1994, Guo et al., 1997, Beltz et al., 2003). In a multi-step process, including the 
conversion of –sssDNA to +sssDNA and subsequent formation of cDNA, the viral 
genome is integrated into the host genome. For this event to occur, it is believed that 
the viral Vpr protein assists with the passage through the nuclear pores (Heinzinger 
et al., 1994, Popov et al., 1998, Vodicka et al., 1998). However, a recent study 
 ϭϱ
suggests that the Vpr rapidly dissociates from the CA after fusion and quickly directs 
to the nucleus, probably rather suggesting to assist with antagonizing innate 
immunity responses than nuclear transport (Desai et al., 2015). Within the nucleus, 
the viral cDNA is integrated into mainly transcriptionally active areas of the host 
genome to form the provirus (Schröder et al., 2002, Mitchell et al., 2003, Lewinski et 
al., 2005). Here, HIV-1 is dependent on the cellular machinery to produce full length 
and spliced viral RNA transcripts (Coffin et al., 1997).   
 
1.2.4 Virus assembly, budding and maturation 
 
Virion morphogenesis consists of three phases leading to the production of 
infectious particles that ensure the comprehensive packaging of all necessary 
components. The first phase is the assembly where all essential viral and some 
cellular factors are packaged and the particles are constructed. Followed is this by the 
second stage of budding, containing the fusion with the cellular plasma membrane 
and the incorporation of lipid proteins into layers. The final state includes the 
structural rearrangements and the production of mature viral particles (Sundquist and 
Krausslich, 2012).  
 
The HIV assembly and budding occurs at specific microdomains in the 
plasma membrane, termed as lipid rafts (Nguyen and Hildreth, 2000, Holm et al., 
2003). The Gag and GagPol precursor proteins are targeted to the plasma membrane, 
bind and multimerizing to form complexes, visible in EM as dense lining on the 
inner side of the host cell plasma membrane (Gelderblom et al., 1988, Gelderblom, 
1991). These complexes are responsible for simultaneously mediated protein-protein 
 ϭϲ
interactions, Env concentration and genome RNA packaging. The Gag polyprotein 
multimerization requires the C-terminal domain of CA, including the spacer peptide 
SP1 (Reicin et al., 1995, Kräusslich et al., 1995, Gamble et al., 1997, Ganser et al., 
1999, Morikawa et al., 1999, Lanman et al., 2003, Ganser-Pornillos et al., 2004) and 
the NC domain. The CA domain is believed to promote Gag to Gag interactions 
whereas this is stabilized by the NC domain associated to the RNA (Campbell and 
VM., 1995, Campbell and Rein, 1999, Cimarelli et al., 2000, Muriaux et al., 2001). 
The incorporation of Env glycoproteins is mediated by these polyproteins which are 
delivered by vesicular transport from the endoplasmic reticulum (ER). The direct 
interaction between the MA and the cytoplasmic tail of gp41 mediates the 
incorporation of the trimeric complexes (Yu et al., 1992, Dorfman et al., 1994, Freed 
and Martin, 1996, Murakami and Freed, 2000). During the assembly process, 
accessory proteins are also integrated, such as the viral Vpr protein that is bound to 
the p6 domain of the Gag polyprotein (Lu et al., 1995, Kondo and Göttlinger, 1996, 
Selig et al., 1999). Besides the Vpr, p6 domain also contains binding domains for the 
short sequence motifs that associate with TSG101 and ALIX of the cellular 
endosomal sorting complexes for ribosomal transport machinery (ESCRT) pathway 
which mediates the release of the viral particles (Sundquist and Krausslich, 2012). 
Not only viral proteins but numerous cellular proteins are recruited and packaged 
into the assembling virion. Cell surface proteins and other cellular proteins have been 
found actively packaged through viral protein or nucleic acid interactions into virion 
membranes (Cantin et al., 2005, Chertova et al., 2006, Ott, 2008). Gag 
multimerization increases exponentially until a plateau is reached. Upon 
multimerization termination, the budding process is mediated which results in the 
release of immature virions. These formed HIV particles are enclosed in the host 
 ϭϳ
cell-derived lipid bilayer. In order to facilitate this process, HIV uses the cellular 
ESCRT machinery that regulates vesicular budding into late-endosomal multi-
vesicular bodies (MLV) (Freed, 2002, Stuchell et al., 2004, Jones and Mak, 2005). 
 
The subsequent step is the maturation which includes the cleavage of the 
individual virus domains. During this process, fundamental structural and 
morphological rearrangements occur, resulting in the formation of the mature virion, 
containing a typically cone-shaped CA core (Sundquist and Krausslich, 2012, Freed, 
2015). An autoprocessing mechanism releases the RT from the GagPol polyprotein 
(Debouck et al., 1987, Louis et al., 1999). The proteolytic processing of the Gag and 
GagPol polyprotein occurs sequentially and controlled which leads to the production 
of fully processed MA, CA, NC, p6 as well as PR, RT and IN (Hill et al., 2005) 
(Figure 1.5).  
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Figure 1.5 HIV-1 budding and maturation. Cytosolic Gag monomers are initiated to produce 
multimers by amino-terminal myristylation inside the matrix (MA) subunit. Additional binding of 
viral RNA results in a myristate exposure and the predominantly plasma membrane-directed 
recruitment of the Gag-RNA complex. Further organization and multimerization of Gag and Gag-Pol 
polyproteins at the plasma membrane leads to the budding process. The interaction of the MA with 
Env mobilizes the Env polyproteins into the budding virions. During this process, ESCRT proteins 
interact with p6 and cellular factors TSG101 and ALIX which initiates the scission machinery that, in 
turn, removes the connection of the budding particle to the plasma membrane. Gag and Gag-Pol 
multimerization activates viral protease which cleaves Gag into and separates its subunits. During 
these structural rearrangements, distinctive compartments are created. The Figure is adapted from 
(Martin-Serrano and Neil, 2011). 
ǇƚŽƐŽůŝĐ'ĂŐŵŽŶŽŵĞƌ
ǇƚŽƐŽůŝĐ'ĂŐ
ŵƵůƚŝŵĞƌ
DǇƌŝƐƚĂƚĞ
ĞǆƉŽƐƵƌĞ
DĞŵďƌĂŶĞͲĂƐƐŽĐŝĂƚĞĚ
'ĂŐŵƵůƚŝŵĞƌŝǌĂƚŝŽŶ
Ŷǀ
ƵĚĚŝŶŐĂŶĚ
^ZdƌĞĐƌƵŝƚŵĞŶƚ
^ZdͲŵĞĚŝĂƚĞĚ
ŵĞďƌĂŶĞ ƐĐŝƐƐŝŽŶ
WƌŽƚĞĂƐĞĂĐƚŝǀĂƚŝŽŶ
ĂŶĚŵĂƚƵƌĂƚŝŽŶ
ZEďŝŶĚƐƚŽE
ZE
 ϭϵ
1.3 HIV’s hijacking strategies to gain access to cellular 
mechanisms 
 
During the HIV-1 replication cycle the virus has to navigate through the 
complexity of the host cell by constant counteracting the cellular defense system. 
HIV-1 developed multiple processes to assist with its mainly unrestricted movement 
within the cellular cytoplasm. Such events include the selectively packaging of 
cellular proteins during assembly and alteration of phosphorylation patterns of 
cellular proteins to modify their functions.  
 
1.3.1 Cellular proteins involved in HIV replication 
 
Viruses not only rely on the cellular machinery but also are able to 
manipulate their proteins in its favor to facilitate successful replication. Similar to 
other viruses, HIV-1 encodes a limited number of proteins which is insufficient for 
the creation of newly formed particles. In the early days it was believed that the 
budding process excluded host proteins from the viral surface (Závada, 1982) but 
numerous studies revealed that some cellular proteins are enriched in the mature 
virus. Therefore, HIV selectively attaches or packages cellular factors that are 
important helpers. As HIV buds, it incorporates a variety of cellular proteins, either 
into the lipid bilayer or directly into the nascent virion. Some proteins appear to be 
incorporated into most HIV virions while others may be incorporated into selected 
virion populations or types. This variety suggests that some incorporations are 
essential for broadly used cellular proteins and others might be dependent on HIV 
variants or their specific interaction mechanisms with the host. Four comprehensive, 
 ϮϬ
independent screens identified numerous host factors that are important in different 
phases of the HIV replication cycle (Brass et al., 2008, Zhou et al., 2008, Konig et 
al., 2008, Yeung et al., 2009) as well as a meta-analysis further examining the 
combined results of three of these studies (Bushman et al., 2009).  
 
Brass et al. used a siRNA screen to identify cellular proteins associated with 
HIV in the early phases of infection. The initial screen included siRNAs covering 
approximately 20,000 genes which resulted in the identification of 273 that had 
significant impacts on HIV replication. In particular, late-acting host factors involved 
in viral assembly and egress were identified. Further analyses revealed previously 
unknown roles for several components of the nuclear pore, autophagy, retrograde 
vesicular transport and the mediator complex (involved in the activation of 
transcription) (Brass et al., 2008).   
 
Zhou et al. used also an siRNA screen covering all stages of HIV infection 
from viral entry to release and spread. This screen of approximately 20,000 genes 
revealed 311 that were associated with HIV (232 confirmed), including 267 that 
were not previously linked to the virus. Fifteen genes were among those that were 
also identified by the Brass group and of those overlapping genes, 7 were associated 
with roles in HIV replication, including the well-known CD4 and CXCR4. Further 
overlapping genes were the DEAD box RNA helicase 3 (DDX3X), potentially 
involved in HIV RNA export, while its knockdown impairs viral replication (Sharma 
and Bhattacharya, 2010) and nuclear factor NF-κB (RELA), involved in the 
mediation of HIV transcription (Rattner et al., 1993). In addition to the mediator 
complex components, identified by Brass et al., several other components were 
 Ϯϭ
identified, confirming the role of the mediator complex in HIV replication (Zhou et 
al., 2008).  
 
Konig et al. focused on early events in HIV replication by excluding the Env-
dependent entry, so that this study focused on phases between uncoating and protein 
synthesis. A genome-wide siRNA analysis with interrogation of human interactome 
databases identified 213 host cellular factors with 11 confirmed HIV encoded 
proteins. Important modulators of HIV early infection stages included protein 
complexes involved in ubiquitination, proteolysis, DNA damage response and RNA 
splicing. Fifteen proteins were found to have diverse functional roles, including 
nuclear transport, ubiquitination and transcription that influenced HIV nuclear import 
or viral DNA integration. This group also identified 40 new factors that were shown 
to act at initiation and/or kinetics of HIV DNA synthesis, including cytoskeletal 
regulatory proteins, cellular factors involved in post-translational modification and 
nucleic acid binding proteins (Konig et al., 2008). 
 
Yeung et al. used a RNAi-based screen of HIV host factors by targeting more 
than 54,000 Jurkat mRNA transcripts. This study identified 252 individual mRNA 
transcripts, whereas 22 were confirmed to contribute to HIV replication. Overlapping 
with the three studies presented above, were proteins that are involved in cellular 
signaling pathways and protein complexes, including NF-κB, protein kinase B 
(AKT) and Peroxisome proliferator-activated receptor γ (PPAR-γ) signaling 
(involved in glucose metabolism), and the nuclear pore complex. 
 
 ϮϮ
Not only HIV infection-based screens were performed but also studies to 
evaluate host proteins that are incorporated into the HIV virions were conducted. 
This investigation identified 79 clustered proteins that were shared between the 
different cell-derived HIV particles. These clusters included an extensive collection 
of actin isoforms, human leukocyte antigen (HLA) proteins, chaperones and some 
previously identified HIV replication-related cellular factors. Notable other proteins 
were proteins of the ERM family (ezrin, radixin, moesin), dynamin-associated 
proteins and cyclophilin A (Linde et al., 2013). By comparison with a study that was 
performed similar to this study, 26 proteins overlapped between them, with 16 
proteins that had been described to be associated with HIV beforehand and 10 
cellular factors with undefined linkages. The majority of these proteins were 
associated with the actin cytoskeleton, ERM proteins, cyclophilin A, heat shock 
proteins and membrane proteins (Chertova et al., 2006, Linde et al., 2013).   
 
Despite the fact that the screens were performed in similar manners and there 
were only slight differences in the cellular and viral systems, a relatively small 
number of identified proteins that are important for HIV replication overlapped. This 
suggests a broad variety of involved pathways and cellular factors that accumulate in 
a growing list of hijacked proteins by HIV. The strength of the RNAi-based screens 
lies in the ability to identify protein networks and macromolecular complexes that 
are involved in HIV infection. Based on the information gained from such protein 
network screenings, several conserved proteins of the endosomal sorting complexes 
required for transport (ESCRT) machinery were identified in numerous studies and 
therefore this pathway is one of the more well-documented examples.  
 
 Ϯϯ
1.3.2 ESCRT machinery is an important component in HIV replication 
 
The assembling HIV particle packages all the required components for 
successful re-infection with the enrichment of viral and cellular factors, particularly 
essential for rapid and early entry processes. Since HIV lacks the appropriate 
machinery to remodel the factors important for viral membrane integration and 
budding, HIV is dependent on the available cellular mechanism to release its newly 
formed, immature virions, which is provided by the ESCRT protein complex. Pre-
packaging of cellular proteins concomitantly occurs during the budding event with a 
strong involvement of the ESCRT machinery. Proteins that are associated with the 
ESCRT are repeatedly detected in screens that target to identify cellular factors 
within HIV-1 virions despite variations in the experimentation. Therefore, the pre-
requisite of ESCRT-mediated budding processes are the initiation for pre-entry 
events involving essential cellular proteins. 
  
A variety of studies showed that several proteins are involved in this process 
with the tumor susceptibility gene 101 (TSG101) and apoptosis-linked gene 2-
interacting (ALIX) proteins at the forefront. Hereby, the essential events to create the 
spherical particle are driven by the Gag polyprotein which mediates the plasma 
membrane binding, protein-protein interactions, concentration of viral Env protein 
and genome RNA packaging. However, the budding process itself that releases the 
virion is mediated by the host ESCRT machinery. In particular, the ESCRT pathway 
is responsible for the termination of the Gag polymerization and catalyzes release 
(Morita and Sundquist, 2004, Bieniasz, 2009, Carlton and Martin-Serrano, 2009, 
Usami et al., 2009, Hurley and Hanson, 2010, Peel et al., 2011). The HIV p6 
 Ϯϰ
domains bind onto a specific domain of the TSG101 subunit of the ESCRT 
(Pornillos et al., 2002, Im et al., 2010) and the ESCRT factor ALIX (Strack et al., 
2003, Usami et al., 2009). The amino-terminal ALIX domain is also associated to 
HIV NC, whereas this interaction seems to be essential for viral replication, since 
mutations in this domain resulted in budding defects (Popov et al., 2008, Popov et 
al., 2009, Dussupt et al., 2009). Essentially, TSG101/ESCRT-I and ALIX both 
function by recruiting downstream ESCRT-III which forms long filaments that coil 
around the site of membrane tightening, prior to cleavage (Adell and Teis, 2011, 
Jouvenet et al., 2011). These filamentous structures are also present in multivesicular 
body formation where they prevent cargo proteins from escaping into cellular 
cytoplasm (Adell and Teis, 2011). In this manner the ESCRT machinery mediates 
membrane fission and ESCRT factor recycling.  
 
1.3.3 Modification of cellular proteins by phosphorylation  
 
Based on the gained information in RNAi screens and individual studies, it is 
possible to identify mechanisms that can be further examined. Numerous cellular 
pathways are hijacked and proteins regulated to complete the HIV replication cycle 
and ensure successful cell-to-cell transmission. The manipulation of signaling 
pathways and therefore reprogramming the target cell seems to be actively promoted 
by HIV. However, little is known about the extent to which viruses reprogram target 
cells during entry and what consequences this might have on virus replication. Since 
cellular signaling is an attractive target for drug developments, the knowledge about 
virus-induced signaling rearrangement may assist with novel antiviral drug targets. 
Followed on from RNAi screens, one such reprogramming mechanism is the 
 Ϯϱ
phosphorylation-dependent manipulation of cellular proteins by HIV 
(Wojcechowskyj et al., 2013). Mass spectrometry (MS)-based phosphoproteomics 
technology revealed 239 phosphorylation sites from 175 genes that significantly 
changed in the abundance within a short time (1 min) of exposure to HIV, including 
several proteins that are knowingly impacted by HIV-receptor binding. Follow up 
detailed mechanistic experiments showed that one HIV-responsive phosphoprotein, 
Serine/Arginine repetitive matrix 2 (SRRM2 or SRm300), regulated HIV gene 
expression and splicing in multiple cell types, suggesting that HIV may reprogram 
the cellular splicing machinery to facilitate efficient replication. Such studies have 
the potential to reveal how the virus turns its target cells into optimal hosts and gives 
insights into ways to antagonize these manipulations.   
  
1.3.4 HIV modifies cellular cofilin by phosphorylation 
 
Similar to the ESCRT machinery-involved cellular proteins that are 
consistently detected in a variety of screens, cofilin is a relevant protein for HIV-1 
infection and appears repeatedly in numerous screens. Its association to the cellular 
cytoskeleton gives an example for the importance of HIV-1 gaining access to the 
interior actin network, potentially for capsid core movement and RNA delivery. 
Cofilin seems to be a key protein that is linked to cellular factors of similar 
cytoskeleton-mediated pathways and proteins, showing the importance of the actin 
network accessibility. 
 
HIV-responsive modification of cellular protein function by phosphorylation 
is inefficiently examined with only some studies on cellular phosphoproteins, 
 Ϯϲ
including cofilin (Yoder et al., 2008, Wu et al., 2008), protein kinase A (Barnitz et 
al., 2010) and tyrosine kinase that targets the NF-κB pathway (Feng et al., 2016). 
The proteins associated with the cytoskeleton are important targets of HIV whereas 
one example protein is cofilin, whereas its phosphorylation appears to be caused by 
the virus and seems to play an essential role during the entry steps of viral 
replication. Cofilin is a ubiquitous actin-binding factor required for reorganization of 
actin filaments. It is a member of the actin depolymerizing factor ADF/cofilin family 
that is involved in the prevention of actin reassembly. The activity of ADF/cofilin is 
regulated by phosphorylation and dephosphorylation whereas the phosphorylated 
form results in the inactivation of this protein. The function of cofilin is critical for T 
cell migration and activation. In unstimulated, resting CD4+ T cells, cofilin is 
deactivated by phosphorylation. During HIV-1 infection, the viral envelope-CXCR4-
derived signaling activates cofilin to counteract the actin restriction in resting cells, 
resulting in the enhancement of T cell activation and virus replication. Resting T 
cells from HIV infected patients showed significantly higher levels of active cofilin, 
suggesting that these resting cells could prime cofilin activity in vivo to facilitate 
HIV replication (Wu et al., 2008).  Inhibition of HIV-mediated actin rearrangement 
significantly decreased viral latent infection of resting T cells. HIV-mediated 
activation of cofilin may lead to abnormal T cell migration and activation that could 
contribute to viral pathogenesis (Yoder et al., 2008). 
 
An important aspect for HIV-1 therapeutics is the knowledge that the virus 
has the ability to remain in a latent state during antiretroviral therapy. This is a hurdle 
as the virus persists in long-lived cellular reservoirs, preventing virus eradication. 
Little is known about the establishment and maintenance of this latency but it is 
 Ϯϳ
believed that cellular factors and their regulation by HIV play a role. One possibility 
of such specialized mechanisms might be the HIV-responsive phosphorylation of 
cellular proteins. Our growing understanding assists with broadening our knowledge 
about involved pathways in HIV infection which, in turn, helps with the development 
and design of new therapeutic targets to successfully restrict HIV infection.  
 
1.4 Imaging HIV-1   
 
Analyses of the HIV structural features are extremely challenging due to the 
very small size of HIV at approximately 100 – 200 nm (Briggs et al., 2003) and often 
substantially smaller inner components of the particle. In order to tackle these 
obstacles, sophisticated imaging techniques were developed that contributed to a 
comprehensive insight into the structure and the viral interaction network during the 
past years. Two elementary techniques are on the forefront, the electron microscopy 
(EM) and fluorescence microscopy (FM) which consist of a broad spectrum of 
methods that enable imaging such ultramicroscopic infectious agents. Structural 
biological studies have revealed near-atomic views of numerous HIV features which 
will be further discussed in this chapter. This gradually broadens our understanding 
of the variety of HIV structures and their interactions. 
 
1.4.1 Conventional fluorescence microscopy   
 
A widely used and well established method is the conventional fluorescence 
microscopy which enables the visualization of proteins and their interactions. This 
technique mainly utilizes the incorporation of fluorescent proteins (FP) into the 
 Ϯϴ
genome or uses fluorescently conjugated antibodies, targeting specific proteins. The 
discovery and further developments of the green FP (GFP) has revolutionized cell 
biology (Presley et al., 1997, Lippincott-Schwartz et al., 2001, Miyawaki, 2003) and 
is one of the predominantly used methods to date. Since viruses are very small agents 
with a size ranging between 20 to 300 nm, tracking them within the cell is 
challenging. Therefore, the FPs became an important tool in viral investigations. 
Successful examples for such fluorescence studies are the visualization of HIV, 
rotavirus, herpes simplex virus (HSV) and rabies virus (RV) which resulted in 
valuable insights into sub-cellular localizations and tracking profiles in infected cells 
(Desai and Person, 1998, Charpilienne et al., 2001, McDonald et al., 2002, Finke et 
al., 2004). Originating from the GFP, other FPs with different fluorescent dyes were 
uncovered and are being used in broad applications ever since, such as the red 
fluorescent mCherry (Shaner et al., 2004), which assisted with the visualization of 
protein interactions within the viruses. Especially for HIV studies, the combination 
of internal fluorophores provides a powerful way for intraviral mechanisms and 
intercellular communications by imaging multicolored fluorescence. Utilizing dual 
labelled GFP-Vpr virions with mCherry associated to a sequence targeting the 
plasma membrane, gave valuable insight into the membrane fusion process 
(Campbell et al., 2007) which is an important event in understanding virus and host 
cell interactions. Based on these examples, imaging becomes more and more 
paramount for infection progression and success, not only limited to HIV but also 
adaptable to other viruses.  
 
Another method that is extensively used for mainly localizing tissue- and 
cell-internal proteins is the fluorophore-conjugated-antibody-labelling-based imaging 
 Ϯϵ
technique (Cummings et al., 2008). Valuable information can be acquired either by 
using the antibodies by themselves or in combination with FP incorporation to 
identify and monitor proteins. In the past years, intensive developments in the 
specificity of the antibodies and intensity of conjugated fluorescent dyes promoted 
these techniques to an equally used level like the FP labelling. This method has a 
broad application in numerous fields to assist with unveiling information, essential 
for diseases interpretation.  
 
Limitations of the conventional microscopy for predominantly the virology is 
the use of these large FPs or antibodies which exceed the sizes of a viral proteins. 
Additionally, these associations have consequences for the functionality of viral 
proteins, potentially accounting for the compromised infectivity. In this context, the 
development of smaller and more precise fluorescent dyes, either incorporated into 
the proteins directly via a recognizable motif or conjugated to antibodies can be used. 
Examples are fluorescent dyes that are specifically developed for higher resolution, 
such as the Alexa-Fluor series or FlAsH/ReAsH, that is examined in the next 
paragraph (Section 1.4.2). However, the resolution limit restricts their use as it 
ranges around 250 nm and a single fluorescent signal is often greater than most virus 
particles, such as HIV with 100 – 200 nm (Briggs et al., 2003). Therefore, the 
ultimate goal was and still is to improve the imaging approach to minimize the 
resolution to a very small nanometer scale range and adjust fluorophores to meet 
these criteria. This reduction in the resolution limit was achieved by super-resolution 
microscopy whereas ongoing efforts try to further decrease this limit. 
 
 
 ϯϬ
1.4.2  Super-resolution fluorescence microscopy   
 
To study events at nano-scale ranges, super-resolution techniques are 
attractive tools. There is a variety of super-resolution techniques available, including 
structured illumination microscopy (SIM) (Marno et al., 2015), stimulation emission 
depletion (STED) (Müller and Heilemann, 2013), stochastic optical reconstruction 
microscopy (STORM) (Rust et al., 2006, Trkola et al., 2013) (Figure 1.6) and 
photoactivatable localization microscopy (PALM) (Betzig et al., 2006, Manley et al., 
2008). However, because of the extensive spectrum of methods and the fact that this 
study utilized two methods from the list, the following paragraph will focus on 
STORM and PALM only. The principle of these techniques is single molecule-based 
where only a subset of fluorescent molecules of interest are activated and switching 
on. Therefore, the fluorophores are not activated at any time and appear in a dark and 
light state. Even the fluorescent molecules appear to have a larger size, the fact that 
they can be separated provides a determination of their centroids with nanometer-
level precision (Gelles et al., 1988, Yildiz et al., 2003), following a single molecule 
localization concept. Over numerous cycles the on and off states of the molecules in 
a stochastic manner contribute to a reconstruction of all localized points. STORM 
usually uses antibodies with a length of about 15 nm that are conjugated to pairs of 
cyanine dyes which act as reporter and activators to switch between the on and off 
states. The more recently developed technique of direct STORM (dSTORM) 
(Heilemann et al., 2008) enables the localization of individual dyes, such as Alexa-
Fluor, which cycles between dark and light states to obtain super-resolution images. 
PALM can use photoactivatable dyes attached to genetically expressed motifs to 
achieve the blinking mode. This method will be further described in a separate 
 ϯϭ
paragraph (Section 1.4.2.1). Despite the technical differences between the presented 
and other related techniques, they are able to localize the position of molecules of 
interest beyond the diffraction limit to approximately 20 nm. Thus, super-resolution 
microscopy has the potential to approach electron microscopy resolutions by 
utilizing fluorescence signals for protein locations.  
 
Figure 1.6 HIV-1 imaged via super-resolution microscopy. Distribution of HIV-1 Env at the 
plasma membrane of HeLa cells. (A) PALM image of Gag.mEosFP (green) and the corresponding 
dSTORM image of Env stained with AlexaFluor 647 (red). Scale bar corresponds to 1 μm. (B) 
Individual HIV-1 assembly sites from the boxed regions. Scale bars correspond to 100 nm. Images are 
adapted from (Trkola et al., 2013).  
 
1.4.2.1 Biarsenical tetracysteine labelling for PALM imaging   
 
Since conventional microscopy uses large FPs that interfere with the viral 
genetics, constant developments try to reduce the disruptions fluorophore conjugated 
attachments have on viral protein functionalities. Such approach is the biarsenical 
tetracysteine (TC) labelling method which was designed for live-cell imaging 
(Griffin et al., 1998). This technique attaches a six to twelve amino acid TC motif 
(Cys-Cys-Xxx-Xxx-Cys-Cys) into specific positions of genomes, usually on the 
carboxy-terminal or amino-terminal end of a viral protein. These TC motifs can be 
recognized by membrane-permeable biarsenical dyes, such as the green fluorescin 
 ϯϮ
arsenical hairpin binder-ethanedithiol (FlAsH-EDT2) or red fluorescent arsenical 
hairpin binder-ethanedithiol (ReAsH-EDT2) (Adams et al., 2002, Martin et al., 
2005). Compared to the commonly used GFP with a size of 25 kDa, these small TC 
tags only have a size range of 0.5 – 1 kDa. Additionally, for studying viral properties 
or behaviour, it is fundamental to attain a less likely interference with viral 
structures, infectivity or interplay between the virus and cellular factors. In this 
manner, viruses can be visually monitored in their natural environment which is 
achieved for a variety of HIV proteins. Here, the TC tag has been successfully 
inserted at the 3’ end in numerous HIV genes, such as matrix (Gousset et al., 2008, 
Turville et al., 2008), integrase (Arhel et al., 2006), nucleocapsid (Pereira et al., 
2011) and vesicular stomatitis virus (VSV) MA (Das et al., 2009, Mire et al., 2009) 
by maintaining viral infectivity. This system simplifies studies on structural HIV 
features, including particle-related investigations via the MA protein labelling as 
well as investigations on internal NC. The CA core is a distinctive feature within the 
particle which delineates from the entire particle and inner core compartments. 
Therefore, CA labelling of infectious HIV particles would assist with localizations 
and positioning studies of core internal components to broaden our understanding of 
interactions within or between the inside and outside of the core. However, it was 
demonstrated that the CA lattice arrangement seems to pose a barrier for such 
labelling (Pereira et al., 2011). Thus, we are reliant on TC labelled fluorescent 
imaging by using available labelled components for HIV internal structural studies, 
but lacking the core distinction.     
 
 
 
 ϯϯ
1.4.2.2 Imaging internal viral features using super-resolution 
microscopy   
 
While HIV external structures, such as Env and the outer viral membrane, are 
easier to image, inner virion features are more difficult to visualize. One of the most 
noticeable structures in the virion which was defined via EM studies and biochemical 
analyses, is the cone shaped CA core with a consistent length of 100 – 200 nm and 
width of approximately 50 – 60 nm (Höglund et al., 1992, Welker et al., 2000, 
Briggs et al., 2003, Benjamin et al., 2005). CA is a difficult object to explore because 
of its asymmetry and unstable nature. However, a combination of imaging and 
biochemical analyses revealed that CA assembles into a highly organized cone with a 
hexagonal lattice structure and that it is curved at either end by pentameric caps 
(Ganser et al., 1999). With the knowledge about the CA structure and its position 
within the HIV particle, core-internal explorations via super-resolution microscopy 
are possible but appropriate labelling is difficult or does not depict the in vivo state of 
HIV. Several approaches have been developed to visualize such individual subviral 
structures, including the incorporation of fluorescent proteins into the HIV genome 
which compromises infectivity (Panchal et al., 2003, Muller et al., 2004, Lanman et 
al., 2008, Das et al., 2009). To overcome this limitation, virus variants were 
generated that carried incorporated stainable tags fused to structural viral proteins 
(Griffin et al., 1998). This strategy was well suited for live-cell imaging and enabled 
the visualization of HIV inner features, such as HIV matrix (MA) (Gousset et al., 
2008, Turville et al., 2008), HIV integrase (IN) (Arhel et al., 2006) and vesicular 
stomatitis virus (VSV) MA (Das et al., 2009, Mire et al., 2009) without largely 
affecting viral infectivity. However, this tagging sometimes also compromises the 
 ϯϰ
biological properties of the virus which can be partially rescued by the production of 
particles with a mixture of tagged and untagged proteins from separate genomes, 
necessary for HIV NC (Pereira et al., 2011). A variety of HIV proteins could be 
labelled and studied in this manner but it failed to produce functional, fluorescently 
labelled CA proteins that were integrated into the core. However, the CA core is an 
attractive key feature due to its involvement in numerous, multi-leveled interactions 
but genome-internal tagging with functional CA was never achieved on infectious 
particles (Pereira et al., 2011). Since the ultimate goal is the structural analyses by 
uncompromised protein functionality and therefore maintenance of infectivity, the 
ordered lattice structure represents a barrier to successfully incorporate tagged 
labelling.    
 
The techniques to investigate very small sized HIV components are available 
and constant improvements allow the near-atomic imaging. The methods reach a 
point where precise sizes, localizations and positions of such small elements can be 
visualized. Previously, these documentations were reliant on EM which shows those 
core-internal complexes as dense compartments. Since there is a variety of 
components within the HIV particle, discerning these specific elements, has been 
difficult. Therefore, characteristics of those components were the only indication for 
identification, such as the susceptibility to radiation in EM. In fact, a study postulated 
that the NC-vRNA complex seems to be located in a specific region within the CA 
compartment which was detected via a technique that utilizes the susceptibility of 
NC to radiation damage in EM (Fontana et al., 2015). Since the NC is associated 
with the vRNA, it is impossible to determine the exact component that is responsible 
for this radiation damage in the bubblegram. Protein-specific or sequence-specific 
 ϯϱ
labelling would assist with the distinction and positioning of core-inner 
compartments, such as NC (TC labelling attached to NC protein) and vRNA 
(sequence-specific probe labelling associated with vRNA). 
 
1.4.2.3 Imaging external viral features using super-resolution 
microscopy   
 
Imaging assisted with the identification of numerous structural properties. 
Important studies include the differences in the immature and mature compartment 
arrangements via EM (Briggs et al., 2003, Schur et al., 2015). These studies revealed 
specific properties of the HIV virion from time of assembly through to the 
maturation process before developing distinguishable structures (Figure 1.2). An 
important example to visualize such features was the clarification of the Env trimer 
structure via EM in combination with crystallography (Lyumkis et al., 2013, Julien et 
al., 2013), which enlightened the field about potential ways of interactions between 
the virus and the target cell for adequate attachment and drug targets. Hereby, the 
additional knowledge, that was gained about the amount of HIV Env structures on 
the viral membrane surface, as being approximately 7 – 14 glycoproteins showed the 
limitation of CD4 binding of HIV Env to the host cell. This opens the possibility for 
CD4 mimicking drugs to block Env attachment with low concentrations of such 
mimicking compounds. Based on EM studies and the knowledge of the spike-like 
structure on the viral surface, super-resolution microscopy studies showed the 
clustering of Env on the mature virion (Chojnacki et al., 2012). Recognizing this 
directed clustering was possible through the development of sophisticated labelling 
and high resolution microscopy. This demonstrates that the field is slowly 
 ϯϲ
understanding the extend of structural characteristics and their biological relevance 
which, in turn, creates the basis for possibilities to design specific antagonistic 
interactions with these features. The extension of the knowledge that these few Env 
clustering potentially prepare HIV for CD4 receptor engagement and might have 
consequences for subsequent replication steps shows the importance of such 
investigations. Similar to that is the  ‘outside-in’ signal that was seen in herpes 
simplex virus where cellular receptor engagement led to the release of viral tegument 
proteins form the capsid complex (Meckes and Wills, 2008). Therefore, this would 
broaden our understanding of ‘outside-in’ signaling mechanisms of HIV, whereas 
dual fluorescence super-resolution microscopy is an attractive tool for these studies.  
 
1.4.3 Electron microscopic imaging  
 
Fluorescence imaging is limited in its application and cannot visualize 
ultrastructures, such as HIV internal compartments. Although super-resolution 
microscopy is able to distinguish shapes, like the ellipsoid structure of the CA core, 
the exact cone-shape is disguised by the fluorescent corona. In order to accurately 
study the shape and size of HIV inner features, it is often advantageous to combine 
the FM with the EM. A further advantage of the EM technique is the visualization of 
such ultrastructures to sizes that range in the picometers. EM is reliant on high and 
low density differences, enabling the detection of structural variations in 
compartments. EM studies are very valuable for HIV structure discoveries, 
development stages of the virus and broadening of our understanding for cell-to-cell 
transmissions. A very important aspect is the structural arrangement of virions 
whereas EM imaging enables insights into deep and difficult to access 
 ϯϳ
compartments. Through the years, the EM technique was continually developed 
which resulted in numerous methods, including negative staining EM, cryo-EM, 
cryo-electron tomography and the specific type of EM, scanning EM (SEM). The 
reflected selection of available EM methods was utilized in this study and therefore, 
the following paragraph will focus on these techniques only.  
 
The negative staining EM is a method to obtain phase contrast images by 
using heavy metal salts, as their ions interact with the electron beam. This is 
followed by a staining step and a subsequent drying process which leads to the loss 
of the hydration shell around the specimen. Consequently, this can lead to the loss of 
the specimen’s natural shape which limits its application. Nonetheless, HIV particle 
studies benefit from negative staining EM by the less elaborate structural analyses 
which enable the easy and rapid data collection. Due to higher amounts of electron 
absorption through the stain compared to the surrounding medium, those detectable 
density differences are responsible for the appearance of structures (Ohi et al., 2004, 
Harris et al., 2006). This technique with its relatively easy preparation of specimen, 
enables the study of HIV-internal component shapes, such as the CA core feature. 
Since it is one of the biggest compartments within the HIV particle and appears to 
have a distinctive cone-shape and a strong density (Gelderblom et al., 1988, Welker 
et al., 2000, Briggs et al., 2003), the detection and identification of the core by 
negative staining EM is fairly easy.   
 
Cryo-EM and tomography are EM techniques that use similar methods 
whereas the tomography additionally provides three dimensional (3D) views of the 
specimen. As its name implies, the cryo-EM technique uses cryogenic temperatures 
 ϯϴ
to preserve the sample, it also does not use any staining and therefore shows the 
specimen in their native environment. In contrast to the negative staining, the 2D 
images of cryo-EM enable native analyses of the unaltered shapes of the specimen. 
Besides the advantage of preserving the shape of the specimen, such as the spherical 
structure of HIV, it also allows the relatively rapid analyses of numerous particles in 
a short time, compared to the tomography. Due to the 2D imaging in the cryo-EM, an 
extended view of the spherical feature of the HIV virion cannot be assigned and 
relies on the elaborate tomography. However, for analyses of HIV particles or some 
external and internal features, the cryo-EM examination is extensively used (Fuller et 
al., 1997, Nermut et al., 1998, Briggs et al., 2004, Briggs et al., 2006a).      
 
Cryogenic electron tomograms (cryo-ET) utilize the same preparation 
technique like the cryo-EM but the imaging adds a rotation of the specimen holder to 
ensure a different angled view by tilting around an axis. Resulting consecutive 2D 
images can be combined to produce 3D reconstructions. The 3D imaging of the cryo-
ET serves to bridge the information gap between atomic structures and EM 
reconstructions that can reveal the cellular or viral architectures (Baumeister et al., 
1999, Luciü et al., 2005, Subramaniam, 2005). In the case of HIV, a reconstructed 
tomogram demonstrated the spherical structure of the particle with its Env spikes and 
the position of the CA core within (Zhu et al., 2003, Liu et al., 2010). It also was 
possible to use this technique to study the architecture of the virus-cell contact region 
from chemically fixed specimen (Sougrat et al., 2007). The cryo-ET established as 
one of the well-used techniques to investigate external, internal as well as 
maturation-related structures in HIV. Research groups discovered the distinct 
features that the immature and mature structure of HIV distinguishes (Figure 1.7) 
 ϯϵ
(Benjamin et al., 2005, Briggs et al., 2006b, Wright et al., 2007, Briggs et al., 2009) 
which was an advantage for further studies of structures and interaction profiles. 
Cryo-ET examinations of mature HIV virions demonstrated that the conical cores 
were unique in structure and position but also demonstrated similarities in size and 
shape, the distance of the base of the cone to the MA layer and the range of the cone 
angle (Benjamin et al., 2005, Briggs et al., 2006b). The fact that the CA core of HIV 
has the distinct cone-shaped dense structure, accurate size measurements and shape 
analyses are possible with the 3D reconstruction.   
 
 
Figure 1.7 Cry-electron microscope images and representation of immature and mature HIV-1 
virions. Cryo-electron micrographs of an immature particle with radial Gag layers (A) and a mature 
virions, showing distinctive compartments (B) appearing during maturation. Schematic representation 
of the structures obtained from the EM analyses for immature HIV-1 (C) and mature virions (D). The 
figures are adapted from (Balasubramaniam and Freed, 2011). 
 
 
SEM is a specific method of EM that provides information about the surface 
topography and composition of the specimen. Produced images are obtained by 
scanning the sample with a focused beam of electrons whereas the electrons 
interacting with the atoms in the specimen surface. This technique gave insights into 
 ϰϬ
cell-to-cell transmission mechanisms of HIV which broadened our knowledge about 
early entry and re-infection (Nikolic et al., 2011). SEM can be used to study surface 
texture of HIV components which can reveal information about any surface 
modifications on these compartments.  
 
1.5 Rationale and objectives  
 
The early entry stages in HIV-1 infection from CD4 engagement to 
internalization of the CA core into the cellular cytoplasm are well characterized 
(Wilen et al., 2012). Nonetheless, there are unknown events in the very early onset of 
HIV entry that have not been investigated so far. This is mainly due to the wide 
assumption that viruses are static, ultramicroscopic infectious agents that only can 
remodel after entering the target cell. A clearer and comprehensive understanding of 
the role of viral alterations and the involvement of cellular factors during the first 
contact with the host has the potential to answer questions in basic HIV biology, 
reveal details of virus-host relationships and identify new targets for antiviral 
therapies. The overall intension of this thesis is to examine the impact of early entry 
phases on the HIV particle. 
 
Although the HIV field agrees that the virus is pleomorphic in size, it is 
believed that the HIV particle rearranges only after the fusion with the cellular 
membrane. Chapter 3 uses cryo-EM, cryo-ET and dSTORM analyses to explore 
whether HIV does have a static structure at CD4 engagement or whether it is capable 
of alterations to prime for subsequent entry steps. 
 
 ϰϭ
It is known that HIV co-packages cellular proteins into the virion during 
assembly (Segura et al., 2008, Raghavendra et al., 2010, Linde et al., 2013). 
However, it is unclear for what reason HIV incorporates some of these factors and 
what role they have during early infection. This is examined at CD4-mediated entry 
of HIV, using a CD4 mimic on cell-free virus, in Chapter 4. Hereby, a 
phosphoproteomics screen was utilized to investigate alterations on co-packaged 
cellular proteins during CD4 engagement and examine whether HIV is capable of 
undergoing such altering phosphorylation processes prior to entry. 
 
Since we have little knowledge about HIV particle-internal and, especially, 
core-internal alterations on compartments and nano-size components during 
infection, the development of a comprehensive fluorescence imaging tool will assist 
with the dissection of such subparticle architectures. Therefore, the approaches in 
Chapter 5 represent progresses in the development of imaging tools that can be used 
to visualize HIV subparticle architectures during early entry stages and potentially 
associated alterations.   
 
 
 
 
 
 
 
 
 
 ϰϮ
2 Materials and Methods 
 
2.1 Cell culture 
 
Transfections, co-transfections and subsequent virus productions were 
conducted in the adherent human embryonic kidney cell line 293T (HEK293T) 
which stably expresses the large T antigen of SV40 (Pear et al., 1993). The episomal 
replication of plasmids containing the SV40 origin is extensive in these cells with a 
high level of copy numbers. HEK 293T cells were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) (Gibco/BRL, USA) containing 10% heat 
inactivated foetal calf serum (FCS, Invitrogen) and 100 U of penicillin per mL and 
100 μg of streptomycin per mL (Invitrogen, Australia). Cells were cultured in 150 
cm2 flasks and passaged every 3-4 days or when there was a confluency of about 
80%.  
 
TZM-bl cells (a kind gift of Professor Gilda Trachedjian, Burnet Institute, 
Melbourne) are an adherent HeLa cells-derived indicator cell line which stably 
express large amounts of CD4, CCR5 and constitutively express CXCR4. They also 
contain separate integrated copies of the luciferase and β-galactosidase genes under 
the HIV-1 promotor control. The TZM-bl cell line is highly sensitive to infections 
with diverse HIV-1 isolates and enables quantitative infection analyses by using 
either β-galactosidase or luciferase receptor expression (Section 2.7). The cells were 
maintained in 150 cm2 flasks and passaged every 3-4 days or whenever around 80% 
confluent.     
 
 ϰϯ
2.2 HIV-1 virus constructs 
 
HIV-1 particles were derived from pNL4-3 proviral DNA (NIH AIDS 
Research and Reference Reagent Program, Dr. Malcolm Martin (Adachi et al., 
1986)) containing the infectious molecular clone of the CD4 and CXCR4-tropic 
HIV-1. Tetracysteine (TC) tagged constructs and the plasmids containing the 
inactivated version of Rev as well as the non-frameshift NFS of HIV-1 were 
generated previously (Pereira et al., 2011). Briefly, stitch PCR mutagenesis on full-
length pDRNL with sequence specific primers were used to introduce the TC motif 
at either C-terminal or N-terminal regions within targeted sites in the viral genome 
(see Chapter 5 Figures 5.1 and 5.2). The mutagenic region was amplified via HIV-1 
specific primers and subcloned into the pDRNL backbone construct using 
appropriate restriction sites. In the Gag or GagPol precursor protein of all constructs, 
the TC tag was inserted five amino acids down- or upstream of each protease 
cleavage region. Furthermore, an AG linker with the NaeI restriction site was 
introduced in all plasmids for improved screening purposes. To maintain the viral 
protease cleavage sites, the first or last five amino acids of the viral protein coding 
sequences were repeated.  
 
HIVΔRev plasmid for the co-transfection with the HIVCA-TC was created by 
integration of an early termination codon in the BamHI site and a frameshift into 
exon 2 of the Rev sequence. In this manner, the Rev function is inactivated. For the 
co-transfection system with HIVNC-TC, a non-frameshift plasmid HIVNFS was 
generated which contains codon modifications in the -1 frameshift slippery sequence 
in the gag reading frame. This enables the expression of Gag but not the Gag-Pol 
 ϰϰ
polyprotein. Hereby, the wild type sequence of HIV-1 was replaced with 5’ 
CTTCCTCGGGAAGATATGGCCATCACACAAAGGTAGACCT 3’ between the 
nucleotide regions 4240-4266 and subcloned via the ApaI and BclI sites of the HIV-
1 molecular clone (Hill et al., 2002). 
  
HIV A204C, HIV E45A, HIV MN, HIV PR[-] plasmids were generated in the 
laboratory previously and used as control viruses in the cell-free fate-of-capsid 
assays. HIV A204C and E45A are hyperstable core mutants that were additionally 
used to mediate expansion and core isolation experiments. The GFP-Vpr and 
mCherry-Vpr plasmids were generated previously whereas these constructs were 
used in co-transfections for dual fluorescence experiments.  
       
2.3 HIV-1 virus production by transfection 
 
HIV-1 particles were produced via poly(ethylenimine) (PEI; Polyscience Inc., 
Warrington, PA, USA). HEK293T cells were plated at a concentration of 5 x 106 
cells per mL and maintained in 18 mL of DMEM media. 24 hours post-plating 
transfections of HEK293T cells were conducted with 12-15 μg corresponding 
proviral DNA and 9 μL PEI (1 mg/mL) per 1 μg DNA. In the case of generating 
mCherry-Vpr labelled HIV or dual labelled HIVTC, the mCherry-Vpr plasmid was 
added to the co-transfection and adjusted to all corresponding DNA constructs at the 
appropriate ratio (Table 2.1). After 10 minutes incubation at room temperature, the 
DNA/PEI mix was resuspended in 200 μL DMEM (no FCS and antibiotics) and 
added dropwise to the cell culture. Forty hours post-transfection for TC-tagged HIV-
1 (Section 2.4) and 48 hours for unlabeled virus, the supernatant of HEK293T cells 
 ϰϱ
was harvested and purified by centrifugation for 30 minutes at 1,500 x g, 4oC to 
remove cell debris. 
 
Table 2.1 TC labelling of HIV constructs 
 
HIV DNA Co-transfected HIV DNA Ratio Theoretical TC 
attachment 
 
HIVMA-C-TC 
 
HIVCA-N-TC 
 
HIVCA-N-TC 
 
HIVCA-N-TC 
 
HIVNC-N-TC 
 
 
 
HIVΔRev 
 
HIVΔRev 
 
HIVΔRev 
 
HIVNFS 
 
 
 
1 
 
4:1 
 
1:1 
 
1:5 
 
4:1 
 
 
 
100% 
 
80% 
 
50% 
 
16.7% 
 
80% 
 
 
 
2.4 Metabolic FlAsH labelling and purification of HIV-1 
 
Eight hours post-transfection 500 nM FlAsH (a Kind gift of Associate 
Professor Stuart Turville, UNSW Australia), premixed with 10 μM 1,2-Ethanedithiol 
(EDT, Sigma-Aldrich, Australia) (FlAsH-EDT2) was added to the HEK293T 
producer cells and the virus production proceeded for further 40 hours. Viral 
particles were isolated, purified (as described previously) and filtered through a 0.2 
μm filter (Sartorius, Germany). Non-attached excess biarsenical FlAsH dye was 
removed by a sucrose (Sigma, Australia) density gradient. ranging from 32.5% to 
55% in 2.5% increments and centrifuged at 100,000 x g for 16 hours at 4oC (SW41 
rotor; L-90 Beckman ultracentrifuge). Virus-containing fractions 3 to 10 were 
collected, pooled and the virus particles purified through a 20% sucrose-PBS 
solution by ultracentrifugation (SW32Ti rotor) at 100,000 x g for 1.5 hours and 4oC. 
 ϰϲ
Further removal of excess FlAsH was necessary and achieved by replacing the 
sucrose density gradient with an OptiPrep (Sigma, Australia) density gradient. The 
gradient ranged from 6% to 18% in 1.2% increments with an ultracentrifugation at 
250,000 x g for 1.5 hours at 4oC (SW41 rotor) before fractions 9 to 11 containing the 
virus particles were collected and merged. The pooled fractions were concentrated by 
an additional ultracentrifugation through a 20% sucrose-PBS cushion. The 
concentrated viruses were quantified via micro ELISA anti-HIV-1 p24-CA assay 
(Section 2.6) and stored at -80oC until further analysis. 
 
2.5 HIV-1 virus purification and concentration 
 
Viral particles obtained from the culture media were purified by filtration 
through 0.2 μm sterile syringe filter and ultracentrifugation through a 20% sucrose 
cushion using an SW32Ti rotor in an L-90 ultracentrifuge at 100,000 x g for 1.5 
hours at 4oC. Virus pellets were re-suspended PBS and the virions were quantified 
via micro ELISA assay (Section 2.6). The concentrated viral stocks were frozen at -
80oC until further analysis.  
 
2.6 HIV-1 p24 ELISA 
 
HIV-1 p24 CA protein in virion pellets were quantified using a coated murine 
anti-HIV-1 capture antibody (anti-p24-CA) micro ELISA XB-1000 assay (XpressBio 
Life Science, USA) according to manufacturer’s instructions. 
 
 
 ϰϳ
2.7 Infectivity assay 
 
The HIV-1 infectivity was assessed in the TZM-bl cell line-based luciferase 
reporter assay. TZM-bL cells were plated at 5 x 104 cells per well in 96-well flat 
bottom white plates containing 100 μL DMEM supplemented with 10% foetal calf 
serum, 100 U/mL of penicillin and 100 μg/mL of streptomycin. Twenty-four hours 
post-plating, the media was removed and the cells were infected with 50 μL virus at 
a start concentration of 100 ng equivalent amounts according the determined values 
attained from anti HIV-1 (p24-CA) micro ELISA assay (Section 2.6) and 5-fold 
serial dilutions in duplicates. The viruses and cells were incubated in 100 μL DMEM 
media containing 15 μg/mL diethylaminoethyl-dextran (DEAE-dextran; Sigma-
Aldrich, USA) for 46 hours at 37oC, 5% CO2 after spinoculation at 161 x g for 2 
hours at 4oC. Fourty-eight hours post-infection, 100 μL media was aspirated and the 
remaining 50 μL mixed with 50 μL Bright-Glo luciferase reagent (Promega, USA). 
The luminescence was measured after at least 2 minutes of lysis incubation at room 
temperature using the FLUOstar OPTIMA multi-detector reader (BMG Labtech, 
Germany). The infectivity is detected as relative luminescence units (RLU) and the 
percentages of infectivity levels calculated compared to wild type HIV-1.      
 
2.8 Infection of Jurkat T cells 
 
Infections were performed on T cell lines as described previously (Pereira et 
al., 2012). Briefly, for non-synchronised infection, Jurkat cells (NIH AIDS Reagent 
Program, USA) were mixed with HIV-1 particles (normalised to 1000 ng of p24 per 
 ϰϴ
million cells) followed by spinoculation at 17°C for 2 h at 1,200 × g. A concentration 
of 0.2 μg/mL AMD3100 was added to uninfected Jurkat cells at 37°C incubation for 
20 minutes prior to spinoculation with HIV-1 particles. Infections were then carried 
on for 2 hours at 37°C incubation (5% CO2). The cells were washed three times with 
PBS to remove unbound virus. Adding paraformaldehyde to a final concentration of 
4% stopped the infection. Cells were then stored on ice for immediate dSTORM 
analysis. 
 
2.9 Treatment of cell-free viruses with sCD4 or NBD556 
 
sCD4 was produced by Progenics Pharmaceutical, Inc. and obtained through 
the NIH AIDS reagent program. Treatment concentration of sCD4 was with either 50 
ȝg/mL or 500 μg/mL against 5000 ng p24/mL virus (as determined by p24 
concentration), which was selected as closest to the suppressive concentration used 
in an in vitro tissue culture infection experiment. More specifically, for each 
treatment with 50 ȝg/mL of sCD4, 50 ȝL of viral suspension (normalised to 10000 
ng of p24 per mL) was incubated with 50 ȝL of sCD4 (100 ȝg/mL). The NBD556 
treatment followed the same principle using 100 μg/mL (low concentration) or  
1mg/mL (high concentrations) to adjust the smaller size of the molecules. For all 
treated samples a buffer treated control was run concurrent to sCD4 treatment and 
from the same aliquot of virus. Incubation was for a minimum of 2 hours at 37°C 
(5% CO2). Adding paraformaldehyde to a final concentration of 4% stopped the 
incubation and inactivated the buffer and sCD4 treated virus. When high sCD4 
concentrations (500 μg/mL) were used on WT or mutant HIV-1 to demonstrate the 
 ϰϵ
specificity of the event, a lower virus concentration was used. After the reaction was 
stopped and the virus inactivated, samples were aliquoted and stored at -80°C. 
 
2.10 Nucleic acid removal via Benzonase 
 
In order to remove nucleic acid contaminations in the HIV-1 virus solutions 
obtained from the transfection procedure prior to PCR studies, Benzonase 
endonuclease (Sigma-Aldrich, Australia) was used. Concentrated virus stocks of 50 
μL volume were treated with 250 U/mL of Benzonase in MgCl2 solution for 1 hour 
at 37oC. Followed was this treatment by the direct RNA and/or DNA extraction from 
the cell-free virions for viewRNA (Section 2.18) studies or a sCD4 or NBD556 and 
dNTP pre-treatment was conducted for NERT (Section 2.11) analyses beforehand.  
 
2.11 Natural endogenous reverse transcription (NERT) 
 
The HIV-1 was subjected to the NERT analyses to study potential initiation 
of reverse transcription in CD4 engaged virus particles. Equivalent amounts of HIV-
1 virions were pre-treated with sCD4 or low and high concentrations of the NBD556 
analogue (Section 2.9). After the incubation, 200 μM dNTPs were added to the 
appropriate samples and treated for another 2 hours. The dNTP treatment was 
adjusted to results obtained from previous studies (Zhang et al., 1996). After the 1 
hour Benzonase treatment, the enzyme was removed by PBS wash and replaced with 
DMEM media and incubated for another 14 hours at 37oC. The samples were 
prepared for DNA extraction and qPCR analysis (Sections 2.12 to 2.14) immediately 
after the incubation.  
 ϱϬ
2.12 Virion lysis, RNA/DNA extraction and qPCR preparation 
 
Quantitative PCR analyses were either mediated on DNA extracted HIV-1 
virions for NERT (Section 2.11) and viewRNA or RNA extractions that were reverse 
transcribed into cDNA via RT synthesis for viewRNA only (Sections 2.13, 2.14 and 
2.18). Concentrated virions or pre-treated HIV-1 particles at a volume of 100 μL 
were lysed with a qPCR lysis buffer containing 1 x Cell lysis buffer (Qiagen, 
Germany), 1 x HF buffer, 0.5% vol/vol Triton X-100, 0.5% vol/vol NP-40 and 75 
μg/mL proteinase K. The samples were incubated for 1 hour at 56oC and afterwards 
the enzyme was heat inactivated for 10 min at 95oC. Samples were stored at -20oC 
until further analyses. 
 
RNA extraction for the viewRNA qPCR analysis was performed via the 
TRIzol method (Life Technology, Australia). The lysed HIV-1 virion samples were 
divided into RNA and DNA extraction. For the RNA preparation 500 μL TRIzol 
reagent was added to 500 μL virions and the suspension was incubated for 5 min at 
room temperature. Afterwards, 100 μL chloroform was mixed into each sample and 
incubated for another 5 min at room temperature. To separate the RNA, DNA and 
protein phases, a centrifugation for 15 min at 12,000 x g and 4oC was performed. The 
RNA remains in the aqueous phase which is collected and 0.25 mL Isopropanol is 
added, incubated for 10 min at room temperature, followed by a centrifugation at 
12,000 x g for 10 min at 4oC. The precipitated RNA is collected and washed in 0.5 
mL 75% ethanol. The RNA was collected by centrifugation at 7,500 x g for 5 min 
and 4oC before air-dried for 10 min and resuspended in 50 μL nuclease-free water. 
The RNA samples are stored at -80oC until further analysis. DNA extractions, 
 ϱϭ
obtained from the separated other half of the HIV-1 virion samples, was mediated 
directly from the lysed HIV-1 virions using the DNeasy blood and tissue kit (Qiagen, 
Germany) following the manufacturer’s instructions. The DNA samples were stored 
at -20oC until further analysis.  
 
2.13 RNA reverse transcription synthesis 
 
The SuperScript III reverse transcription system (Qiagen, Germany) converts 
viral RNA into cDNA for subsequent qPCR analysis. The first-strand cDNA 
synthesis reaction contained 2 μM HIV-1 specific primers to gag, 10 mM dNTPs and 
5 μg RNA. This reaction was incubated for 5 min at 65oC, followed by an annealing 
step on ice for 2 min. The cDNA synthesis mix, containing 10 x RT buffer, 25 mM 
MgCL2, 0.1 M dTT, 40 U/μL RNaseOUT and 200 U/μL SuperScript III reverse 
transcriptase, was added to the RNA/primer mixture and incubated for 50 min at 
50oC. The reaction was terminated by heat inactivation for 5 min at 85oC. The RNA 
digest was performed with 2 U RNaseH which was incubated for 20 min at 37oC. 
The samples were immediately analyzed for cDNA products via qPCR.  
 
2.14 Quantitative PCR for HIV-1 reverse transcription products 
 
Quantification of HIV-1 virion-derived reverse transcription products was 
performed via quantitative PCR (qPCR) in a Mastercycler Realplex detection system 
(Eppendorf, Germany). Each PCR reaction contained 1 x SYBR Green mix, 450 nM 
forward and reverse primers, 200 μM dNTP, 1 x Phusion High Fidelity (HF) buffer, 
1U Phusion High Fidelity DNA polymerase enzyme  and 5 μL normalized virus 
 ϱϮ
solution in a 15 μL reaction volume. HIV-1 specific primer pairs were used to detect 
early products, minus strand strong stop –sssDNA (Fwd: 5’-
GGCTAACTAGGGAACCCACTG-3’ and Rev: 5’-
CTGCTAGAGATTTTCCACACTGAC-3’), and late products, gag (Fwd: 5’-
TCTGGACATAAGACAAGGACCAAAGG-3’ and Rev: 5’-
ACATTTCCAACAGCCCTTTTTCCTAG-3’). The DNA concentration was 
normalized via NanoDrop spectrometer quantification to 5 μg and used in three 10-
fold dilutions in duplicates. The HIV-1 qPCR conditions were a hot start 
denaturation of 98oC for 31 sec followed by 35 rounds of cycling at 98oC for 18 sec, 
then 72oC for 1 min and 60oC for 15 sec.   
 
2.15 Cell-free Fate-of-capsid assay 
 
Sample virus stocks with equivalent concentrations of 10 μg virus according 
the p24-CA protein measured by micro ELISA assay (Section 2.6) in a total volume 
of 100 μL was used in untreated and treated HIV-1. The sCD4 or NBD556 treatment 
(Section 2.9) was performed for 2 hours before the cell-free fate-of-capsid assay was 
undertaken, an amended version of the original assay (Yang et al., 2014). The 
untreated and treated samples were divided into 5 x 20 μL aliquots and each sample 
was treated with the corresponding concentrations of Triton X-100 (Sigma-Aldrich, 
Australia), ranging from 0.375% to 3% in 2-fold increasing increments. The 
reactions were incubated for 20 min at room temperature before diluting each sample 
with 60 μL PBS. The HIV-1 pellets were collected by centrifugation for 10 min at 
25,000 x g (Eppendorf Benchtop centrifuge, Germany) and 4oC. The pellets were 
resuspended in 80 μL PBS and prepared for western blot analyses.   
 ϱϯ
2.16 HIV-1 capsid core isolation 
 
Capsid core isolation was performed on 200 μL of a 500 ng/μL concentrated 
HIVE45A virus. The buffer for the core isolation contained 2% Triton X-100 (Sigma, 
Australia), 200 mM NaCl and 100 mM MOPS (pH 7.0). The lysis of the HIV-1 
envelope was achieved by incubating the virions in the isolation buffer for 3 min 
before the suspension was diluted in 1.5 mL mild isolation buffer containing 100 
mM NaCl, 50 mM MOPS (pH 7.0) and 0.5% Triton X-100. Virion core recovery 
was attained by centrifugation for 10 min at 25,000 x g and 4oC. Followed was this 
recovery by two washing steps with 100 mM NaCl and 50 mM MOPS (pH 7.0) for 8 
min at 25,000 x g and 4oC. The cores were collected in 20 μL PBS plus 4% 
paraformaldehyde (PFA). Methodical instructions were adapted and adjusted from 
the core isolation technique used previously (Welker et al., 2000). The samples were 
stored at -80oC until imaging processing. 
 
2.17 Immunoblot analysis 
 
Viral particles from harvested and purified processes or CD4 engagement 
treated HIV-1 were used to monitor protein profiles or CA-related differences 
between the samples. All virion pellets (except Triton X-100 pre-treated particle 
pellets) were lysed in TBS lysis buffer, containing 1 x Tris-buffered saline, 10 μL 
Nonidet P-40 per mL, 1% Triton X-100, 20 mM phenylmethylsulfonyl fluoride 
(PMSF), 1 μM pepstatin and 1 μM leupeptin at a concentration of 40 μg per p24-CA 
per mL. Virion lysis was supported by at least three freeze-thawing cycles. The lysed 
viruses were mixed with 5 x loading buffer, consisting of 100 mM Tris-HCl (pH 
 ϱϰ
6.8), 1.6% β-mercaptoethanol, 3% SDS and 0.3% bromophenol blue, incubated for 
10 min at 95oC and resolved by SDS Polyacrylamide gel electrophoresis (SDS-
PAGE). Resolved proteins were blotted onto nitrocellulose membrane (Amersham, 
USA) and incubated for 16 hours in blocking buffer (5% blocking powder (Bio-Rad, 
Australia) resolved in water) at 4oC. Proteins were identified using a CA specific 
antibody or pooled HIV-1 seropositive patient sera. The membrane was washed three 
times in TBS and 0.5% Tween (TBST) and the membrane was incubated with a 
species-specific horseradish peroxidase conjugated secondary antibody (DAKO, 
Denmark) for 1 hour at room temperature. Proteins were visualized using an 
enhanced chemiluminescence reagent (Bio-Rad, Australia) and exposed in a 
ChemiDoc MP system (Bio-Rad, Australia).  
       
2.18 ViewRNA experiments 
 
To assess the positioning of viral RNA in the HIV-1 particles dual 
fluorescence attached to HIV-1 specific probes was used in a viewRNA assay 
(Invitrogen, Australia). The viewRNA technique was adapted from a cell-based 
method (Chin et al., 2015) to cell-free virion samples in this study. The probes used 
in this assay were Gag RNA probe set (3 sets) for HIV NL4-3 (bases 873-1907) type 
6 conjugated to AF647 (red fluorescent) and Env RNA probe set (3 sets) for HIV 
NL4-3 (bases 7601-8775) conjugated to AF488 (green fluorescent) (Jomar Life 
Research, Australia). Equivalent concentrations of the virus samples (1 μg) 
according the p24-CA micro ELISA assay (Section 2.6) were fixed in 4% 
paraformaldehyde (PFA) for 1 hour. The virus suspension was washed three times in 
PBS by centrifugation at 12,000 x g for 10 min and 4oC. Ethanol sterilized cover 
 ϱϱ
slides were pre-treated with 0.1% Poly-L-Lysine (Sigma, Australia) for 30 min 
before PBS washing and attachment of the virus for 1 hour at room temperature. The 
procedure for the viewRNA was followed as described in the manufacturer’s 
instruction with permeabilisation and protease digest. The hybridization of the probe 
was amended to a simultaneous incubation of the virus samples, initially for 35 min 
at 60oC, followed by 3 hours at 40oC. Continued was the assay by pre-amplification, 
amplification, hybridization with labeled probes mix and sample imaging. Initially, 
the imaging was tested in a confocal fluorescence microscope for fluorescence 
detection. 
     
2.19 Fab fragment preparation 
 
The Fab fragments of CA-183 (NIH AIDS Reagent Program) and VRC01-
Env (a kind gift of Professor Damian Purcell, University of Melbourne, Australia) 
antibodies was an essential tool to assess Env to CA positioning of HIV-1 during 
maturation. The preparation was performed by Dr Hanumat Tanwar with access to a 
protein equipped laboratory using the Pierce Fab Preparation Kit (Thermofisher, 
Australia) with a papain digestion. A small scale papain digestion of monoclonal 
antibodies (CA-183 and VRC01-Env) at concentrations of 3.2 mg/mL was utilized to 
optimize Fab fragment production. Briefly, to 90 μL Papain (ex Papaya Latex, 
P3125; Sigma, Australia) in 225 μL 50 mM Tris, 3 mM EDTA (pH 7.0), 0.02% 
NAN3 was added 7.5 μL 0.1 M DTT (15.4 mg/ 1.0 mL H2O) and incubated at 37oC 
for 30 min. The reaction was desalted on a 5 mL GE Fast desalting column and 0.25 
mL fractions (7-11) collected. Monoclonal antibody and papain mixtures were 
incubated at 37oC for 1 hour and the digestion was quenched by the addition of 0.5 
 ϱϲ
M Iodoacetamide (48 mg/ 0.5 mL H2O). This was incubated for 15 min at room 
temperature, followed by the addition of 4 x non-reducing buffer which was then 
incubated for 3 min at 100oC. Subsequently, this cleaves directly into Fab and Fc 
fragments and the Fab fragments were then used for APEX AF antibody labelling. 
 
2.20 Alexa Fluor conjugation of antibodies 
 
CA-183 antibody, VRC01-Env antibody and VRC01-Env (Fab) antibody 
were used to conjugate fluorescent Alexa Fluor (AF) via the APEX Alexa Fluor 
antibody labelling kit (Invitrogen, Australia). CA-183 antibody (20 μg) was 
conjugated with AF647 (red fluorescent dye) and VRC01-Env as well as the VRC01-
Env (Fab) antibodies (20 μg each) were conjugated with AF488 (green fluorescent 
dye). The conjugation was performed following the manufacturer’s instructions. The 
labelled antibodies were stored at 4oC until further usage. 
 
2.21 Scanning electron microscopy 
 
The isolated cores obtained from HIVE45A virus were fixed in 4% 
paraformaldehyde (PFA) before used in scanning electron microscopy. The core 
samples were added to Formvar/carbon-coated 400-mesh copper grids (Polysciences, 
USA). Water was chemically extracted from the sample by using a graded series of 
ethanol, ranging from 30% up to 100% in 20% and 10% increments with final 
changes to anhydrous ethanol (three changes). A critical point dryer (BAL-TEC CPD 
030, Germany) was used to prevent damage to the specimen during air drying by 
replacing the ethanol with carbon dioxide under pressure and temperature changes, 
 ϱϳ
following the manufacturer’s instructions. Pressure and Temperature changes were 
conducted several times until ethanol was fully replaced. The specimen grids were 
mounted onto 1 cm disc stubs with glue onto a silver platelet. The specimen on the 
grid was coated with a gold/palladium layer in the JEOL JFC 1600 auto fine sputter 
coater (JEOL, Germany) using an argon laser. The specimen was imaged using 
JEOL JSM-6700F scanning electron microscope (JEOL, Germany).          
 
2.22 Negative staining EM specimen preparation and collection 
 
The 4% paraformaldehyde fixed virus samples were used at about 1.5 μg in 
10 μL aliquots for EM imaging. Formvar/carbon-coated 400-mesh copper grids 
(Polysciences, USA) were cleaned in a plasma cleaner (Glow discharger PDC-32G, 
Harrick Plasma, USA) following the manufacturer’s instructions before sample 
administering. The virus sample was absorbed onto the carbon-coated copper grid for 
10 min. The grid with the virus sample was washed with H2O and stained with 2% 
w/v uranyl acetate (Sigma, Australia) for approximately 30 min at room temperature. 
Residual fluid was removed with filter paper and the grid was dried for at least 2 
hours in a grid holder before visualization. The HIV-1 core samples were imaged 
using the JEOL 1400 transmission electron microscope using 15,000x magnification.  
  
2.23 Cryo-EM specimen preparation and data collection 
Paired aliquots of sCD4 and buffer treated HIV-1 were thawed at room 
temperature for 10 minutes. Cell-free sample (6 ȝL) was applied to the top surface of 
a glow discharged, perforated carbon film on a hexagonal mesh EM gold sample grid 
(CF-MH-2Au-50, Protochips, USA), followed by application of 2 ȝL of 10 nm 
 ϱϴ
colloidal gold solution (Sigma Aldrich, Australia). Samples were blotted for 30 
seconds at above 80% humidity, from the reverse side with filter paper before 
immersion freezing in liquid ethane using a semi-automated plunging apparatus 
(CryoplungeTM3 - Cp3, Gatan, USA). Low dose (35-50 e-/Å2) cryo-EM micrographs 
were captured on either an Ultrascan 1000 2k × 2k CCD (charge-coupled device) 
camera fitted to a JEOL 1400 microscope operated at 120 kV and 15,000X 
magnification, corresponding to a pixel size of 0.69 nm, or using an Utrascan 1000 
(Gatan, Pleasanton, CA) on an FEI Tecnai F30 microscope (FEI, Eindhoven) 
operated at 300 kV and 15,000X magnification, corresponding to a pixel size of 0.71 
nm.   
 
2.24 Cryo-EM tomographic reconstruction 
Cryo-ET tilt series of cell-free HIV-1 particles in specific conditions were 
collected on the same equipment by tilting the specimen from -65o to +65o at 2o 
increments, with a total dose of approximately (3,500 e-/nm2) and a defocus value of 
5 μm. Three-dimensional reconstructions were computed using the 3D feature-
tracking algorithm implemented in JEOL Composer software.   
 
2.25 EM Image processing 
Image refinement was carried out using Normalize Local Contrast (Integral 
Image Filter) and Anisotropic Diffusion 2D implemented within Fiji (a bundled 
version of ImageJ) (Rasband, 1997-2014). Virus particle size was determined 
manually using ImageJ by two independent analysts. Particle average diameter was 
determined by manually defining the length and width of each particle (analyst 1) or 
 ϱϵ
by defining the perimeter and having length, width and average diameter computed 
by Image J (analyst 2). All samples were blinded prior to analysis by analyst 2. For 
segmentation and 3D rendering, a contrast normalized reconstructed volume was 
processed using ImageJ. The 3D cryo-EM tomographs were analysed using IMOD 
(Regents of the University of Colorado) (Kremer et al., 1996, Mastronarde, 1997), 
with the volume computed by IMOD after the matrix and capsid perimeters were 
manually defined. Statistical significance was determined as described below. 
 
2.26 Confocal fluorescence microscopy 
 
Confocal fluorescence microscopy was used to assess FlAsH fluorescence 
levels in TC-labelled HIV-1. TZM-bl cells were plated in 24-well plates onto ethanol 
cleaned cover glasses at a concentration of 5 x 105 cells/mL per well and incubated at 
37oC and 5% CO2. After 24 hours, equivalent concentrations of 200 ng p24-CA 
value each FlAsH and mCherry dual labelled virus, previously resuspended in 500 
μL DMEM media containing 10% FCS and 100 U/mL penicillin and 100 μg/mL 
streptomycin were added. All following steps were performed in the dark to 
minimize photobleaching. The cells were spinoculated for 10 minutes at 161 x g at 
17oC to assist with the attachment of the viruses, before incubating for the remaining 
time at 37oC, 5% CO2. Infections were terminated by removing the virus suspension 
and washing with PBS three times before fixing the cells in 4% paraformaldehyde 
(PFA) for 1 hour. Past the incubation the TZM-bl cells were washed again three 
times in PBS and three times in tissue culture (TC) water. Nuclear staining of DNA 
with DAPI was performed for 15 minutes under continues agitation. Following the 
staining, DAPI was washed off with three steps of 5 minutes TC water incubations. 
 ϲϬ
The cover glasses were mounted onto ethanol sterilized microscope slides and 
sealed. Images were acquired on a Leica SP5 confocal microscope (Leica 
Microsystems, Germany) using 40x or 63x magnifications.  
 
2.27 Immunofluorescence staining for dSTORM 
 
Cells and viruses were fixed with 4% paraformaldehyde, as described 
previously and stored either on ice (cells) or frozen in aliquots (virus). Immediately 
before the assay, samples were permeabilized with a solution of Triton-X 1% in 
PBS. Afterwards the samples were stained sequentially with a 1st and 2nd antibody. 
The first antibody was either mouse anti-matrix (SVM-33) antibody MH-SVM33C9, 
ATCC, Manassas, VA (Akzo Nobel N.V.) or mouse anti-capsid (AG3.0) antibody 
(obtained through the AIDS Research and Reference Reagent Program, Division of 
AIDS, NIAID, NIH from J. Allan) (Simm et al., 1995). The secondary antibody was 
from donkey specific to mouse F(ab’)2, conjugated to Dylight 649 (715496150, 
Jackson ImmunoResearch). To perform dSTORM, we used an oxygen-scavenging 
buffer11 solution (25 mM HEPES, 25 mM glucose, 5% glycerol, 0.05 mg/ml glucose 
oxidase and 0.025 mg/ml horseradish peroxidase, supplemented with 20 mM 
cysteamine; all from Sigma). 
 
2.28 Image acquisition  
 
The principle and instrumentation of dSTORM have been extensively 
described previously (van de Linde et al., 2011). dSTORM acquisition was 
 ϲϭ
performed in an oxygen-scavenger buffer using a total internal reflection 
fluorescence microscope (ELYRA; Zeiss) with a 100x oil-immersion objective 
featuring a numerical aperture of 1.46. Lasers 405 nm and 642 nm were used for 
activation and excitation of Dylight 649, respectively. The samples were prepared for 
dSTORM by illuminating with maximum power of 642 nm at 20 mW for a few 
seconds to block the Dylight 649 in a dark triplet state. For the acquisition, 405 nm 
laser was set in the range 10-100 μW for activation and 642 nm laser at 15 mW for 
excitation. For a single acquisition, 20,000 images of 25x25 μm were recorded with 
a cooled, electron multiplying charge-coupled device camera (iXon DU-897D; 
Andor) using 30 ms for exposure time. Finally, for each dSTORM acquisition, an 
additional image was recorded at 488 nm of the same area to identify the position of 
the GFP fused to vpr protein. The images were recorded using Zeiss Zen software 
(Rossy et al., 2013). 
 
2.29 dSTORM data processing and analysis  
Processing of the raw images, including molecule detection and drift 
correction was carried out with Zeiss Zen 2010D Software (version 7.0.0.366). After 
Gaussian and Laplace filtering, events were judged to have originated from single 
molecules when I − M > 6S, where I is event intensity, M the mean image intensity 
and S the standard deviation of image intensity. The center of each point-spread 
function was then calculated by fitting to a two-dimensional Gaussian distribution. 
Drift correction was performed using a method based on triangulation of localization 
data and a piecewise-linear drift model. The x-y position coordinates of each detected 
spot were stored in a table. Events with localization precision worse than 50 nm were 
 ϲϮ
discarded (Williamson et al., 2011). GFP images were analyzed with the same 
detection method to identify the localization of the GFP-Vpr.  
 
For morphological analysis, the dSTORM pointillist images were analysed 
with a Matlab routine. Clusters were detected and morphologically analysed using a 
method similar to that described by Lelek et al. (Lelek et al., 2012). To ensure each 
analysed cluster is a genuine HIV particle, first we identify the location of the 
highest density (which is the centre of the cluster) within a 250 nm radius of a single 
GFP localization. Then starting from the point of maximum density as the centre, we 
drew circles by 10 nm increments, and calculated the density in each ring defined by 
two successive circles. If the calculated densities decreased more than 99.5%, 
between successive rings, we stopped the incrementation and the cluster is identified. 
Clusters containing less than 500 positions were not included in the analysis; only 
very dense clusters were used in order to obtain accurate measurements of virus 
sizes. Clusters with larger than 250 nm radius were discarded to ensure that the 
clusters retained for morphological analysis were individual clusters and not 
aggregates of virus particles. The individual clusters were rotated to align the 
principal axis using principal component analysis. Next, a density map was obtained 
by applying a smoothed 2D histogram, binning the positions in 500 x 500 pixel grids 
and convoluting with a Gaussian function of standard deviation 5 nm. Each cluster 
density map was normalized proportionally to the number of localizations. A binary 
image of each cluster was obtained after thresholding at full width half maximum 
(FWHM), and used to determine the characteristics of the virus particles such as the 
area, diameter, width and length.  
 
 ϲϯ
Each virion can be regarded as a single measurement. On average, we 
detected ~1000 MA and ~1500 CA localizations per wild-type virus particle. The 
accuracy of a structure is defined by the Nyquist-Shannon sampling theorem, which 
states that one needs twice as many point localizations (i.e. two-fold over-sampling) 
for a given resolution (Thompson et al., 2010). With an average area of ~8171 
nm2 for MA and <4800 nm2 for CA, the average distance between localization is 
~2.8 nm for MA and <1.8 nm for CA. This means that the accuracy of our size 
measurement for each cluster, the Nyquist resolution, is ~5.6 nm for MA and ~3.6 
nm for CA.  
 
The resolution limit of a structure detected with dSTORM can be further 
improved by averaging, in our case by calculating the means, standard deviations and 
standard error mean of typically 100-300 individual virus particle per condition, 
therein lies the statistical power of dSTORM data. Averaging of dSTORM images of 
the nuclear pore complex was recently used to detect differences in distances 
between subunits of less than 1nm (Szymborska et al., 2013). 
 
2.30 HIV samples preparation and sCD4 treatment for Mass 
spectrometry 
 
Four batches of HIV virus were purified for this study. They are HIV NL4-
3/SupT CL.30; HIV MN/H9 CL.4; HIV BAL/SupT1; and HIV MN CL.4/CEM-SS, 
each with a biological control. Matching micro vesicles (MV) were also purified 
from the same medium.  A total of 22 viral and MV samples without and with sCD4 
treatment were included in this study. For the sCD4 (Vendor, USA) treatment of 
HIV samples, each of ~170 μg of p24 equivalent of HIV was suspended in 0.66 mL 
 ϲϰ
PBS buffer, a 50 μg of sCD4 at 1 ug/μL was added to the sample. The samples were 
then incubated at 37oC for 90 min with agitation every 15 min.  The lysis buffer was 
added to the samples at a final concentration of 1% SDS, 30 mM Tris pH7.8, 7.56 
mM MgCl2, 1 mM EDTA, 2 mM Na3VO4, Phosphatase inhibitors cocktail 2 and 3 
(1:100, Sigma P5726, P0044, USA), 2 μg/mL or 307 nM Aprotinin (Sigma A6103, 
USA), 10 μg/mL or 21 μM Leupeptin (Roche 11017101001, USA), 50 ng/mL or 50 
nM Calyculin A (Calbiochem 208851, USA), 1 mM PMSF.  Samples were boiled 5 
min in the lysis buffer.  For HIV samples without sCD4 treatment, the viruses were 
incubated in 37oC for 90 min before being boiled in the lysis buffer for 5 min. 50 μg 
of sCD4 was then added to the boiled sample and samples were boiled for additional 
2 min to inactivate the sCD4. For micro-vesicles samples, ~500-750 μg of MV was 
suspended in 0.66 mL PBS, the without or with sCD4 treatment was handled 
similarly as to the viral samples. Samples were kept frozen before being further 
processed. 
  
2.31 Preparation of HIV viral peptides for Mass spectrometry 
 
Twenty-two viral protein lysate preps were quickly thawed in hot water for 1 min 
and centrifuged at 20,000 x g for 5 min. A 30 μL sample was taken from each 
preparation for protein concentration measurement via micro BCA assay 
(Thermofisher Scientific, USA). The protein samples were reduced with DTT at 5 
mM for 0.5 h at 37oC and followed by alkylation with 20 mM iodoacetamide for 0.5 
h at 37oC in the dark. Proteins were precipitated with 4 volumes of cold acetone 
overnight at -20oC.  The protein precipitate was centrifuged at 20,000 x g for 5 min 
and washed 2 x with 80% cold acetone. The proteins were then digested with trypsin 
 ϲϱ
(Promega V511A, USA) at 1:50 protein:trypsin m/m ratio in the digestion buffer 
(protein: digestion buffer ratio m/v 1:1.2) overnight at 37oC.  The digestion buffer 
consisted of 50 mM NH4HCO3 and 0.05% RapiGest acid labile surfactant (Waters 
186001861, USA). RapiGest was hydrolyzed with trifluoroacetic acid (TFA, Fluka, 
TX1276-6, USA) at 0.5 % v/v final concentration for 1 hr at 37oC and was removed 
via centrifugation at 20,000 x g for 20 min. One μL of the RapiGest digests were 
kept from each sample and a validation run was performed to test the sample fidelity. 
The remaining clarified tryptic peptides were desalted with a 10 mg Oasis HLB 96 
well desalting plate (Waters 186000128, USA), eluted with 3 x 100 μL 80%, 0.1% 
TFA. 5% of the peptides were removed to a smaller tube for proteomics studies, the 
remaining peptides were used for the phosphoproteomics studies. Peptide samples 
were lyophilized and stored at -80oC. 
 
2.32 Basic reversed-phase separation of peptides and generation of 
proteome samples for analysis 
 
To reduce peptide complexity, samples were separated by basic reversed-
phase chromatography. The 5% desalted peptides were reconstituted in Solvent A 
(2% acetonitrile, 5 mM ammonium formate, pH10) and centrifuged at 10,000 x g to 
clarify the mixture before it was transferred into autosampler tubes. Basic reversed-
phase chromatography was conducted on a 2.1 x 100 mm 3.5-Micron Zorbax 300 Å 
Extend-C18 column (Agilent, USA), using an H-Class Acuity UPLC instrument 
(Waters). Prior to each separation, the column performance was monitored via house 
made BSA/Fetuin peptides standards. Solvent A and Solvent B (90% acetonitrile, 5 
mM ammonium formate, pH10) were used to separate peptides by their 
 ϲϲ
hydrophobicity at a high pH.   The peptides were separated at a flowrate of 300 
μL/min for a total 39 min with an increased percentage of solvent B in a nonlinear 
gradient (0% for 3 min;  6%  for 2 min, 14% for 7 min,  14% for 11 min, 34% for 5 
min, 65% for 1 min, 100% for 2 min, 0% for 9 min for equilibration). Eluted 
peptides were collected in 96 × 0.5 mL well plates (Eppendorf) with 1 min (300 μL) 
per fraction. The 36 peptide fractions were combined into 4 subfractions in a 
serpentine, concatenated pattern, to generate subfractions of similar complexities that 
contain hydrophilic as well as hydrophobic peptides (reference Carr).  Subtractions 
were lyophilized and dissolved at 100 ng/μL in 0.1% TFA for mass spec analysis. 
 
2.33 Phosphopeptides enrichment and mass spectrometry analyses 
Phosphopepitdes were enriched using immobilized metal affinity 
chromatography in batch mode. The remaining 95% of the peptides were dissolved 
in an equilibration buffer (EB, 250 mM acetic acid /30% acetonitrile) before mixing 
with IMAC beads (PHOS-Select Iron Affinity Gel beads, Sigma P9740). The IMAC 
beads were vortexed until they are uniformly suspended. A 400 μL of the 50% slurry 
was taken into a 0.22-um nylon Spin-X centrifuge tube filter (Corning). The beads 
were wash 3 x with 500 μL EB buffer at 8000 x g and stored in 800 μL EB.  A 10 μL 
of the beads prepared as above were added to the peptide dissolved in EB. The 
peptides and the IMAC beads were incubated for 30 min at 120 x g in a thermomixer 
at room temperature. The peptides and the beads mixture were placed in the 96-well 
glass fiber filter plate, washed 2 x with 400 μL EB, 2 x with 400 μL 80% 
acetonitrile/0.1% TFA, 1 x with 400 μL 30% acetonitrile/water under vacuum. The 
phosphopeptides were eluted with 200 μL of 400 mM ammonium hydroxide/30% 
 ϲϳ
acetonitrile. All eluted phosphopeptides were lyophilized and re-dissolved in 0.1% 
TFA/water in the autosampler for LC/MS analysis. The mass spectrometer run was 
followed by data-dependent LC-MS/MS scans and the files were processed using 
MaxQuant.  
 
2.34 Statistical analysis 
 
The statistical significance between treated and untreated conditions with the 
reported sample sets (30 - 500 data points per set) were assessed. For all paired 
samples (buffer treated and sCD4 or antibody treated), we performed two-tailed 
unpaired t-test to compare the means of two unmatched data, derived either from 
virus particle diameters (EM) or from the scatter plots (dSTORM) as well as the 
cumulative distribution of two groups (treated and untreated). To statistically analyse 
multiple replicates, we used two-way ANOVA, analyzing both the treatment effect 
and any effects due to variation in viral batches and/or assays. This was done to 
remove any bias due to individual virus batches or assays. For all methods, assays 
were run with at least 2 independent batches of virus, and with three replicate assays 
unless otherwise stated. Data from infection studies and qPCR analyses of HIV-1 
were evaluated by Mann-Whitney test. All the statistical tests were performed using 
GraphPad Software from Prism. In the statistical difference was defined as non-
significant when p>0.05, or statistically significant when p<0.05 (notation *), p<0.01 
(notation **), p<0.001 (notation ***).  
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3.1  Abstract 
 
 Viruses are often thought to have static structures, and they only remodel 
after the viruses have entered target cells. Here, we detected a size expansion of virus 
particles prior to viral entry using cryo-electron microscopy (cryo-EM) and single 
molecule fluorescence imaging. HIV expanded both under cell-free conditions with 
soluble receptor CD4 (sCD4) targeting the CD4 binding site on the HIV-1 envelope 
protein (Env) and when HIV binds to receptor on cellular membrane. We have 
shown that the HIV Env is needed to facilitate receptor induced virus size 
expansions, showing that the ‘lynchpin’ for size expansion is highly specific. We 
demonstrate that the size expansion required maturation of HIV and an internal 
capsid core with wild type stability, suggesting that different HIV compartments are 
linked and are involved in remodeling. Our work reveals a previously unknown 
event in HIV entry, and we propose that this pre-entry priming process enables HIV 
particles to facilitate the subsequent steps in infection. The HIV CD4 engagement 
did not show a modified core stability or initiation of reverse transcription-related 
 ϲϵ
processes whereas the possibility of the involvement of other replication steps is 
being assessed. 
           
3.2  Introduction 
 
 Cell-free infectious viruses are ultramicroscopic infectious agents that are 
often viewed as being metabolically inert and static in structure, as viruses can only 
replicate within cells of living hosts. Human immunodeficiency virus (HIV) particles 
have electron dense cone-shaped cores, and are pleomorphic in size, with diameters 
that range between 100 nm and 200 nm (Briggs et al., 2003). The interactions 
amongst HIV envelope (Env) proteins, cellular receptor CD4 and co-receptors 
(CXCR4 or CCR5) during entry are well documented (Wilen et al., 2012), and a 
series of structural reorganizations of the viral envelope proteins and the cellular 
receptors must follow to facilitate membrane fusion and viral entry (Wilen et al., 
2012). It is currently unknown whether structural reorganization would occur within 
the internal compartments of HIV prior to entry to facilitate infection. Observations 
with the herpes virus system suggest that receptor engagement of pre-entry viruses 
may alter the internal capsid core by releasing the viral tegument protein from the 
capsid shell (Meckes and Wills, 2008). 
 
The combination of the miniature- and the pleomorphic-nature of HIV 
(Briggs et al., 2003, Benjamin et al., 2005), and the resolution limits of conventional 
fluorescence microscopy techniques (Müller and Heilemann, 2013, Chojnacki and 
Muller, 2013) have made it difficult to discern whether any nano-scale internal 
structural re-organization may exist at the pre-entry step of HIV infection. Recent 
 ϳϬ
applications of state-of-the-art imaging and fluorescent probing techniques have 
revealed previously unattainable details of HIV replication, such as the detection of 
surface HIV Env trimer redistribution during virus maturation (Chojnacki et al., 
2012), the mechanism of tetherin-mediated HIV restriction (Lehmann et al., 2011), 
the assembly of HIV Gag and Pol proteins (Gunzenhäuser et al., 2012, Lelek et al., 
2012, Bharat et al., 2014, Van Engelenburg et al., 2014, Lelek et al., 2014, Schur et 
al., 2015), the recruitment of HIV Env and ESCRT during viral assembly (Muranyi 
et al., 2013, Prescher et al., 2015, Van Engelenburg et al., 2014), and the structural 
details of HIV Env at the early stages of infection (Bartesaghi et al., 2013, Lyumkis 
et al., 2013, Munro et al., 2014).  
 
In the current work, we have used: (1) three dimensional (3D) structural 
reconstruction from cryo-electron microscopy (EM) tomography; (2) two 
dimensional (2D) projection images from cryo-EM; and (3) cluster distributions of 
protein localizations recorded with direct stochastic optical reconstruction 
microscopy (dSTORM) super-resolution fluorescent imaging; to show that cell-free 
HIV underwent size expansion upon receptor engagement with soluble CD4 and 
when HIV binds to cellular membrane CD4 receptor during infection. Our data 
showed that both the outer parameters of viral particles and the internal viral core 
expanded as detected by cryo-EM and dSTORM analyses. Further, expansion was 
highly specific and required the engagement of the CD4 binding sites on the HIV 
Env. However, we could not demonstrate that these structural changes extended 
core-internally by examining the nucleocapsid proteins. Here, we did not observe 
significant alterations in the cluster distributions analyzed by dSTORM. The cryo-
EM virus size estimations of untreated and soluble CD4 treated HIV were recorded 
 ϳϭ
(blinded, and with independent operators) using either pairwise analysis and/or with 
multiple batches of viruses to ensure the pleomorphic size of HIV was not a 
confounding factor. We have also demonstrated that blocking virus maturation or 
cross-linking of capsid proteins within the viral core prevents virus particle size 
expansions upon receptor engagement. Our dSTORM super-resolution fluorescent 
imaging data on the early steps of HIV infection in T cells provided evidence that 
these receptor engagement-mediated virus size expansions occur at the pre-entry 
stage of HIV infection. The data showed that, at the CD4 attachment, core stability 
and reverse transcription processes were not evidently initiated but this does not 
exclude the possibility that the expansion is important for subsequent phases beyond 
the CD4 association.   
 
The majority of the experiments and data analyses in this chapter was 
conducted by Dr Son Pham (my co-supervisor, Deakin University/AAHL/CSIRO, 
Australia). In co-operation with my co-supervisor, we performed EM imaging (cryo-
EM and cryo-ET) and analysis of HIV particles, initially as part of the training. We 
also conducted preparation experiments together for dSTORM, that were sent to Dr 
Thibault Tabarin for analyses (UNSW, Australia).   
 
 
 
 
 
 
 
 ϳϮ
3.3  Results 
 
3.3.1 Cryo-EM tomograms demonstrate that soluble CD4 caused cell-
free HIV to expand 
 
Using dSTORM super-resolution fluorescent imaging analysis, we previously 
reported that the clusters of both matrix (MA) and capsid (CA) proteins associated 
with HIV particles undergo significant redistribution after infection (Pereira et al., 
2012). To independently assess whether the engagement of the primary receptor CD4 
with HIV is sufficient to induce size expansion, we compared the sizes of both the 
viral exterior (matrix protein lattice) and the internal capsid core in cell-free viruses 
before and after treatment with soluble CD4 (sCD4) receptor. Both high (500 
μg/mL) and low (50 μg/mL) concentrations of sCD4 were used to mimic the sCD4 
suppressive concentration (Groenink et al., 1995). Blinded- pairwise-analyses were 
carried out with multiple operators to ensure impartiality.  
 
In general, cryo-EM tomography is the predominant technique to determine 
the exact size of HIV-1 particles over conventional negative contrast EM imaging 
(Briggs et al., 2003, Benjamin et al., 2005, Subramaniam et al., 2007). Virus particles 
were identified in EM, based on the presence of an internal electron dense core like 
structure. Images of cryo-electron tomography (cryo-ET) tilt series were collected 
with 2o increment, and 3D re-constructions were performed to obtain structural 
models of viral particles (for the principles of cryo-ET, see (Baumeister and Steven, 
2000)). By scanning through structure of various reconstructed models of partial HIV 
particles (that has a thickness ranging from 15 nm to 50 nm, with a slice thickness 
 ϳϯ
increment of 1.37 nm), the 1.37 nm slice with the largest area was assigned as the 
‘center slice’ of the virus. Most HIV particles are ellipsoid and deviate from a perfect 
sphere, however, diameter is often used as a reference to estimate the size of HIV 
particles. Here, diameters of virus from 3D cryo-ET data were estimated by taking 
the average of the distance between two perpendicular axes from the ‘center slice’. 
 
Multiple batches of HIV were treated with low (50 μg/ml) or high (500 
μg/ml) concentrations of sCD4 for independent-, blinded-, pairwise-diameter and -
volumetric analyses (Figure 3.1 – 3.2). Mean matrix (MA) diameter difference was 
detected when high (Figure 3.1 C – D) concentration of sCD4 was used to treat HIV. 
3D cryo-ET reconstruction showed cell-free HIV had a mean diameter of 124 nm 
(SEM ± 3.2 nm), which significantly increased (P<0.01) to 134 nm (SEM ± 2.5 nm) 
after incubation with high concentrations of soluble CD4 (Figure 3.1 C – D).  
 
As cryo-ET 3D reconstruction was not feasible for large amounts of ‘full 
volume’ virus particles, we compared the volumes within the MA lattice and the 
capsid (CA) core before and after sCD4 treatment using the 15 nm thick central 
section (partial virus volume) of the cryo-ET reconstructions (Figure 3.1 E – H, 
Figure 3.2). A significant size difference of central MA volume of 33% (P<0.01) was 
detected when the viruses were treated with high concentrations (500 μg/mL) of 
sCD4 (Figure 3.2 A – B). Likewise, a significant volume increase of 26% was 
detected with the 15 nm thick central capsid slice (Figure 3.2 C – D). Treatment of 
HIV with low concentrations of sCD4 (50 μg/mL) did not yield significant changes 
in diameter (Figure 3.1 A – B) or 15nm central volume of the matrix (Figure 3.2 E – 
 ϳϰ
F), but a significant increase within the 15 nm central volume of capsid was 
detectable (Figure 3.2 G – H). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1:  Cryo-EM tomograms illustrate soluble CD4 can cause cell-free HIV to have an 
increase in matrix diameter. Low (50 μg/mL) and high (500 μg/mL) concentrations of sCD4 were 
used for treatment analyses in (A – B) and (C – D), respectively. A and C. Mean matrix diameters 
from three independent sets of cryo-EM tomogram reconstructions were compared in a pairwise- and 
blinded-fashion. By scanning through each of the 1.37 nm thick cryo-EM tomogram slice, the one 
with the greatest area was assayed as the central slice of the virus. The MA diameter was estimated 
based on the average length of the two longest perpendicular axes on the central slice. B and D. 
Cumulative percentage of viruses with indicated or larger MA diameters of untreated HIV (blue) and 
of sCD4 treated HIV (red) were presented. E – H. The 15nm thick central portions of the tomogram-
reconstructed models were selected for volume comparison. The thickness ‘15nm’ was arbitrary 
selected to maximize the number of reconstructed models available for comparison. E and G. 
Examples of cryo-EM images from cryo-EM tomogram of untreated-HIV (E) and sCD4 treated-HIV 
(G) were presented. F and H. Examples of reconstructed models from cryo-EM tomogram of 
untreated-HIV (F) and sCD4 treated-HIV (H) were presented. n values are number of virus particles 
used in each arm of the pairwise-, blinded-comparisons. Statistical analyses were carried out using 
 ϳϱ
two-way ANOVA. * is P< 0.05; ** is P< 0.01; *** is P< 0.001. Error bars are standard error of the 
mean. 
 
Figure 3.2:  Cryo-EM tomograms illustrate soluble CD4 can cause cell-free HIV to have an 
expanded matrix and capsid volume. High (500 μg/mL) and Low (50 μg/mL) concentrations of 
sCD4 were used for treatment analyses in (A – D) and (E – H), respectively. Multiple sets of cryo-EM 
tomogram reconstructions were compared in a pairwise- and blinded-fashion. By scanning through 
each of the 1.37nm thick cryo-EM tomogram slice, the one with the greatest area was assayed as the 
central slice of the virus. The 15nm thick central portions of the tomogram-reconstructed models were 
selected for volume comparison. The thickness ‘15nm’ was arbitrary selected to maximize the number 
of reconstructed models available for comparison. A and E. The MA volumes from different sets and 
batches of HIV were compared. B and F. Cumulative percentage of viruses with the indicated or 
higher MA volumes of untreated HIV (blue) and of sCD4 treated HIV (red) were presented. C and G. 
The CA volumes from different sets and batches of HIV were compared. D and H. Cumulative 
percentage of viruses with the indicated or higher CA volumes of untreated HIV (blue) and of sCD4 
treated HIV (red) were presented. n values are number of virus particles used in each arm of the 
pairwise-, blinded-comparisons. Statistical analyses were carried out using two-way ANOVA. * is P< 
0.05; ** is P< 0.01; *** is P< 0.001. Error bars are standard error of the mean. 
 
 ϳϲ
3.3.2 CD4 receptor mediated pre-entry virus size expansion is 
supported by 2D cryo-EM projection and dSTORM super-
resolution fluorescence image analyses 
 
As HIV are pleomorphic, the low throughput nature of cryo-EM tomography 
limits the number of conditions that can be sampled to dissect the biological details 
of this pre-entry HIV Env and CD4 receptor interaction. We therefore examined 
whether alternative and more rapid procedures could be used as an independent tool 
to validate that soluble receptor engagement induced virus size expansion. Six 
batches of viruses and nearly 1500 HIV particles of cryo-EM 2D projections (Figure 
3.3 A – B) were used for independent pairwise, blinded virus diameter estimations 
(Figure 3.3 A – E). Diameters were calculated as the average distance between two 
perpendicular axes of the 2D cryo-EM projection images. All six batches of viruses 
consistently showed an increase of virus diameter upon sCD4 treatment, which 
increased from 122.6 nm (SEM ± 2.4 nm) to 133.8 nm (SEM ± 2.3 nm) (Figure 3.3 
C – D).  
 
dSTORM super-resolution imaging was also used to independently assess 
whether virus-associated MA and CA molecules redistribute upon receptor 
engagement. The locations of viral proteins (MA and CA) were estimated using 
appropriate primary anti-viral protein antibodies and corresponding species-specific 
secondary antibodies that are tagged with dSTORM compatible fluorophores. A 
localization precision of 20 nm resolutions was achieved with dSTORM (Figure 3.4). 
Virus particle-associated GFP-Vpr was used as a locator to identify true virus-
associated MA or CA proteins from background (Figure 3.4 A – B). Gaussian fitting 
model, cluster detection and alignment were used to determine the morphological 
 ϳϳ
features and the projected dimensions of the virus-associated MA and CA clusters 
(Figure 3.4 C – G). Repeated analyses showed that both the cluster areas of virus-
associated MA and CA molecules have increased significantly upon sCD4 treatments 
(Figure 3.5 A – F), supporting the notion that cell-free HIV underwent size 
expansion upon sCD4 engagement. 
 
dSTORM comparison between: (1) the newly formed HIV from infected 
Jurkat cells; and (2) HIV particles that have been arrested at the early stages of 
infection using CXCR4 co-receptor blocker AMD3100 (Donzella et al., 1998) also 
revealed an increase of the clustering areas of MA molecules just prior to virus entry 
(Figure 3.5 G – I), showing that the size expansion of HIV also occurs in natural 
infection process prior to virus entry. 
  
Although both cryo-EM 2D and dSTORM analyses are less well suited to 
estimate the true dimensions of the virus particles compared to 3D cryo EM 
tomogram reconstructions, both analyses confirmed that soluble CD4 induces HIV 
size expansion of both the MA shell and the CA core portions of the viruses. 
 ϳϴ
 
Figure 3.3:  2D cryo-EM projections confirm sCD4 treatments induce HIV to expand. A – B. 
Examples of 2D cryo-EM projections images used for virus MA diameter estimations. C. Mean 
matrix diameters from six independent sets of 2D cryo-EM projections were compared in a pairwise- 
and blinded-fashion. The MA diameter was estimated based on the average length of the two longest 
perpendicular axes of the virus particles. D. Cumulative percentage of viruses with indicated or larger 
MA diameters from untreated HIV (blue) and from sCD4 treated HIV (red) of the 2D cryo-EM 
projections data were presented. E. Mean MA diameters comparisons from 6 sets of cell-free HIV that 
have been untreated vs sCD4 treated (500 μg/mL). n values are number of virus particles used in each 
arm of the pairwise-, blinded-comparisons. Statistical analyses were carried out using two-way 
ANOVA (C). Internal pair statistical analyses were done with two-tailed unpaired t-test. (E).  * is P< 
0.05; ** is P< 0.01; *** is P< 0.001. Error bars show standard error of the mean (D).  
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Figure 3.4: dSTORM morphology analysis of protein clusters of cell-free HIV particles. A. 
Reconstructed dSTORM image of individual immuno-labelled capsid (CA) localisations (red dots). 
Individual GFP spots of GFP-Vpr (green dots) were identified using a Gaussian fitting model. B. 
Selection of CA clusters for inclusion in morphological analysis (highlighted area from A). Clusters 
of CA localizations outside a 250 nm radius of a GFP position and CA cluster sizes with a radius 
>250 nm were excluded (red dotted square). Further, clusters that contain less than 500 localizations 
were also excluded as few localization per cluster reduces the accuracy of the dSTORM size 
measurements. Importantly, only clusters that fulfill both sets of criteria (size/density and GFP-Vpr 
association) were included in the analysis (blue square). (C – F) Cluster detection and alignment. 
Clusters were identified with incremental circles until the density of localization in a ring defined by 
two successive circles is less than 0.5% of the density from the previous ring. Principle component 
analysis was used to identify the long axis within individual CA clusters (D) and aligned to north-
south orientation (E). F. CA clusters were converted to normalized density maps, shown with in a 
heat map representation. G. Binary map of a CA clusters, obtained by applying a FWHM threshold to 
density maps. Morphological parameters, such as area, length of the long and short axes were 
extracted for individual CA cluster from binary maps. 
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Figure 3.5: dSTORM super-resolution analyses detect viral protein cluster size expansion upon 
virus and CD4 receptor engagement. The mean dSTORM estimated areas of MA (A) and CA (C) 
protein molecule clusters from different sets and batches of cell-free HIV were compared. B and D. 
Cumulative percentage of viruses with indicated or higher dSTORM estimated areas of MA (B) and 
CA (D) protein molecule clusters of untreated HIV (blue) and from sCD4 treated HIV (red) were 
presented. The length of antibodies used in dSTORM overestimated the actual size of protein clusters. 
E. Mean dSTORM estimated MA area comparisons from 2 sets of cell-free HIV that have been 
untreated vs sCD4 treated (500 μg/mL); F. Mean dSTORM estimated CA area comparisons from 2 
sets of cell-free HIV that have been untreated vs sCD4 treated (500 μg/mL); G. The dSTROM 
estimated areas of MA protein molecule clusters from different sets and batches of newly formed HIV 
that are being released from Jurkat cells (blue) and pre-entry HIV that are arrested on the cell surface 
via CXCR4 co-receptor blocker AMD3100 (red). H. Cumulative percentage of viruses with indicated 
or higher dSTORM estimated areas of MA protein molecule clusters of newly released HIV (blue) 
and pre-entry AMD3100 membrane arrested HIV (red) were presented. I. Mean dSTORM estimated 
MA area comparisons from 2 sets of: (1) Jurkat cellular membrane-associated newly released HIV vs 
(2) Jurkat cellular membrane-associated pre-entry arrested HIV. n values are number of virus particles 
used in each arm of the pairwise-, blinded-comparisons. Statistical analyses were carried out using 
two-way ANOVA (A, C and G). Internal pair statistical analyses were done with two-tailed unpaired 
t-test. (E, F, I). * is P< 0.05; ** is P< 0.01; *** is P< 0.001. Error bars show standard deviation (B, D, 
H). 
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3.3.3 Super-resolution fluorescence imaging indicates no CD4 
receptor-mediated NC protein cluster alterations 
 
Since MA and CA showed a size expansion upon CD4 engagement, the next 
step was to assess whether there are alterations within the CA core. The changes in 
the MA and CA sizes might indicate that other components are also affected, such as 
the RNA within the core or the attached NC. Viral RNA is difficult to visualize, 
while there are fluorescently labelled associated proteins available, like the NC. NC 
is a very small (only 55 amino acid long) protein that is located within the CA core. 
Due to its chaperone activity, it is presumably bound to the viral RNA and therefore 
an attractive protein to detect potential core-internal alterations, mediated by CD4 
engagement. Based on the initial size change observation, potential rearrangements 
within the core were analyzed by NC cluster distributions in dSTORM. This work 
was performed in co-operation with our collaborator Yui Yamamoto (UNSW, 
Australia) as utilized beforehand. Cell-free HIV was treated with 50 μg/mL sCD4 for 
2 hours before analyzing NC protein cluster distributions with super-resolution 
microscopy. The locations were estimated via a gene integrated motif labelling that 
was tagged with a PALM super-resolution compatible fluorophore (FlAsH) which is 
described in more detail in Chapter 5. In order to distinguish between virus-related 
NC from background, particle-associated mCherry-Vpr was used as locator 
reference. The localization precision of 20 nm was achieved as described previously 
as well as the Gaussian fitting model was also used to detect and align identified 
morphological features and dimensions of the NC clusters (see Section 3.3.2). Upon 
CD4 engagement there were no significant differences detected in the PALM 
analyses of the virus-associated NC cluster diameters (Figure 3.6). Untreated HIV 
 ϴϮ
virions ranged around a mean of 98 nm diameter which was only slightly elevated in 
the sCD4 treated virions to an approximate mean of 101 nm, that showed no 
significant size changes due to the broad distribution of the data points. However, 
this does not rule out that higher amounts of HIV particles might correct this 
insignificant elevation and would result in an efficient difference. Therefore, the low 
particle number from this preliminary dataset that was used to estimate the diameter 
distributions of the NC clusters, restricted the statistically relevance and has to be 
increased in further investigations.    
 
Figure 3.6: PALM super-resolution microscopy shows that soluble CD4 does not significantly 
alters NC cluster distribution in cell-free HIV. Low (50 μg/mL) concentration of sCD4 was used 
for treatment, mimicking CD4 receptor attachment . A genome-internal motif was incorporated into 
the N-terminal region of NC and attached with FlAsH dye which was used to estimate the diameter 
distribution of protein molecule clusters of untreated (blue) and sCD4 treated (red) HIV. Internal pair 
statistical analyses were carried out using a two-tailed unpaired t-test.    
 
3.3.4 Engagement of CD4 binding site in HIV Env is the lynchpin of 
virus size expansion 
 
Next, we used an envelope negative HIV (Env [-]) to assess the specificity of 
the receptor-mediated size expansion of HIV. We performed independent, pairwise, 
blinded assessment of nearly 650 virus particles from different batches of HIV in 
four different sets of experiments with two different concentrations of sCD4 (50 
μg/mL and 500 μg/mL). Our data showed that there were no significant differences 
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on the diameter of Env [-] HIV particles before and after sCD4 treatment (Figure 
3.7). These data provided evidence that the sCD4 receptor induced size expansion 
was specific and that the engagement of CD4 binding site on the HIV envelope acted 
as the lynchpin of virus expansion prior to virus entry. 
 
 
Figure 3.7:  Envelope deleted HIV are unable to expand upon sCD4 treatment. Low (50 μg/mL) 
and high (500 μg/mL) concentrations of sCD4 were used for treatment analyses in (A – B) and (C – 
D), respectively. A and C. Mean matrix diameters from independent sets of 2D cryo-EM projections 
of Env [-] HIV were compared in a pairwise- and blinded-fashion. The MA diameter was estimated 
based on the average length of the two longest perpendicular axes of the Env [-] HIV particles. B and 
D. Cumulative frequencies of the MA diameters from untreated Env [-] HIV and from sCD4 treated [-
] HIV of the 2D cryo-EM projections data were presented. E. Mean MA diameters comparisons from 
1 set of cell-free Env [-] HIV that have been untreated vs sCD4 treated (50 μg/mL); F. Mean MA 
diameters comparisons from 3 set of cell-free Env [-] HIV that have been untreated vs sCD4 treated 
(500 μg/mL). n values are number of virus particles used in each arm of the pairwise-, blinded-
comparisons. Statistical analyses were carried out using two-way ANOVA (A and C).  
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3.3.5 CD4 receptor mediated virus size expansion requires multiple 
viral components 
 
It was recently demonstrated that viral protease-induced maturation of HIV-1 
involves re-positioning of Env trimers from random distribution on the surface of 
immature HIV to clustering of Env proteins on the membrane of mature viruses 
(Chojnacki et al., 2012). As this protein clustering seems to be important for efficient 
HIV entry (Chojnacki et al., 2012) , we asked whether there is a mechanistic link 
between Env clustering and the observed CD4 engagement-induced virus 
remodeling. Using a protease-defective point mutant (PR [-], immature HIV) that 
locks HIV in its immature state, 2D cryo-EM projection analyses showed that sCD4 
treatment, even at high sCD4 concentration (500 μg/mL), did not lead to size 
expansion of HIV PR [-] (Figure 3.8 A – B). Hence, the virus maturation process 
and/or the clustering of Env is a pre-requisite for HIV to undergo CD4-induced virus 
size expansion.  
 
One of the hallmarks of HIV-1 maturation is the formation of the cone-
shaped core, through interaction amongst capsid molecules (Ganser-Pornillos et al., 
2007, Pornillos et al., 2011, Zhao et al., 2013). It has been estimated that the broad 
base of the HIV core is within 11 nm from the viral lipid membrane (Benjamin et al., 
2005) while the narrow ends of the core are in close contact with the inner viral 
membranes (Briggs et al., 2006b). Given that the central 15 nm thick 3D cryo-EM 
reconstructed capsid volume (Figure 3.2 C – D, G – H) and dSTORM CA cluster 
area increased upon receptor engagement (Figure 3.5 C – D and F), we asked 
whether the size expansion of the virus would be affected by the stability of the 
 ϴϱ
capsid core. Using mutant HIV with CA A204C that has a hyperstable core and are 
non-infectious (Zhao et al., 2013), 2D cryo-EM projection data (Figure 3.8 C – D), 
dSTORM data of MA area clusters (Figure 3.8 E – F) and CA clusters (Figure 3.8 G 
– H) showed that stabilizing the virus core impaired the ability of sCD4 to induce 
virus size expansion and HIV to infect target cells. These data suggest that size 
expansion involves the participation of different compartments of the virus particle, 
including the internal viral core. Importantly, as a number of non-infectious virus 
mutants (i.e. Env deleted viruses, immature HIV and hyperstable core A204C 
mutant) are also incapable to expand after sCD4 treatment, these data suggest this 
receptor mediated size expansion is likely to be an important biological process. 
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Figure 3.8:  CD4 receptor mediated virus size expansion requires multiple viral replication 
processes. High (500  g/mL) concentrations of sCD4 were used for treatment. Mean matrix 
diameters (A and C) and their cumulative frequencies (B and D) from independent sets of 2D cryo-
EM projections of cell-free PR [-] immature HIV (A – B) or cell-free hyperstable core HIV A204C (C 
– D) were compared in blinded analyses. The dSTORM estimated areas of MA (E – F) and CA (G – 
H) protein clusters of cell-free hyperstable core HIV A204C before and after sCD4 treatment were 
also compared. No size increase has been detected before and after sCD4 treatment using either 2D-
cryoEM projection analyses or dSTORM protein molecule clustering. n values are number of virus 
particles used in each arm of the pairwise-, blinded-comparisons. Statistical analyses were carried out 
using two-way ANOVA. Error bars show standard deviation. 
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3.3.6 Capsid core stability is not affected by CD4 receptor 
engagement using low concentrations 
 
Based on the presented data, our next question was whether this CD4 
receptor-mediated expansion is related to the initiation of subsequent replication 
events, such as the effect on core stability, potentially priming for uncoating. The 
idea was, that the differences in the core size might affect the compactness of the 
core structure. To assess the stability of the CA core at the pre-entry stage, a cell-free 
version of the fate-of-capsid assay (Yang et al., 2014) was used to detect potential 
stability differences by superficially triggering the disassembly process. Cell-free 
HIV virions were treated with low sCD4 (50μg/mL) concentrations. Next, Triton X-
100 was utilized to initiate the uncoating event by a 2-fold increment increased 
treatment for 20 min, ranging from 0.375% to 3%, and core stability was detected by 
CA protein-specific antibody exposure in immunoblot analyses. Since we observed a 
significant expansion in the CA core at low sCD4 concentrations, the initial dataset 
was obtained in this range. There were no significant differences in the core stability 
between plain virions and CD4-receptor engaged HIV (NL4-3) particles and this 
result was consistent with another strain of HIV (MN) (Figure 3.9 A – D). For ease 
of protein level differences between Triton X-100 treatments, the band intensity was 
graphically examined (graphs next to the immunoblot sets). As expected and 
observed beforehand a hyperstable core mutant HIV E45A did not show any 
differences in CA core stability at the pre-entry state (Figure 3.9 E and F). Despite 
low concentrations of sCD4 were efficient to cause expansion in CA, this 
concentration is insignificant to detect any alterations in core stability, at least with 
the sensitivity of our test. 
 ϴϴ
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Figure 3.9:  Low concentrations of soluble CD4 receptor do not affect CA core stability. Low (50 
μg/mL) concentrations of sCD4 (pink) were used for the treatment. Untreated HIV (purple) was used 
as control for the treated virions whereas an additional HIV MN (grey) virus and a hyperstable core 
containing HIV E45A (green) were utilized as comparison. Disassembly of CA cores were triggered 
by increasing concentrations of Triton X-100 detergent and CA proteins in HIV virion pellets were 
detected by CA-specific antibody-derived immunoblotting. Core stability was examined via CA 
protein densities (A, C and E) obtained from 3 independent experiments using 2-3 different HIV 
batches and the band density was quantified and presented as log intensity (B, D and F). Results are 
reported as means of 2-3 independent experiments (±SD) with 2-3 different batches of HIV.  
 
0 0.375 0.75 1.5 3
0
1×106
2×106
3×106 HIV
HIV with sCD4
Triton concentration in %
lo
g 
In
te
n
sit
y
dƌŝƚŽŶyͲϭϬϬƚƌĞĂƚŵĞŶƚ
,/s ϰϱ ,/s ϰϱǁŝƚŚƐϰ
ƉϮϰͲ
dƌŝƚŽŶyͲϭϬϬƚƌĞĂƚŵĞŶƚ
,/sDE ,/sDEǁŝƚŚƐϰ
ƉϮϰͲ
0 0.375 0.75 1.5 3
0
1×106
2×106
3×106
HIV MN with sCD4
HIV MN
Triton concentration in %
lo
g 
In
te
ns
ity
0 0.375 0.75 1.5 3
0
1×106
2×106
3×106
HIV E45A with sCD4
HIV E45A
Triton concentration in %
lo
g 
In
te
n
sit
y
dƌŝƚŽŶyͲϭϬϬƚƌĞĂƚŵĞŶƚ
,/s ,/sǁŝƚŚƐϰ
ƉϮϰͲ
 ϴϵ
3.3.7 High concentrations of CD4 receptor mimic affects capsid core 
stability 
 
Since low concentrations of the sCD4 receptor treatment did not show an 
effect on core stability, we tested a higher concentration. The limited availability of 
sCD4 mimic, led to the change of resource towards the analogue NBD556 (another 
version of a CD4 mimic that blocks the CD4 site on Env). NBD556 has a lower 
molecular weight than the sCD4 mimic which required the adjustment of the 
concentration to 100 μg/mL, instead of 50 μg/mL, for equality purposes. Then, this 
CD4 receptor analogue was tested for its effect on HIV CA core stability in low 
concentrations (100 μg/mL) which confirmed the previous observation that low 
concentrations do not alter core stability (Figure 3.10 A and B). Next, we tested 
higher concentrations of NBD556 (1 mg/mL) which showed that with an increased 
CD4 receptor binding of this mimic, there was a slight effect on the core stability 
detectable (Figure 3.10 C and D).  However, since not all virus batches showed 
conclusive differences in core stability, it is unclear whether the NBD556 binding 
truly caused this change or whether there is another factor adding to this alteration. 
Further investigations are required to determine significant differences in various 
HIV variants. Despite the fact that a higher mimic concentration resulted in a slight 
reduction of CA core stability in some HIV, the inconsistency between various virus 
batches tends to indicate that a higher CD4 engagement is still insufficient for 
detecting core stability changes. Nonetheless, the lack of a control virus for this data 
set makes it difficult to judge core stability variations in some virus batches which 
has to be determined in this context.  
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Figure 3.10:  Low concentrations of CD4 receptor analogue NBD556 do not affect CA core 
stability but high concentrations do show effects. Low (50 μg/mL) concentrations of NBD556 CD4 
receptor analogue (100 μg/mL) (light red) or high (1 mg/mL) (dark red) concentrations of NBD556 
were used for the treatment. Untreated HIV (purple) was used as control for the treated virions. 
Disassembly of CA cores were triggered by increasing concentrations of Triton X-100 detergent and 
CA proteins in HIV virion pellets were detected by CA-specific antibody-derived immunoblotting. 
Core stability was examined via CA protein densities (A, and C) obtained from 3 independent 
experiments using 3 different HIV batches and the band density was quantified and presented as log 
intensity (B and D). Results are reported as means of 3 independent experiments (±SD) with 3 
different batches of HIV. * is P<0.05.  
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3.3.8 Reverse transcription processes are not initiated at pre-entry 
CD4 binding 
 
It is currently unknown where and when the reverse transcription occurs, 
therefore we assessed the possibility that this process is triggered with the CD4 
attachment. Firstly, we assessed the levels of early cDNA products on p24-CA 
normalized cell-free HIV virions, using –sssDNA primers in quantitative PCR at the 
CD4 receptor-mediated pre-entry stage. Equivalent amounts of HIV were pre-treated 
with sCD4 (50 μg/mL) or NBD556 (100 μg/mL or 1 mg/mL) for 2 hours before the 
reverse transcription was initiated by the addition of exogenous dNTPs at 
physiological levels (Zhang et al., 1996) for 16 hours. A Benzonase treatment for 1 
hour was performed to remove residual plasmid contaminations on the virion 
surface, attributed from the transfection procedure, prior to sample preparation for 
qPCR. Compared were the HIV virions without any treatment, sCD4 engaged 
particles and HIV in the pre-entry stage lacking the dNTP trigger for reverse 
transcription. The data demonstrated that no significant levels of early cDNA 
products were detected at CD4 engagement of HIV beyond the untreated HIV virion 
control of approximately 1 x 106 cDNA copies/mL (no dNTP addition). This level of 
cDNA suggests a previous reverse transcribed RNA into cDNA with pre-packaged 
dNTPs (Lori et al., 1992, Trono, 1992, Zhu and Cunningham, 1993, Huang et al., 
1997).  This trend was evident in either low concentration of sCD4 and NBD556 and 
high concentration of the CD4 analogue (Figure 3.11 A and C).  
 
Since the –sssDNA synthesis occurs early in the reverse transcription 
process, we were asking whether this event progressed further and the early products 
 ϵϮ
were already synthesized into late cDNA. Therefore, we tested for the late gag 
cDNA products of HIV using the aforementioned conditions in qPCR. The analyses 
of late gag specific primers-derived reverse transcripts did not show an increase in 
cDNA products either with the low or high concentrations of sCD4 and NBD556 
receptor mimics (Figure 3.11 B and D) at significant levels beyond the control levels. 
The data suggest that at pre-entry the reverse transcription is not initiated or at very 
low levels, under the detection limit for our quantitative PCR system, to obtain 
significant cDNA production. Despite, the data showed an increase in early 
transcripts, the inconsistency between the tested HIV batches indicates that the 
different concentrations of receptor treatment is insufficient to detect true cDNA 
transcripts, beyond the control cDNA production.  
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Figure 3.11:  Reverse transcription is not initiated at pre-entry. Equivalent amounts of HIV were 
pre-treated with Benzonase, and low (50 μg/mL) concentrations of sCD4 (pink) or low (100 μg/mL) 
(light red) and high (1 mg/mL) (dark red) concentrations of NBD556 were used for treatment. 
Untreated HIV (purple) and CD4 receptor only treated HIV (grey) were used as controls. Addition of 
exogenous dNTPs were used to trigger reverse transcription and the cDNA products in the cell-free 
virions were analyzed via quantitative PCR using –sssDNA- (A and C) and gag-specific primers (B 
and D). Results are reported as cDNA copies per mL and represent means of 3 independent 
experiments (±SD) with 3 different batches of HIV.   
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3.3.9 Capsid core isolation can assist to explore core structure 
rearrangements at pre-entry stages 
 
Microscopy on HIV particles is incapable to directly distinguish any 
structural arrangements in the capsid core. The reason is, that the envelope layer 
represents a barrier to detect slight alterations in the structure. Furthermore, the core 
stability analyses showed that at high CD4 receptor concentrations, some HIV cores 
seem to be affected and disassemble more rapidly, compared to untreated viruses. 
This suggests, that there might be rearrangements in the CA core that are 
undetectable by the cell-free fate-of-capsid-assay. In order to consistently examine 
the cone-shaped structure by visualization the core structure directly, the isolation of 
the CA core (Welker et al., 2000) can assist with such accurate explorations. Whilst 
separating the HIV cores from the virion, a detailed examination of the core structure 
by scanning the surface or visualizing differences in the shape by EM can help to 
discern untreated and treated characteristics. Although this technique has advantages 
for our investigations, it also has difficulties to overcome (stabilizing the fragile 
core).  
 
The core isolation method is problematic due to the low stability of the CA 
core after removal of the enveloped membrane of HIV. In order to select only 
completely intact cores, the quintessential balance between the Triton X-100 
treatment intensity, the hypertonic buffering concentration as well as the timing of 
the treatment were determined on initially hyperstable core-derived virions (HIV 
E45A). HIV E45A virions were treated with Triton X-100 in a hypertonic buffer to 
gently remove the enveloped membrane by the detergent and the strong buffering to 
 ϵϱ
preserve the core structure. CA cores were collected in hypertonic conditions via 
centrifugation and the cores were selected for their intact core surface in SEM and 
analyzed for any possible defects or core-internal leaking in TEM. The surface scan 
with SEM indicated that the outer structure of the cores was undamaged (Figure 3.12 
A). Later, this will assist with examining the features for any alterations in the CD4 
engaged cores, compared to untreated CA cores. Intact structures of the virions and 
the traditional cone shape was then certified via TEM imaging with negative 
staining. These images endorsed the pre-scanned clustered groups of several cores 
(Figure 3.12 B). For increased accuracy the clusters of cores have to be separated in 
order to determine potential structural differences which is problematic in core 
clusters. Once the conditions for the wild type HIV without a stabilized CA core are 
in place, structural characteristics can be imaged by SEM and TEM to discern 
potential alterations between plain virions and CD4 engaged particles. 
 
 
   A                B 
 
 
 
    
 
 
Figure 3.12:  SEM and negative staining TEM detect intact HIV CA cores. Gentle Env membrane 
removal was obtained via Triton X-100 treatment in a hypertonic buffer. CA core extraction and 
collection was conducted under buffered centrifugation and the cores were imaged in SEM (A) and 
negative staining preparation followed by TEM (B). Intact CA cores were identified by density 
variations and cone-shape structures. For ease of identification the SEM CA core structures were re-
colored (red). 
HIVE45A
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3.4 Discussion 
 
Meckes and Wills have previously reported an ‘outside-in’ signal can be sent 
through virus membrane during receptor engagement. The interactions of herpes 
simplex virus with its cellular receptor can lead to internal release of the viral 
tegument proteins from the viral capsid complex (Meckes and Wills, 2008).  In 
agreement with the observations in Herpes simplex virus (Meckes and Wills, 2008), 
our current study provides direct evidence that cell-free HIV is able to receive an 
external trigger (here engagement of the CD4 binding site on Env) to elicit nano-
scale virus structural reorganization. Our evidences are as followed: (1) soluble CD4-
engagement can cause cell-free HIV to expand; (2) virus size expansion is highly 
specific and does not occur with Env [-] HIV mutant; and (3) CD4-mediated virus 
expansion is dependent on viral replication processes, such as the maturation of HIV 
and the wild type stability of virus core.  Together, we propose that HIV-1 undergoes 
a pre-entry priming process, which may enable viral particles to facilitate subsequent 
infection processes. 
 
We present data using three independent techniques; multiple batches of 
viruses; and pairwise, blinded analyses to demonstrate that CD4 receptor 
engagement induced virus size expansion. Due to the inherent but distinct limitations 
of these different techniques, it is not expected these approaches would necessarily 
yield identical estimated values regarding the size of HIV. Amongst these 
approaches, the estimations from 3D cryo-ET reconstruction are likely to be the 
closest to the true HIV particles. 3D cryo-ET analyses showed that the mean MA 
diameter of the particles expanded from 124 nm (SEM ± 3.2 nm) to 134 nm (SEM ± 
 ϵϳ
2.5 nm) and the volume enclosed by the 15 nm central capsid expanded by 26% after 
incubation with high concentrations of soluble CD4. The expansion of the matrix 
lattice measured here may require an expansion of the lipid envelop surrounding the 
matrix lattice, raising the question about the involvement of lipids and membrane-
associated proteins in such process. 
 
Unlike host cells, viruses do not have the capacity to synthesize lipids, raising 
the question of how the virus membrane compensate for this estimated increase in 
surface area upon CD4 engagement. One potential explanation is that, as HIV-1 
contains tightly packed lipid molecules in form of rafts microdomains (Brügger et 
al., 2006), a repacking (possibly via phase transition) of lipid molecules during viral 
entry may account for the increase in membrane surface area during receptor 
engagement, a process that is analogous to the rearrangement of cholesterol-
sphingolipid enriched rafts microdomains during cellular signalling events (Simons 
and Gerl, 2010). It is however important to acknowledge that it is currently unknown 
how different virus-associated lipid rafts components are packed in an infectious 
HIV particle (Brügger et al., 2006), and whether both rafts and non-rafts ‘nano’-
domains co-exist within the membrane of these 100 – 200 nm virus particles. Recent 
work has implicated HIV may enter the target cell at the juncture of liquid ordered-
rafts domain and liquid disordered-non-rafts domains to promote fusion (Yang et al., 
2015), and it is tempting to speculate that both rafts and non-rafts ‘nano’-domains 
may co-exist in HIV particles. The clustering of HIV Env protein during virus 
maturation (Chojnacki et al., 2012) would suggest the virus lipid membrane during 
viral assembly is likely to be sufficiently fluid that can support the movement of 
proteins and perhaps repacking of lipid molecules. More sophisticated tools are 
 ϵϴ
needed to define the dynamics of lipid and protein movement within the viral 
membrane. 
 
Our data rule out, both the pleomorphic nature of HIV and the size variation 
amongst different batches of HIV as contributors to the observed size expansion of 
HIV. Given the lack of virus size increase in our Env negative HIV, immature HIV, 
and hyperstable core HIV mutant, we can also rule out that experimental conditions 
(such as detergent used in dSTORM analysis and the osmolality of buffer) bias our 
data. The requirement of HIV envelope to support sCD4 mediated virus size 
expansion argues for the specificity of the process, indicating that CD4-Env 
engagement is the lynchpin of this virus size expansion process. Conceptually, the 
CD4-Env interaction induced changes in internal virus structure and appears to be 
similar to cellular signaling events. It is currently unclear whether such a process 
could be related to the classical signaling events in eukaryotic cells and/or involves 
virus co-packaged host derived signaling molecules (Chertova et al., 2006).  
 
The most likely role of this receptor engagement-induced size expansion of 
HIV (which is similar to the release of tegument proteins in the case of Herpes 
simplex virus (Meckes and Wills, 2008)) is the priming of the virus to commit to the 
next phase of the infection process. As such commitment may expose vulnerable and 
highly conserved epitopes of the virus and hence may elicit a strong immune 
response, one would predict that this pre-entry priming event is initiated in a highly 
specific and timely manner to avoid pre-mature exposure of these epitopes. 
Interestingly, sCD4 that prematurely induces such priming events also induces strong 
antiviral activities. Madani et al. (Madani et al., 2014) reported small molecule CD4-
 ϵϵ
mimetics are able to sensitize HIV-1 to neutralization, while Munro et al. (Munro et 
al., 2014) observed that CD4 engagement leads to remodeling of HIV Env proteins 
from a dynamic state to a more stabilized conformation. Huang et al. (Huang et al., 
2014) have observed that receptor engagement of virus particles leads to a strong 
binding of broadly neutralizing antibody 35O22, and suggested this was achieved by 
raising the Env spike 15Å away from the viral membrane after CD4 engagement 
(Huang et al., 2014). Although these studies focus primarily on the rearrangement of 
Env on the membrane surface upon CD4 engagement and structural rearrangement 
of the Env protein itself is sufficient to expose the Achille’s heel of HIV for immune 
attack, our data however provide direct physical evidence that these pre-entry 
priming structural rearrangement also extend to the internal virus architecture. These 
data are consistent with each other that the pre-entry priming of HIV particles via the 
unique properties of CD4-Env engagement can lead to remodeling across many viral 
compartments of HIV, highlighting the existence of a previously un-appreciated 
process in HIV entry.  
 
The finding that a specific trigger induces HIV size expansion and requires 
multiple HIV compartments suggests that virus remodeling is similar to changes seen 
in metastable structures. Indeed, viruses can be described as being locked in 
metastable conformations and poised to undergo major conformational changes 
during assembly and entry (Steven et al., 2005, Marsh and Helenius, 2006). Our data 
suggest that HIV is a metastable virus prior to cell entry, which enables remodeling 
of the entire virus. Recent reports have shown that retroviral capsid can assume 
different hexamer conformations (Gres et al., 2015, Obal et al., 2015), suggesting 
different hexamers within the HIV capsid core may have different packing. Given 
 ϭϬϬ
these new findings, a possible explanation for our observations would be that sCD4 
engagement of HIV Env might have shifted the equilibrium of the HIV CA hexamer 
packing from having various types of CA hexamers to common CA hexamer packing 
that resulted in a larger capsid core. However, sophisticated molecular dynamics 
analyses (Zhao et al., 2013) are needed to determine whether cell free HIV capsid 
cores are indeed able to ‘breath’ as seen with the West Nile virus envelope (Dowd et 
al., 2011) and/or the reversible opening of Hepatitis B virus core (Rabe et al., 2009).  
 
The observation that the CA core expands with the entire HIV particle at pre-
entry suggests not only an ‘outside-in’ signal is present but also hints to the initiation 
of subsequent processes important for successful infection. Despite this signaling 
cascade is true for the MA and CA, the NC seem not to be affected which indicates 
that the signal either does not reach core-internally or NC is not targeted. However, 
the fact that a small particle number was explored means a larger sample number is 
detrimental to confirm or rule out the travel of the signaling cascade further into the 
CA core. The unusually long cytoplasmic tail of retroviruses (Postler and Desrosiers, 
2013) might contribute to the signal transduction between the Env, MA and might 
reach the CA but whether this is true and there is an extended signal further into the 
core, has to be examined. Additionally, whether other elements within the CA core 
are affected or the core serves as a barrier is unclear. Because of the CA core 
involvement and the structural adaptation at CD4 receptor binding, it is tempting to 
speculate that the uncoating and the linked reverse transcription (Xu et al., 2013, 
Francis et al., 2016) might be in preparation at the very early phase in the HIV 
replication cycle. However, the findings did not unambiguously confirm this 
proposal as we were unable to link either subsequent processes to the CD4 
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engagement stage. Nonetheless, even there was no striking evidence of infection-
related events at the CD4 receptor engagement, studying co-receptor binding or 
fusion processes might give more insight into the fate of the virion in these steps and 
might enlighten about their potential requirements for the initiation of pre-entry 
replication.      
 
Our data uncover a previously unknown process of HIV entry. This 
phenomenon of pre-entry priming of HIV upon receptor engagement may represent a 
general principle for other enveloped viruses to prime metastable cell-free virus in 
order to commit to the next phase of viral infection. Understanding the details of 
these priming events may lend to a fresh perspective in the development of novel 
HIV therapeutics.  
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4 Cell-free HIV-1 is capable of undergoing 
phosphorylation events upon CD4 receptor 
engagement 
 
4.1 Abstract 
 
 Receptor engagement by HIV during host cell entry activates signaling 
pathways in the cells that can reprogram the cell for successful viral replication. 
Shortly after the contact of HIV with target cells, cellular proteins that are involved 
in numerous signaling pathways can undergo HIV-responsive phosphorylation. It is 
believed that these phosphorylation events only occur during entry of HIV into the 
host cell. Here, we demonstrate that cell-free HIV is capable of undergoing 
phosphorylation processes of pre-packaged cellular proteins at CD4 engagement, 
using a quantitative phosphoproteomics screen. We used 4 different virus groups to 
identify phosphorylation on common cellular proteins whereas some of those cellular 
factors were phosphorylated upon CD4 engagement. These identified cellular factors 
seem to be specifically selected and be involved in a signaling cascade, potentially to 
activate T cells which allows HIV to enter. The majority of these proteins could 
assist HIV with early entry, while the minority of these proteins might have multiple 
functions, including the participation in subsequent replication processes.   
 
 
 
 
 ϭϬϯ
4.2 Introduction 
 
Viruses, such as HIV, not only rely on cellular proteins to facilitate infection 
but often directly manipulate cellular signaling mechanisms to ensure efficient 
replication. This is mainly due to the limited number of proteins which is insufficient 
for successful establishment of infection. Challenging for HIV is the simultaneous 
activation of cellular signals for its entry and prevention of cell-mediated signaling to 
initiate immune response. For example, vaccinia virus (Mercer and Helenius, 2008), 
herpes viruses (Soroceanu et al., 2008) and enteroviruses (Coyne and Bergelson, 
2006) are able to gain access to cells upon viral engagement to cell surface receptors. 
In this manner they are capable of inducing signaling cascades that can assist with 
internalization and the facilitation of viral replication. Accessing those cellular 
signaling mechanisms and their usage is similar between these viruses and HIV. The 
knowledge, we gain from other viruses, can assist with studying similar mechanisms 
and therefore enables a better understanding of the infection success of HIV. This, in 
turn, can help with the design of novel antiviral therapeutics. 
 
One of the most critical steps in HIV infection is the entry phases whereas the 
successful signaling is essential for subsequent replication of the virus. HIV can only 
efficiently replicate in activated T cells. Since the number of in vivo circulating T 
cells in the activated state is low (Stevenson et al., 1990), the virus has to have 
strategies in place to infect resting T cells. Since, HIV cannot efficiently replicate in 
these cells, but actively integrate its genome (Han et al., 2004), this might give the 
virus a head start to rapidly progress with replication, once the cellular activation 
occurs. Therefore, mechanisms have to be available to mediate both, the infection of 
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activated and resting T cells. The attachment of HIV to CD4 as well as the co-
receptors, CCR5 and CXCR4, are essential as the interaction enables the viral 
envelope protein to undergo conformational changes that on one hand facilitates 
fusion between the viral and cellular membranes and on the other hand enhances T 
cell activation and virus replication (Briant et al., 1996, Davis et al., 1997). Previous 
studies revealed that HIV is capable of inducing phosphorylation processes to 
modify cellular proteins during entry that can modulate various early steps of viral 
replication. Such HIV-regulated phosphorylation was found in cofilin (Yoder et al., 
2008), moesin (Barrero-Villar et al., 2009), filamin (Jiménez-Baranda et al., 2007) 
and Rho guanine nucleotide-exchange factor LARG (Hodges et al., 2007). This way 
of manipulating cells for infection was seen in activated T cells. However, it is 
unclear whether HIV manipulates cellular proteins during entry into the target cell or 
whether the virus has mechanisms in place to undergo phosphorylation at pre-entry. 
  
Previous screens on the linkage of cellular factors and HIV infection revealed 
a high variety (Brass et al., 2008, Zhou et al., 2008, Konig et al., 2008, Yeung et al., 
2009, Bushman et al., 2009). Hereby, it was not only shown that HIV accesses and 
needs an extensive number of proteins to establish successful replication during 
infection but also its virions contain a variety of  proteins pre-packaged during 
assembly (Segura et al., 2008, Raghavendra et al., 2010, Linde et al., 2013). A 
majority was identified as cytoskeleton-related proteins. These factors were mainly 
involved in the regulation of microtubules, actin and T cell activation which 
previously showed clear links to HIV biology (Stevenson et al., 1990, Liu et al., 
2009). Such pre-packaged cytoskeleton-related cellular factors included dynamin and 
ezrin (Liu et al., 2009, Linde et al., 2013). Furthermore, cell membrane associated 
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proteins, including SPN (Navare et al., 2012), SLC38A1 (Matheson et al., 2015), 
SPTBN1 (Dai et al., 2013), and FNBP1 (Shrivastava et al., 2016) and the early entry-
activated phosphoprotein LAT (Wojcechowskyj et al., 2013) were linked to HIV 
beforehand as well. These proteins are mainly involved in early entry processes, 
important for the infection of activated T cells, but this might also be targets to gain 
access to resting T cells. Actin is associated to T cell activation (Liu et al., 2009), 
which strengthens the possibility that HIV uses cellular factors to activate entry 
processes, mediate HIV-induced signaling and ensures movement through the 
cytoplasm towards the nucleus. Therefore, it is possible that some proteins, that are 
essential for T cell activation and entry are co-packaged during HIV assembly to 
make them available with CD4 attachment. Subsequently, they are then used by HIV 
to gain access to the resting cell by autonomously activating their functions.  
 
It is known that HIV is capable of manipulating cellular proteins by 
phosphorylation and therefore altering their functions during infection. Currently, the 
phosphoproteomics screen by Wojcechowskyj et al. on HIV-responsive 
phosphorylation of cellular factors, is the closest related to very early entry of HIV 
on target cells (Wojcechowskyj et al., 2013). Wojcechowskyj et al. obtained a global 
view of signaling events by mediating a rapid contact of HIV with primary CD4+ T 
cells (1 min) which potentially includes pre-packaged protein usage. Hereby, it was 
revealed that 239 phosphorylation sites of cellular proteins from 175 genes were 
changed at this early state. Several of these proteins were known to be impacted by 
HIV-receptor binding but they also identified several previously uncharacterized 
HIV host factors. A noticeable protein was the serine/arginine-rich (SR) splicing 
factor SRm300, or as known by its alternative name SRRM2, which suggested that 
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HIV modulates the host cell alternative splicing machinery during entry to facilitate 
virus replication and release. The fact, that the HIV infection is stopped after 1 
minute (potentially too short for accessing further downstream internal proteins), 
indicates that it is likely that HIV selectively incorporates SRRM2 into the 
assembling virion. However, SRRM2 was not listed in studies that identified pre-
packaged cellular factors previously. This might be due to the used procedures to 
obtain internal proteins which could also miss out on packaged cellular factors.  
 
An important cellular association that is modified during HIV infections is 
the cellular ESCRT machinery and the related proteins (McDonald and Martin-
Serrano, 2009, Schmidt and Teis, 2012, Bleck et al., 2014, Van Engelenburg et al., 
2014, Meng et al., 2015, Prescher et al., 2015). It is an essential mechanism for the 
assembly and budding of HIV particles and is well characterized. Cellular proteins 
that are involved in this machinery, include TSG101 and the MVB protein family. 
Studies on these proteins showed that they are essential for HIV replication and play 
an important role in the assembly and scission of virions from the cellular membrane. 
Silencing of TSG 101 and MVB proteins demonstrated to result in defective 
assembly and budding. All the presented examples indicate that HIV is dependent on 
a broad variety of cellular proteins to establish and complete successful replication 
steps. This suggests that we have identified a small portion of essential cellular 
proteins so far and that there is an extended association, HIV has to establish in order 
to produce infectious particles to re-infect and spread.        
 
The overall goal of this chapter is to explore whether HIV is capable of 
inducing modifications of cellular proteins at the CD4 attachment stage. To obtain 
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this early entry stage, cell-free HIV was engaged to a soluble version of the CD4 
receptor, mimicking host cell binding, and so preventing HIV from progressing 
further in infection. At this specific stage of HIV infection, a variety of proteins, 
involved in T cell activation, cytoskeleton association, splicing processes and 
assembly-related pathways, showed extensive phosphorylation. Since the majority of 
these phosphoproteins are generally involved in entry stages, it is tempting to believe 
that their functions are important to HIV for T cell activation to gain access to resting 
cells. 
 
4.3 Results 
 
4.3.1 CD4 receptor-mediated phosphorylation occurs in HIV-1 
virions 
 
It is known that HIV is capable of virus-responsive phosphorylation on 
cellular proteins in the early entry steps of infection. Since the shortest association 
between HIV and the cell lasted only 1 min, there might exist the possibility that 
such cellular proteins were pre-packaged and triggered rapidly, potentially even 
before entry. However, whether HIV is capable of undergoing phosphorylation in the 
virion, was not examined so far. Therefore, we explored whether cell-free HIV is 
capable to induce phosphorylation processes that occur during CD4 receptor 
association by mass spectrometry on 4 different virus groups that was performed by 
Dr Steven Seeholzer (DBHI, Childrens Hospital, USA) and Professor Johnson Mak 
(Deakin University/ CSIRO, Australia). Hereby, HIV was used to infect different cell 
types and the particles were harvested to obtain HIV MN from CEM-SS cells, HIV 
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BaL form SupT1 cells, HIV NL4-3 form SupT1 cells and HIV MN from H9 cells. 
The different cell types mirror the various protein compositions in the assembled 
virion that are required for a specific cell type which also seems to influence the 
packaging of cellular proteins (Mariani et al., 2014). In addition to that, different co-
receptor usage of HIV was selected for comprehensiveness. We reasoned that 
potential variations exist between CCR5 (BaL) and CXCR4 (MN, NL4-3) co-
receptor using HIV to ensure appropriately adaptation to differences in the entry. The 
different cell types (CEM, SupT1 and H9) might assign for variations in 
phosphorylation processes to accommodate cell type-specific conditions. In contrast 
to other studies, all virus groups utilized here were cell-free and either untreated or 
pre-treated with a soluble version of the CD4 receptor (sCD4) at a concentration of 
50 μg/mL, before analyzing them in MS. Microvesicles were used as control for 
physiological protein phosphorylation levels during sCD4 treatment. We deemed a 
phosphorylation in CD4 engaged cell-free HIV compared to cell-free CD4 engaged 
microvesicles as important when the measurement of fold differences was 
approximately 1 log or above. 
 
Out of 17,000 peptides, 607 peptides were identified that showed different 
patterns of phosphorylation between cell-free HIV and CD4 engaged virions, that 
were significantly distinguished from the microvesicle control. From these peptides, 
156 phosphopeptides in HIV MN/CEM-SS, 154 phosphopeptides in HIV 
BaL/SupT1, 134 phosphopeptides in HIV NL4-3/SupT1 and 163 phosphopeptides in 
HIV MN/H9 were detected. Within each phosphoprotein, we could find single or 
multiple peptides that have undergone phosphorylation. By composing a Venn 
diagram, we could illustrate the relationships between the HIV groups regarding their 
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common and uniquely phosphorylated proteins. We selected the top 15 overlapping 
common phosphorylated protein sets between the 4 different virus groups. The outer 
values in the diagram assign for unique phosphoproteins to one virus group while 
further inwards, the values show overlapping of phosphoproteins between 2, 3 and 4 
virus groups. To maximize confidence in the importance of those proteins, we 
selected common phosphoproteins between all 4 virus groups. When comparing all 4 
groups of viruses to discern common phosphorylated proteins that were frequent 
between all of them, there was a 2.7% homology (red square) which identified 12 
phosphoproteins (Figure 4.1 and Table 4.1). Since we were interested in the proteins 
that frequently reappeared in all 4 virus group lists, we concentrated on the 12 
identified phosphoproteins in further examinations. 
 
Eight of the 12 identified proteins, SPN, SLC38A1, LAT, SPTBN1, FNBP1 
SRRM1, SRRM2 and MVB12B, showed strong phosphorylation, compared to the 
background levels of the microvesicles. The remaining 4 proteins did not 
demonstrate a log fold difference that met our selection criteria. Since 8 
phosphoproteins revealed interesting patterns to follow up in more detail but the 
timeframe restrictions only enable an overview about all selected proteins, this 
chapter will focus on highlights about each phosphoprotein and their relation to HIV 
infection. Based on the list of identified common phosphoproteins, we then were 
interested in interaction partners with proteins, known to be regulated by HIV. The 
STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) database 
assisted with such interaction patterns, either directly or indirectly by examining 
shared networks with associated proteins. It showed that from the 8 cellular factors, 
all showed interactions with known cellular proteins that were previously linked to 
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HIV infection. We also compared the identified proteins with RNAi screens of 
human cellular factors of previous studies but did not find any overlapping with our 
identified proteins (Brass et al., 2008, Zhou et al., 2008, Konig et al., 2008, Yeung et 
al., 2009). This suggests that there are differences in screening cell-associated 
infections against cell-free HIV virions or there might be variations when exploring 
modification mechanisms of proteins (in our study the phosphorylation). However, 
there was overlapping with the phosphoproteomics screen of Wojcechowskyj et al. 
that showed conserved splicing proteins with our study, namely phosphoproteins 
SRRM1 and SRRM2 which is examined later in the Chapter (Section 4.3.7) 
(Wojcechowskyj et al., 2013). Regarding individual cellular protein studies, a 
comprehensive comparison will examine common proteins to our study that are 
summarized in the http://www.ncbi.nlm.nih.gov/news/08-11-2016-hiv1-update/ 
database. Since the phosphorylation data were obtained recently, a broader analysis, 
including all available individual studies on the 8 selected cellular proteins, will 
follow beyond this documentation.  
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Figure 4.1: Common and different phosphorylation between 4 virus groups summarized in 
Venn diagram. Cell-free HIV virions were treated with 50 μg/mL sCD4 and subjected to mass 
spectrometry analyses. Pre-packaged and phosphorylated human cellular proteins were identified from 
4 groups of viruses and compared regarding their reoccurrence. Common cellular factors between the 
virus groups were mapped according their occurrence of overlapping phosphoproteins in 1, 2, 3 or 4 
virus groups.   
   
 
 
Table 4.1: Common phosphoproteins between 4 HIV groups.  
 
  
Gene symbol Cellular pathway Previously linked to HIV 
 
ARHGAP15 actin  
CDCA3 cell division 
FNBP1 involved in vesicle scission yes 
LAT T cell activation yes 
MVB12B ESCRT; protein sorting yes 
RPS26 protein synthesis 
SLC38A1 metabolism, transport yes 
SPN T cell activation yes 
SPTBN1 actin yes 
SRRM1 splicing yes 
SRRM2 splicing yes 
THRAP3 splicing 
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4.3.2 Pre-entry phosphorylation of SPN (CD43) by HIV-1 
 
The Sialophorin (SPN) protein was identified via its strong phosphorylation 
and that it was highly targeted at numerous sites by all HIV in this study. Sialic acids 
are thought to play a major role in cell-to-cell interactions whereas it has been shown 
that HIV alters the SPN function through modifications of the sialylation status of 
this molecule (Lefebvre et al., 1994). This HIV-mediated hyposialylation may 
explain alterations in T cell functions and the observed viability of the virus in HIV 
infected individuals. Manipulating SPN in this manner is a mechanism used by HIV 
in activated T cells. However, HIV is also able to infect resting T cells and also 
integrate its genome into regions of actively transcribed genes but cannot reproduce 
without cellular activation (Han et al., 2004). Therefore, the phosphorylation of SPN 
at the pre-entry stage might be a mechanism that is necessary to activate the T cells 
and ensure access of HIV to these cells. After cellular activation of the T cell, the 
hyposialysation of SPN might assist with further manipulation of HIV to proceed 
into replication processes. Furthermore, SPN is necessary for T cell migration 
(Cannon et al., 2011), whereas this is mediated by cytoskeletal movements. If SPN is 
regulated by HIV, potential interactions of SPN with other proteins that are 
associated with the actin filaments can show altered functions. In this manner, a 
changed protein functionality might influence the filament movement and therefore 
decrease T cell migration. In turn, this could undermine the immune response. 
Supported is this by a recent study that demonstrated that SPN is down-regulated in 
early and late infection (Navare et al., 2012), possibly preventing immune response 
activation and altering of protein-protein interactions. It could be imaginable that 
HIV phosphorylates SPN to activate the resting cell and gain access. Since, SPN is 
 ϭϭϯ
an extracellular protein, potentially associated with the viral membrane during 
assembly, it might be the first contact to trigger T cell activation and assist with entry 
of HIV. The fact, that SPN is downregulated during infection in cells, could indicate 
that the virus is dependent on this cellular protein to gain access to the resting cell 
but has to decrease its concentration to prevent a potential defense response later in 
infection.  
  
The interaction of HIV with the actin filament network is important to 
establish successful entry. Therefore, it seems likely that HIV modifies protein-
protein interactions that are associated with this network. A previous study showed 
that the polymerization of actin is essential for the assembly of high concentrations 
of CD4 receptor and CXCR4 co-receptor on the plasma membrane to ensure fluent 
invasion of the host cell by HIV (Liu et al., 2009). In this regard, it is tempting to 
propose that SPN function is an essential precursor for early infection (Figure 4.2), in 
gaining easier access to the target cell, mediating fusion with the cell membrane and 
facilitating smooth movement to the nucleus. It has also been shown that SPN 
functions as a potent co-activator for T cell receptor/co-receptor (TCR/CD3)-
dependent induction of HIV LTR-driven transcription which led to an increased 
production of infectious particles (Barat and Tremblay, 2002). This suggests that 
SPN could be a co-stimulatory cell surface constituent that can modulate HIV 
genome integration into active sites of the cellular genome. It can be important for 
further rapid transcription, translation and expression of viral proteins, once the 
cellular activation commences. 
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Direct or indirect association of SPN to known HIV-regulated proteins was 
assessed in the STRING database. It revealed that ezrin (EZR) was one cellular 
factor that seems to be involved in the same or similar pathway as SPN and showed a 
direct link. EZR is a cytoplasmic peripheral membrane protein that serves as an 
intermediate between the plasma membrane and the underlying actin cytoskeleton. In 
order to ensure undisturbed entry and movement of HIV within the cell, the 
cytoskeleton might assist with this. We assumed an association of SPN with other 
actin-related proteins beforehand and here the EZR shows such linkage which might 
serve as connection between the outer and inner cellular environment. Accessing this 
network assures HIV the access to the cell by hijacking its own cellular components 
and network. Knockdown experiments of EZR in producer cells, resulted in the 
accumulation of released HIV particles with impaired infectivity (Roy et al., 2014) 
suggesting an important role in HIV replication for cytoskeleton proteins. EZR was 
also found in cell-free HIV particles (Linde et al., 2013), suggesting the importance 
for cytoskeleton-related proteins to establish successful integration. Although EZR 
was phosphorylated at the pre-entry stage in our study, it was not detected in all HIV 
at the required noticeable levels (according to our criteria). However, the interaction 
with phosphorylated SPN could have been established early on, at least in some HIV. 
Further investigations have to determine the extent of protein-protein interactions 
with SPN.  
 
There are 5 phosphorylation sites targeted by HIV on the SPN protein which 
suggests an extensive regulation at CD4 engagement. Regulating SPN at the early 
stages seems to be associated to multiple functions, including T cell activation, 
immune response regulation, cytoskeleton modification and protein-protein 
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interactions. Since the targeted serine and threonine phosphorylation sites are in 
close proximity (at position 336, 337, 341, 343 and 355), SPN could either have 
important similar or related functions that are useful for resting T cell activation and 
HIV entry or the virus is highly manipulating a specific function. This would be 
dependent on the folding profile of this protein which can reveal genome regions that 
have to be close for specific functional properties. However, when closely examining 
the individual phosphorylation sites, it shows that only one threonine region (T343) 
is targeted by all HIV (MN, NL4-3 and BaL) whereas all other serine and threonine 
regions (S336, S337, S355 and T341) are selectively targeted by individual virus 
groups (BaL/SupT1, NL4-3/SupT1 and MN/CEM-SS). Since all serine 
phosphorylation regions (S336, S337, S355) are targeted by HIV that were harvested 
from SupT1 cells (BaL/SupT1 and NL4-3/SupT1), this indicates that it might be a 
cell type dependent modification. It could mean that this specific phosphorylation of 
SPN is required for this specific T cell type in order for HIV to start infection. The 
remaining threonine phosphorylation at position 341 is also only targeted by one 
virus, HIV MN/CEM-SS which could be a cell type dependent regulation (Table 
4.2).  
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Figure 4.2: Schematic presentation of a model for the involvement of SPN during infection of T 
cells. SPN is associated to Ezrin, a known protein, important for HIV replication. It is involved in 
cell-to-cell transmission and T cell migration which might assist the virus with the entry by 
autonomous activation of the entry event. The involvement with the cytoskeleton through the 
association of SPN to Ezrin not only mediates entry processes but might also enable movement within 
the cytoplasm on the way to the nucleus. 
 
 
Table 4.2: Pre-entry phosphorylation of SPN in HIV.  
 
Peptide Phosphorylation 
site 
log FC HIV group 
 
GSGGDKGSGFPDGEGS*SRRPTLTTFFGRRKS 
 
SGGDKGSGFPDGEGSS*RRPTLTTFFGRRKSR 
 
PTLTTFFGRRKSRQGS*LAMEELKSGSGPSLK 
 
KGSGFPDGEGSSRRPT*LTTFFGRRKSRQGSL 
 
SGFPDGEGSSRRPTLT*TFFGRRKSRQGSLAM 
 
S336 
 
S337 
 
S355 
 
T341 
 
T343 
 
 
 
2.5424 
 
2.5424 
 
2.2305 
 
1.1187 
 
2.1067 
1.3295 
0.8756 
 
BaL/SupT1 
 
BaL/SupT1 
 
NL4-3/SupT1 
 
MN/CEM-SS 
 
MN/CEM-SS 
NL4-3/SupT1 
BaL/SupT1 
 
4.3.3 Pre-entry phosphorylation of SLC38A1 (SNAT1) by HIV-1 
 
Another protein that was identified in all tested virus groups was the Solute 
carrier family 38 member 1 (SLC38A1) which was shown to be involved in HIV 
infection beforehand via its alias SNAT1 (Matheson et al., 2015). In general, 
SLC38A1 is a transmembrane amino acid transporter whereas T cell activation 
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requires upregulation of the amino acid metabolism, regulated by SLC38A1. 
Matheson et al. showed that HIV Vpu binds endogenous SLC38A1 which led to its 
ubiquitination and subsequent downregulation. Therefore, it seems that HIV requires 
the decrease of this protein for successful viral replication (Oswald-Richter et al., 
2004). However, the phosphorylation and potential activation at CD4 attachment in 
the cell-free virion suggests that the virus is dependent on SLC38A1 to infect resting 
cells and activate the protein to allow the entry and possible interaction to other 
proteins. In fact, it seems that SLC38A1 is a linkage between extracellular and 
intracellular proteins, potentially a required intermediate for successful entry of HIV 
(Figure 4.3). Whether the phosphorylation is essential for the downregulation of 
SLC38A1 in cellular activated cells is unclear. Since we only screened pre-packaged 
proteins for phosphorylation, further experiments in cellular activated T cells will 
assist examining this possibility. However, it might be likely that the mechanism to 
flag some SLC38A1 proteins for ubiquitination requires phosphorylation. In order to 
test this theory, SLC38A1 silencing or overexpression experiments can assist with 
the impact of concentration differences on HIV infection.   
 
Furthermore, using STRING data, SLC38A1 was also indirectly related to 
interact with a protein that is linked to the ESCRT machinery, TSG101. Linked is 
SLC38A1 and TSG101 via the Ubiquitin C protein (UBC). Therefore, we can 
assume that SLC38A1 and TSG101 are involved in linked pathways, potentially 
sharing overlapping through UBC. UBC is an important precursor to regulate the 
concentration of proteins by signaling for their degradation. This linkage indicates 
that HIV could signal for SLC38A1 downregulation by phosphorylation to ensure 
that some proteins are degraded. Matheson et al. also suggested a link to TSG101 
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whereas the depletion resulted in SLC38A1 degradation in endolysosomes by the 
ESCRT machinery. A model could be that HIV phosphorylates SLC38A1 to trigger 
its degradation by signaling for ubiquitination with UBC. The processing 
commences through the ESCRT machinery which leads to downregulation of 
SLC38A1. However, whether the regulation of a balanced concentration is necessary 
at the HIV autonomously activated state of the cell and if so, how this is achieved, is 
unclear. At least, phosphorylation of SLC38A1 seems to be important for the 
attachment of HIV and activation of the resting T cell. Supported is this by the 
observed function as participant in synaptic transmission (Gu et al., 2001), 
suggesting that it is necessary for HIV attachment to the receptor before having 
entered the cell (in the transmission state).  
 
When examining the phosphorylation sites within SLC38A1, it revealed that 
multiple HIV targeted different phosphorylation regions, including serine and 
threonine, that are in close proximity. This suggests that a variety of viruses are 
dependent on a specific function of this protein, potentially its involvement in T cell 
activation. The threonine at position 54 was targeted by two tested HIV from 
different backgrounds (MN/CEM-SS and BaL/SupT1), showing phosphorylation at 
pre-entry, independently of the virus type or cell type. The serine at position 52 is 
only targeted by one HIV type which could be virus and cell type dependent (Table 
4.3).  
  
 
 
 
 ϭϭϵ
     
 
Figure 4.3: Schematic presentation of a model for the involvement of SLC38A1 during infection 
of T cells. SLC38A1 is involved in T cell activation to potentially ensure unimpaired entry of HIV 
into the cells by manipulating the activation status and therefore access of resting T cells. SLC38A1 
seems also associated to UBC for ubiquitination and degradation purposes whereas its concentration 
might be regulated.  
 
 
 
 
Table 4.3: Pre-entry phosphorylation of SLC38A1 in HIV.  
 
Peptide Phosphorylation 
site 
log FC HIV group 
 
GQINSKFISDRESRRS*LTNSHLEKKKCDEYI 
 
INSKFISDRESRRSLT*NSHLEKKKCDEYIPG 
 
 
S52 
 
T54 
 
 
 
1.5754 
 
2.7095 
2.0249 
 
BaL/SupT1 
 
MN/CEM-SS 
BaL/SupT1 
 
 
 
4.3.4 Pre-entry phosphorylation of LAT by HIV-1 
 
The linker for activation of T cells (LAT) is a protein that revealed a specific 
phosphorylation pattern in our MS which showed extensive phosphorylation in 
serine sites. LAT is a transmembrane protein, localized to lipid rafts which is 
phosphorylated following activation of T cell antigen receptor (TCR) signal 
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transduction pathway. Upon phosphorylation, this protein is recruiting multiple 
adaptor proteins and signaling molecules into multi-molecular signaling complexes, 
located near the TCR engagement (Paz et al., 2001, Balagopalan et al., 2010). 
Therefore, this protein could be an intermediate interacting partner for other proteins 
in the early association of HIV with the resting T cell signaling mechanism. HIV can 
achieve this activation of LAT through phosphorylation and develop unimpaired 
invasion. During cellular activation, LAT may be involved in regulating cytokine 
production, proliferation, differentiation and activation of scaffolding proteins. 
Whether HIV is able to activate some functions of LAT by phosphorylation, such as 
interactions with scaffolding proteins or other unknown functions, has to be 
determined. It can be assumed that HIV is reliant on other actin filament-related 
proteins to proceed with its internalization and that LAT is the link to them.  
 
It was shown that HIV interferes with the TCR binding, including the 
disruption of the LAT association to this receptor and its subsequent retargeting to an 
internal compartment (Abraham et al., 2012). This suggests that HIV actively 
prevents the signaling pathway to activate an immune response. After entering, HIV 
has to interfere with the signaling to undermine the recognition for an infected cell 
and its removal. However, based on this knowledge, the phosphorylation of LAT in 
the virion upon CD4 engagement, suggests that this cellular protein is important for 
the entry of HIV into resting T cells by its activation. During infection with cellular 
activation, HIV needs the dissociation of LAT from the TCR receptor to ensure that 
the infected cell is not recognized and further replication steps can occur. 
Furthermore, the STRING interaction network revealed a direct association to the 
lymphocyte-specific tyrosine kinase (Lck) which is also located in the lipid rafts with 
 ϭϮϭ
the LAT. Its function is the phosphorylation of tyrosine residues on certain proteins, 
involved in the intracellular signaling pathways. Therefore, it might be possible that 
the interaction between LAT and Lck initiates the phosphorylation of other proteins, 
important for further cellular movement of HIV. Although Lck was not identified 
with a noticeable phosphorylation pattern (but Lck phosphorylation was observed), 
this does not rule out that LAT interaction further activates the function of Lck. An 
associated function as a complex of LAT-Lck is imaginable.  
 
Lck was linked to HIV beforehand, whereas an increased activity resulted in 
the reduction of HIV replication (Greenway et al., 1996, Yousefi et al., 2003). This 
could be linked to the lower phosphorylation in Lck, whereas the concentration 
might be directly associated with the downstream replication success. However, 
since the infection of resting T cells terminates prior to transcription, this may be 
only a necessary concentration balance for further replication progression, once 
cellular activation occurs. Like LAT, Lck is associated with the exogenous T cell 
receptor (TCR) and regulates its stimulation. HIV Nef protein was previously found 
to modulate the TCR stimulation to balance between T cell activation required for 
HIV spread and prevention of activation-induced cell death. Here, HIV also has to 
prevent immune response via TCR activation which is linked to LAT and Lck. Once, 
LAT-Lck are associated with the TCR for stimulation, Nef seems to interfere 
(however this is not necessarily limited to the Nef function) and prevent the immune 
defense activation, similar to the aforementioned LAT-TCR disruption. The 
reduction of the TCR signal transmission by Nef led to altered actin remodeling 
(Haller et al., 2007). If Nef is essential for actin remodeling, a complex of LAT, Lck 
and Nef might be essential for HIV to move further through the cellular cytoplasm 
 ϭϮϮ
towards the nucleus. Therefore, multiple functions for HIV replication that involves 
LAT and Lck could be possible (Figure 4.4), such as regulation of immune defense 
activation, once HIV enters, and enabling actin filament access of the virus to move 
cell-internally. Such LAT and Lck linkage might be important for the new 
polymerization of actin filaments to create a meshwork that ensures the movement of 
HIV through the cytoplasm.  
 
Furthermore, a study showed the involvement of Lck in the assembly 
whereas the absence of Lck resulted in the reduction of released HIV and virus like 
particles which demonstrated the importance of this protein for targeting Gag to the 
plasma membrane (Strasner et al., 2008). Whether phosphorylated LAT is also 
involved in assembly processes has to be determined. However, as our study 
investigates on potential resting T cell activation and therefore terminates after 
integration until cellular activation, the involvement in the assembly might not be 
likely.  
 
     The phosphorylation of LAT revealed that only serine was targeted by 
CCR5 and CXCR4 using viruses, whereas all have in common that their particles 
were harvested from one cell line infections (SupT1). However why there are only 
serine phosphorylation is occurring, is unclear. It could be linked to the fact that 
there is almost no threonine available in the functional region. Since there are several 
serines in the peptide, that specific serine might be targeted to modify a function that 
is essential for HIV entry. The LAT phosphorylation is targeted by several HIV 
types, harvested from the same cell type. Therefore, it might be important for a 
specific cell type but is co-receptor independent. Noticeable is that S206 and S213 
 ϭϮϯ
are in relatively close proximity and that it is targeted by different viruses, therefore 
indicating that the regulation of the LAT function might be adapted to virus type 
dependent entry requirements (Table 4.4).  
 
 
Figure 4.4: Schematic presentation of a model for the involvement of LAT during infection of T 
cells. LAT is a transmembrane protein that is important for T cell activation and TCR signaling which 
might be hijacked by the virus to reduce the detection of viral infection and preventing the destroying 
process of such cells, once the virus has fused with the cell. It also seems to be involved in the 
remodeling of the actin cytoskeleton which may be important for inner-cellular movement of HIV. 
LAT is associated with Lck, whereas both are linked to the TCR receptor. 
 
 
 
 
 
Table 4.4: Pre-entry phosphorylation of LAT in HIV.  
 
Peptide Phosphorylation 
site 
log FC HIV group 
 
LCVHCHRLPGSYDSTS*SDSLYPRGIQFKRPH 
 
AFSMESIDDYVNVPES*GESAEASLDGSREYV 
 
DDYVNVPESGESAEAS*LDGSREYVNVSQELH 
 
S40 
 
S206 
 
S213 
 
1.3910 
 
2.7447 
 
1.2170 
 
NL4-3/SupT1 
 
NL4-3/SupT1 
 
BaL/SupT1 
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4.3.5 Pre-entry phosphorylation of SPTBN1 by HIV-1 
 
The spectrin β nonerythrocyte 1 (SPTBN1) was a protein that showed 
extensive pre-entry phosphorylation of HIV in our MS screen. SPTBN1 is an actin 
crosslinking and molecular scaffold protein that links the cell plasma membrane to 
the cytoskeleton by binding to actin. It is responsible for shaping the cell, organizing 
transmembrane proteins and arranging organelles. It was recently shown to be a 
required host cell factor in HIV infection (Dai et al., 2013). Dai et al. found that 
SPTBN1 co-localized to the plasma membrane and also the intracellular membrane. 
It was also revealed that this protein has a specific interaction with gag CA and MA 
proteins. This highlights the importance of SPTBN1 for HIV entry processes which 
is supported by the observation that the antagonist IL-27 induced a post-entry block 
to HIV infection in macrophages by suppressing the host factor SPTBN1 (Dai et al., 
2013, Swaminathan et al., 2013). Knockdown of SPTBN1 revealed a strong 
inhibition of HIV infection and conversely its overexpression resulted in an increase 
in HIV susceptibility to macrophages. These results show that HIV induces 
upregulation of SPTBN1 to gain access to the cell and establish infection. Based on 
the presented functional background of this cellular factor, it seems likely that HIV 
uses SPTBN1 in resting T cells to get access to further inwards acting proteins and 
ensures its infection progression up to genome integration. It assigns for the direct 
association of HIV to the actin filaments, potentially assisting the CA core to move 
along the filamentous network towards the nucleus and deliver the viral genome.  
 
The identification of this cellular factor, pre-packaged in the HIV virion, 
shows the vast extend of HIV utilized proteins to gain access to resting T cells and 
 ϭϮϱ
partially establish infection. Moreover, SPTBN1 also targets the cytoskeleton (Figure 
4.5) and the related pathway, in addition to arranging transmembrane proteins that 
are targets of HIV-responsive phosphorylation. Imaginable is that the association of 
SPTBN1 with transmembrane proteins triggers the reorganization of the cytoskeleton 
network and ensures the movement of the HIV CA core within the cytoplasm 
towards the nucleus. Since SPTBN1 binds to actin, it is likely that this protein is 
involved in the cytoskeleton rearrangement, potentially the polymerization of actin. 
This suggests that some identified proteins seem to be entwined and act in similar 
pathways, such as the transmembrane proteins SLC38A1 and LAT and actin-
associated proteins to ensure HIV entry and movement. Although SPTBN1 was 
mainly linked to macrophage infections by HIV in the literature, the here used 
different cell lines (CEM-SS, SupT1 and H9), to produce the particles, indicate that 
targeting same proteins seem not to be restricted to a specific cell type. 
 
The phosphorylation pattern for SPTBN1 revealed that the majority of the 
extensive phosphorylation was found on serine sites (Table 4.5). Whether serine 
phosphorylation targets a specific function is currently unclear. The packaging of this 
protein seem to be important for any HIV targeting any T cells and that SPTBN1 has 
an essential role for infection progression. All phosphorylation sites, either serine or 
threonine are in very close proximity which might hint to a strong regulation of a 
specific function. Furthermore, some phosphorylation (S2160, S2164 and T2159) 
could assign for cell type specific modifications (NL4-3/SupT1 and BaL/SupT1) but 
seem to be independent from the co-receptor usage. This suggests that the 
phosphorylation of some entry-assisting cellular proteins, induced by HIV with CD4 
 ϭϮϲ
engagement may be an elaborate mechanism to establish entry to a variety of cells, 
independently from the state these cells are in, either activated or resting.  
 
 
 
 
Figure 4.5: Schematic presentation of a model for the involvement of SPTBN1 during infection 
of T cells. SPTBN1 is a cytoskeleton associated protein that regulates transmembrane protein 
organization. Due to its involvement in early entry processes, this protein seems to be important for 
the establishment of unimpaired entry. Possibly the association to the cytoskeleton and its 
organization also enables the movement of HIV within the cytoplasm.     
 
 
 
 
Table 4.5: Pre-entry phosphorylation of SPTBN1 in HIV.  
 
Peptide Phosphorylation 
site 
log FC HIV group 
 
TVDTSEMVNGATEQRTS*SKESSPIPSPTSDR 
 
DTSEMVNGATEQRTSS*KESSPIPSPTSDRKA 
 
EMVNGATEQRTSSKES*SPIPSPTSDRKAKTA 
 
MVNGATEQRTSSKESS*PIPSPTSDRKAKTAL 
 
VDTSEMVNGATEQRT*SSKESSPIPSPTSDRK 
 
S2160 
 
S2161 
 
S2164 
 
S2165 
 
T2159 
 
1.4433 
 
1.8018 
 
1.1063 
 
2.8715 
 
1.4433 
 
NL4-3/SupT1 
 
MN/H9 
 
BaL/SupT1 
 
MN/CEM-SS 
 
NL4-3/SupT1 
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4.3.6 Pre-entry phosphorylation of FNBP1 by HIV-1 
 
A noticeable phosphorylation profile was detected with FNBP1, which 
belongs to the formin-binding protein family. FNBP1 is required for the coordinated 
formation of membrane tubules via lipid binding and acts as assistant for actin 
cytoskeleton reorganization during the late stages of clathrin-mediated endocytosis. 
It also enhances actin polymerization, important for the fission of membrane tubules 
to form endocytic vesicles. This protein might be important for HIV to move within 
the cell to deliver the viral genome to the nucleus, as it is involved in the actin 
organization. FNBP1 could be involved in the polymerization of actin to create a 
network, HIV can use to move towards the nucleus and deliver the viral genome. 
Recently, a study showed that FNBP1 is up-regulated and highly expressed in HIV 
infected cells compared to uninfected cells, suggesting an important role for viral 
replication (Shrivastava et al., 2016), potentially due to its membrane binding and 
cytoskeleton reorganization functions. The activation of the upregulation might be 
modulated by phosphorylation and therefore assist with network rearrangements, 
regulated by HIV. FNBP1 was only incorporated in gene expression analyses, 
comparing Nef depleted HIV and wild type, whereas no difference was observed in 
the Nef mutant and therefore the group did not proceed with their investigations.  
 
By phosphorylating FNBP1 in the HIV virions upon CD4 engagement, HIV 
might use this protein to polymerize actin filaments to ensure its movement within 
the cellular cytoplasm. Since this protein is not activated in the resting cell, HIV may 
have to provide this protein in its active state to ensure the integration of its genome 
 ϭϮϴ
into the cellular DNA. Achieved is this potentially by the phosphorylation which, in 
turn, can induce the microtubular network reorganization for HIV’s movement. Since 
FNBP1 was detected at CD4 engagement in this study further detailed analyses of 
this protein is necessary to examine the extend of this protein for HIV replication 
processes by mutation, silencing and overexpression experiments. Nonetheless, the 
interaction with Lck is interesting because FNBP1 could be an important central 
protein in a multiple protein-protein interaction network and is further explored in 
the next paragraph. 
 
To examine this protein further, we investigated on association partners with 
the STRING network and found a direct interaction to dynamin 2 (DNM2) and cell 
division control protein 42 (CDC42). Dynamin is associated with microtubules and 
binds many proteins that bind actin and other cytoskeletal proteins and is therefore 
involved in cell processes, such as endocytosis and cell motility. CDC42 is a protein 
that regulates signaling pathways within the cell, including morphology, migration, 
endocytosis and cell cycle progression. Inhibition of CDC42 resulted in reduced 
numbers of membrane protrusion by HIV (Nikolic et al., 2011). The linkage of 
FNBP1 to DNM2 and CDC42 suggests that the importance of this protein seems to 
be in the interaction with the cytoskeleton to ensure entry into and movement within 
the cell for HIV. All the aforementioned associations indicate that FNBP1 might be 
an important regulator for other proteins of the cytoskeleton. Although, we have 
some insights in the movement of HIV in the cellular cytoplasm and know about the 
association of HIV with the actin filament network and associated proteins 
(McDonald et al., 2002), the exact route of movement is not fully understood. The 
extensive phosphorylation of FNBP1 might be necessary to guarantee high 
 ϭϮϵ
regulation of this protein in combination with interactions to other proteins to assist 
with the establishment of successful entry into resting T cells and genome integration 
(Figure 4.6).  
 
There was a strong phosphorylation at 4 regions within FNBP1, mainly at 
serine positions whereas the majority of those targets were found in the MN virus 
(Table 4.6). Since FNBP1 is linked with the cytoskeleton and the extensive 
phosphorylation of this protein is evident at multiple sites (S296, S299 and T376) 
only in CXCR4 co-receptor using HIV (CXCR4 using MN), this might be dependent 
on the entry route via the specific co-receptor usage. In order to test this hypothesis, 
CXCR4 and CCR5 using HIV with mutations in FNBP1 at the specific 
phosphorylation sites and their combinations will determine the effect on viral 
infection. Whether the serine phosphorylation at position 332, only seen in the 
SupT1 produced HIV NL4-3 virus, is additionally cell type dependent, has to be 
determined.  
 
 
 
 ϭϯϬ
 
Figure 4.6: Schematic presentation of a model for the involvement of FNBP1 during infection of 
T cells. FNBP1 is associated with Dynamin and CDC42 and seems to be involved in early entry 
processes, including cell-to-cell transmission and cytoskeleton-mediated events. The phosphorylation 
may influence the activated function of this protein to ensure unimpaired entry of HIV by prevention 
of downstream cellular defense monitoring as well as enabling the movement within the cytoplasm 
utilizing the cytoskeleton network. 
 
 
 
 
 
Table 4.6: Pre-entry phosphorylation of FNBP1 in HIV.  
 
Peptide Phosphorylation 
site 
log FC HIV group 
 
 
DIEFEDYTQPMKRTVS*DNSLSNSRGEGKPDL 
 
FEDYTQPMKRTVSDNS*LSNSRGEGKPDLKFG 
 
SKGKLWPFIKKNKLMS*LLTSPHQPPPPPPAS 
 
KQQKEPLSHRFNEFMT*SKPKIHCFRSLKRGG 
 
 
S296 
 
S299 
 
S332 
 
T376 
 
 
2.7030 
 
2.7030 
 
1.3462 
 
1.0279 
 
 
MN/H9 
 
MN/H9 
 
NL4-3/SupT1 
 
MN/H9 
 
 
 
 
 
 
 
DĂƚƵƌĞ,/s
ϰƌĞĐĞƉƚŽƌ
ĐŽƌĞĐĞƉƚŽƌ
ŶƚƌǇ
ƵĚĚŝŶŐ
,ŽƐƚĐĞůů
EƵĐůĞƵƐ
&EWϭ W
ǇƚŽƐŬĞůĞƚŽŶ
ƌĞŽƌŐĂŶŝǌĂƚŝŽŶ
ǇŶĂŵŝŶ
ϰϮ
ĐƚŝŶƉŽůǇŵĞƌŝǌĂƚŝŽŶ
ĞŶŚĂŶĐĞŵĞŶƚ
 ϭϯϭ
4.3.7 Pre-entry phosphorylation of SRRM1 and SRRM2 by HIV-1 
 
Serine/arginine repetitive matrix proteins 1 (SRRM1) and 2 (SRRM2) were 
two other candidates identified in MS to reveal obvious phosphorylation pattern and 
as expected, because they are part of one protein family (SR proteins), both were 
targeted almost equally by HIV-responsive phosphorylation. A recent study found 
that SRRM2 was extensively phosphorylated and that silencing this gene led to 
impaired HIV infectivity (Wojcechowskyj et al., 2013). The study showed that HIV 
receptor interactions rapidly modulated phosphorylation of a variety of proteins that 
affect potentially multiple steps of viral replication. With the focus on SRRM2, this 
group demonstrated that its silencing caused a strong reduction in p24 release upon 
infection and that the depletion of SRRM2 resulted in increased tat and nef 
alternatively-spliced transcripts. The nominal data for SRRM1 revealed no 
significant reduction in p24 release and partial modulation of tat and nef transcripts. 
This suggests, that SRRM1 and SRRM2 may regulate HIV splicing in both 
overlapping and distinct protein complexes. When comparing phosphorylation sites 
identified in Wojcechowskyj et al., none of the sites matched with the 
phosphorylation sites identified in our study. This might be due to the fact that this 
group used infected cells for their MS analysis while we used cell-free virus that was 
sCD4 engaged. In contrast to this group, we detected phosphorylation of packaged 
cellular factors in those particles. Surprising is, that we also found SRRM1 and 
SRRM2 splicing factors in our pre-packaged virions. There might be an additional 
function of these proteins in resting T cells, since HIV does not proceed beyond the 
integration level (Stevenson et al., 1990) or these splicing factors are essential to be 
activated early to rapidly continue with post-integration transcription and alternative 
 ϭϯϮ
splicing. Noticeable was, that in the Wojcechowskyj et al. study, the main targeted 
phosphorylation sites were serine-derived, as also seen in our analyses. Whether 
there are functional similarities has to be examined. Both, SRRM1 and SRRM2, 
revealed only serine phosphorylation with some phosphorylation sites in close 
proximity and some further apart. This might hint to separate functions, the proteins 
are involved in, that are used by HIV to ensure successful replication. This is likely, 
as SRRM1 and SRRM2 are involved in numerous pre-mRNA processes and they are 
part of the pre- and post-splicing multiprotein complexes. SR proteins are central 
regulators of cellular splicing whose activity can be modulated by phosphorylation of 
SR domains (Long and Caceres, 2009). Based on the current knowledge and our data 
for SRRM1 and SRRM2, HIV-responsive phosphorylation of these proteins, strongly 
involved in splicing, seems to be essential for mRNA modification after integration 
into the host genome in order to ensure the guidance of viral protein production 
(Figure 4.7). Since we observed phosphorylation on these cellular factors within the 
cell-free viral particle, the potential additional function of SRRM2 by stabilizing 
HIV RNA until the save delivery to the nucleus is likely for the entry of HIV in the 
resting cell. It is believed that SRRM2 can bind to the poly(A)-tail of RNAs. If 
SRRM2 is able to attach to viral RNA, it might assist with the stability of the HIV 
genome.  
 
Most interesting in the phosphorylation pattern is the extensive serine-
directed modification in multiple regions of either SRRM1 and SRRM2 (Tables 4.7 
and 4.8). Such highly targeted phosphorylation indicate a strong modulation of the 
functionality of these proteins.  Directed is this splicing activity probably towards 
viral protein expression by regulating the alternative splicing of the integrated HIV 
 ϭϯϯ
genome. This seems to be likely, once the cellular activation of resting T cells is 
initiated and HIV progresses into post-integration phases. Therefore, the 
phosphorylation of SRRM1 and SRRM2 might be essential for the rapid response to 
this eventuality. For the SRRM1, this seems to be independent from the virus type 
(HIV types MN, BaL and NL4-3), or the cell type, the virion is derived from (CEM-
SS and SupT1). However, SRRM2 appears to be only targeted by CXCR4-mediated 
entry (HIV types MN and NL4-3), independently from the cell type (CEM-SS and 
SupT1). Since the phosphorylation of both proteins seems crucial in several viruses, 
they either work independently and/or dependently on HIV splicing after T cell 
activation. 
 
 
Figure 4.7: Schematic presentation of a model for the involvement of SRRM1 and SRRM2 
during infection of T cells. SRRM1 and SRRM2 are simultaneously targeted and are part of the same 
splicing-related pathway. Both proteins are associated and seem to be involved in potential splicing of 
incoming transcripts or are initiated at pre-entry to rapidly mediate splicing processes downstream. 
The phosphorylation seems to prepare for subsequent events, once the transcription has been initiated 
by cellular activation of the T cell. 
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Table 4.7: Pre-entry phosphorylation of SRRM1 in HIV.  
 
Peptide Phosphorylation 
site 
log FC HIV group 
 
SHSRSPRHRTKSRS*PSPAPEKKEKTPELPEPS  
 
LKVPKPEPIPEPKEPS*PEKNSKKEKEKEKTR 
 
RESPSPAPKPRKVELS*ESEEDKGGKMAAADS 
 
SPSPAPKPRKVELSES*EEDKGGKMAAADSVQ 
 
S209 
 
S260 
 
S458 
 
S460 
 
0.8700 
 
0.9001 
 
0.8941 
 
0.8941 
 
MN/CEM-SS 
 
BaL/SupT1 
 
NL4-3/SupT1 
 
NL4-3/SupT1 
 
 
 
Table 4.8: Pre-entry phosphorylation of SRRM2 in HIV.  
 
Peptide Phosphorylation 
site 
log FC HIV group 
 
STQRPSSPETATKQPS*SPYEDKDKDKKEKSA 
 
RSDTSSPEVRQSHSES*PSLQSKSQTSPKGGR 
 
SKSQTSPKGGRSRSSS*PVTELASRSPIRQDR 
 
S332 
 
S1083 
 
S1103 
 
1.1460 
 
2.1150 
 
1.1694 
 
MN/CEM-SS 
 
MN/CEM-SS 
 
NL4-3/SupT1 
 
 
4.3.8 Pre-entry phosphorylation of MVB12B by HIV-1 
 
One of the most obvious proteins in the list of phosphoproteins that was 
common in all tested viruses is the multivesicular body subunit 12B (MVB12B) 
which is known to be an involved protein in the ESCRT-I complex, a target of HIV. 
The ESCRT machinery involved protein has close association to MVB12A and 
TSG101. Surprising is, that MVB12B was identified in our experiments at a very 
early step in infection, the CD4 engagement. Since it is known to be important for 
HIV replication during assembly and budding, its early detection in pre-packaged 
virions and its phosphorylation triggered by CD4, indicates the importance of this 
protein for HIV infection. Our observation of MVB12B phosphorylation seems to be 
related to an early activation, either by having an additional function or as 
preparation of subsequent replication steps, including assembly and budding in late 
 ϭϯϱ
infection. This is highlighted by the detection of MVB12B phosphorylation in 
numerous virus groups, suggesting it is essential for a variety of virus types. In 
addition, MVB12B was identified and linked to HIV in several other studies 
beforehand, which further supports the importance for viral infection. Since infection 
in activated T cells differs from the resting cell infection, it is surprising why 
MVB12B was activated here and might link to additional functions.  
 
Generally, the function of MVB12B is to mediate the sorting of ubiquitinated 
cargo proteins from the plasma membrane to the endosomal vesicles (Bache et al., 
2003, Katzmann et al., 2003, Lu et al., 2003, Pornillos et al., 2003, Tsunematsu et al., 
2010). ESCRT-I complex plays an important role in HIV budding and protein sorting 
(Morita et al., 2007, Sette et al., 2013), whereas the p6 region of the virus targets the 
proteins of this complex as well as associated cellular factors, such as TSG101 to 
initiate the scission of budding particles (Martin-Serrano and Neil, 2011). The MVB 
protein family was extensively characterized in the past whereas this section will 
concentrate on results that are closest linked to our study. In particular, one group 
investigated the subunits of the MVB12 family, MVB12A and MVB12B, whereas 
their data revealed a reduction of HIV infectivity upon depletion of MVB12B 
(Morita et al., 2007). MS analyses demonstrated similar peptides to the ones 
identified in our screen but showed different phosphorylation patterns. Since the 
infections were cell-derived and did not include any resting cell infection of HIV, 
this might be responsible for discrepancies in phosphorylation patterns of proteins. 
This means that even same identified, phosphorylated proteins, are not necessarily 
show identical patterns between activated proteins, potentially important for 
infecting resting T cells (our study) and functionally modified proteins in activated T 
 ϭϯϲ
cells (Morita et al. study). Morita et al. focused on MVB12A during their 
investigations and therefore incorporated additional mutations into MVB12A that 
were corresponding to MVB12B phosphorylation sites. It was found that they are 
functionally important as they resulted in a block of HIV infectivity, virion release 
and Gag processing. Based on the knowledge about the involvement of MVB12B in 
the assembly process and overall viral infectivity, this suggests that with our finding 
of phosphorylation of this protein in the early stages of infection, cellular protein 
regulation for assembly or general protein regulation might be initiated early on 
(Figure 4.8).  
 
We also generated an interaction network with STRING to explore possible 
known or association partners of MVB12B. As expected, network database analyses 
showed a direct interaction to TSG101, which was also identified in previous studies. 
Since it is unclear why the ESCRT-related MVB12B protein is phosphorylated at the 
potential resting T cell activation for HIV entry, further examinations are 
detrimental. Mutation experiments of the phosphorylation sites in MVB12B, 
separately or their combination, will show the grade of essentiality of the identified 
noticeable phosphorylation. Whether MVB12B is also required for other pathways to 
ensure successful replication progression has to be determined.  
 
When examining HIV-responsive phosphorylation sites during CD4 
association, it revealed that serine and threonine were targeted by various tested 
viruses (Table 4.9). Since the MVB12B is phosphorylated at 3 different positions 
within the protein, this may indicate that it is involved in complex, multileveled 
regulations. The multiple numbers of MVB12B phosphorylation sites might be 
 ϭϯϳ
linked to a possible high post-translational regulation. Overexpression of MVB12A 
and MVB12B showed a strong impact on HIV by reduced accumulation of 
intracellular Gag processing intermediates, immature particles that remain associated 
with the cell surface and the inhibition of HIV release and infectivity (Morita et al., 
2007). This indicates that the regulation of the MVB proteins is essential and might 
be achieved by the phosphorylation and also might require the rapid regulation, once 
the cellular activation commences. It is imaginable, that with the internalization of 
the CA core and the partial disassembly process, MVB12B moves directly to the 
ESCRT machinery to prepare either protein degradation processes or acts as a 
hijacking partner for this machinery for the downstream assembly and budding. 
 
We then tried to match the phosphorylation sites obtained in our study with 
previously identified sites from Morita et al., but none of them were correspondent 
with the ones detected here. There were matching peptide sequences which showed 
overlapping with the peptides in our study (Table 4.9 red peptide amino acids), 
however, mainly threonine phosphorylation was detected. Since there was no 
conserved phosphorylation detectible between this previous study and our 
investigations, discrepancies are possible due to experimental differences. While we 
potentially detected activation of MVB12B, Morita et al. progressed further in HIV 
infection.  
 
A next step was to examine what impact the phosphorylation sites in our 
study have on HIV replication. Post-translational regulation may be initiated in the 
pre-entry phase or additional regulations are possible which has to be further 
determined. This might include the rapid association of MVB12B with the ESCRT 
 ϭϯϴ
machinery to ensure the protein sorting/reorganization and assembly preparations. 
We previously assumed an additional function for the ESCRT machinery in the 
protein degradation which also could play a role here.  
 
Noticeable is that the serine phosphorylation at position 201 is targeted by 
multiple tested virus groups from different infection backgrounds, MN/CEM-SS, 
NL4-3/SupT1 and BaL/SupT1 (Table 4.9). It suggests that this phosphorylation site 
might play an essential role for viral infection, independently of virus type or target 
host cells. Threonine phosphorylation at position 214 is targeted by NL4-3 and BaL 
viruses, that were infected in SupT1 cells which might indicate a cell type-specific 
phosphorylation. All serine and threonine phosphorylation positions are in close 
proximity which indicates the requirement of a specific function of MVB12B that is 
important for the establishment of successful HIV entry or preparation of subsequent 
replication. 
 
Figure 4.8: Schematic presentation of a model for the involvement of MVB12B during infection 
of T cells. MVB12B interacts with TSG101 to mediate assembly processes and is also involved in 
endosomal processing of proteins. The phosphorylation of this protein seems to activate MVB12B in 
order for successful replication events establishment, once T cell activation by the cell commences. 
Because this occurs at the pre-entry stage, subsequent processes seem to require a rapid modification 
early on. 
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Table 4.9: Pre-entry phosphorylation of MVB12B in HIV.  
 
Peptide Phosphorylation 
site 
log FC HIV group 
 
GIWYRMGRVPRNHDSS*QPTTPSQSSAASTPA 
 
 
 
SSAASTPAPNLPRHIS*LTLPATFRGRNSTRT 
 
GIWYRMGRVPRNHDSSQPTTPSQSSAAST*PA 
 
S201 
 
 
 
S224 
 
T214 
  
2.5075 
1.9488 
0.9257 
 
1.6711 
 
1.0412 
 
 
MN/CEM-SS 
NL4-3/SupT1 
BaL/SupT1 
 
NL4-3/SupT1 
 
NL4-3/SupT1 
 
4.4 Discussion 
 
Viruses have evolved mechanisms to interact with host factors and pathways, 
that are involved in numerous steps of replication. Particularly in HIV, a variety of 
studies identified approximately 200 – 300 independent cellular proteins each, that 
were linked to the virus (Brass et al., 2008, Zhou et al., 2008, Konig et al., 2008, 
Yeung et al., 2009, Bushman et al., 2009). This suggests that the extend of HIV-
responsive host protein modifications and the associated mechanisms is vast and we 
have only scratched the surface so far. This enables HIV to infect not only activated 
T cells but also resting cells, although in the later the infection is terminated at 
integration until cellular T cell activation (Stevenson et al., 1990).  
 
It is known that HIV is able to co-package cellular proteins during HIV 
assembly which is believed to facilitate viral-host protein interactions for subsequent 
replication steps (Ott, 2008, Linde et al., 2013). Shortly after HIV enters the cell, it 
was demonstrated that the virus is responsible for the regulation of numerous human 
host proteins. One mechanism that was identified is the phosphorylation of cellular 
factors (Wojcechowskyj et al., 2013). This phosphorylation was observed after 1 min 
 ϭϰϬ
of HIV infection on primary CD4+ cells, potentially too short contact for 
downstream cellular protein phosphorylation. However, whether HIV is capable of 
inducing modifications to pre-packaged cellular proteins in the virion at CD4 
engagement was undetermined so far. In contrast to other studies, our system used 
cell-free virus that was pre-entry activated via CD4 engagement, so the majority of 
phosphoproteins identified in our MS were associated with early mechanisms that 
seem to assist with the activation of resting T cells and the regulation of unimpeded 
entry into those host cells. Such entry-mediated pathways included T cell activation 
(SPN), cell-to-cell transmission (SLC38A1), TCR signaling (LAT), transmembrane 
regulation (SPTBN1) and cytoskeleton-related events (FNBP1). We also found some 
proteins involved in downstream processes, such as splicing (SRRM1 and SRRM2) 
and assembly/budding (MVB12B), that revealed to be phosphorylated at pre-entry. 
However, the proteins involved in splicing and assembly/budding are beyond the 
termination state of HIV infection in resting cells.   
 
It is tempting to speculate that the phosphoproteins found to be associated 
with the cell membrane are involved in a signaling cascade which can promote entry 
and cytoplasmic movements. Since there is no cell association in our study, the 
following result discussion creates a model for the potential involved entry steps 
within a resting T cell to illustrate the effect of HIV-induced protein modifications 
on the infection.  
 
The infection seems to start with the membrane-external SPN protein to 
regulate T cell activation and therefore promoting the viral entry. In a normal 
infection, HIV is dependent on activated T cells to establish successful replication. 
 ϭϰϭ
However, HIV is also able to infect resting T cells by autonomous activation leading 
to successful integration of the viral genome in active cellular genome sites but also 
infection termination until cellular activation (Stevenson et al., 1990, Han et al., 
2004). HIV might  use SPN in order to associate with the cell membrane surface and 
simultaneously prevent the defense system alert (Cannon et al., 2011) which might 
be caused by the internalization later on. Since it is essential to reduce the 
concentration of SPN, because it serves as negative factor for the immune response, 
HIV might have to downregulate this protein after activation and entry. HIV seems 
to achieve this by the hyposialyation (Lefebvre et al., 1994) and the down-regulation 
of SPN (Navare et al., 2012). The SPN decrease might be linked to its function as T 
cell and immune response activator. In an infection HIV is not dependent on T cell 
activation but has to prevent immune response stimulation. Therefore, it is likely that 
HIV activates SPN to gain access to the cell via T cell activation in resting cells but 
once cellular activation is achieved, HIV has to downregulate this protein to 
undermine the cellular immune system. It might be highly regulated by extensive 
phosphorylation, induced by a variety of HIV types whereas it seems to be targeted 
to its specific activation function. Those specific, similar functions might be 
indicated by the close proximity of phosphorylation sites across numerous viruses. 
Close serine phosphorylation sites in only SupT1 cell-derived viral particles, 
suggests cell type-specific modulations, potentially to initially activate its entry and 
subsequent prevention of the immune alert.  
 
Simultaneously, or short thereafter, the transmembrane protein SLC38A1, 
involved in the uptake of nutrients and glutamine transport (Gu et al., 2001), ensures 
the transmission and subsequent uptake of HIV by the human target cell. Usually, 
 ϭϰϮ
HIV downregulates SLC38A1 (Matheson et al., 2015). Since T cell activation 
requires an increased nutrients transport, HIV infection of active T cells is 
independent of this uptake. However, for the infection in resting cells, HIV requires 
the SLC38A1 protein to enter the cell which seems to be achieved by 
phosphorylation. The reason is that SLC38A1 in resting cells will not be in its 
functional state, therefore HIV has to selectively package this protein in order to 
trigger the T cell activation function. HIV seems to target this protein with nominal 
phosphorylation and independent from HIV type and cell type, indicating that this 
protein is essential and the modification of its specific function may require such 
directed modulations.  
 
A protein that links the membrane-external to –internal proteins is the 
transmembrane factor LAT. In the resting T cell, HIV has to activate the 
transmembrane protein LAT and use its properties of interaction to other 
transmembrane and internal proteins to gain access to the cell. The usual function of 
LAT is the activation of the immune defense (Balagopalan et al., 2010) which may 
force the virus to modify its concentration to prevent immune alert, once 
internalized. The phosphorylation of LAT at CD4 engagement suggests an important 
role in cellular entry of HIV which seems to be cell type dependent. Since LAT is 
phosphorylated upon T cell activation and subsequently recruits multiple signaling 
and adapter molecules near the TCR engagement, a phosphorylation might assign for 
the modulation mechanism to influence the cell fate, including scaffolding protein 
activation for successful entry and movement through the cytoplasm towards the 
nucleus. A detailed assessment will have to determine the exact mode of action.     
 
 ϭϰϯ
The previous paragraphs revealed a potential external to internal signaling 
pathway modification whereas the following paragraphs examine the involvement of 
pre-packaged proteins by HIV, regarding the cell-inner regulation. The 
transmembrane proteins could be controlled by SPTBN1, a regulator for this type of 
proteins (Machnicka et al., 2014). As a multi-functional protein, SPTBN1, might be 
important in subsequent signaling pathways, in particular by the involvement of 
cytoskeleton proteins, to ensure the successful cytoplasmic movement of HIV. The 
function as organizing transmembrane proteins and its actin binding properties, show 
the importance for overall external to internal regulations which is essential for the 
unimpaired entry of HIV. Supported is this by the fact that downregulation of 
SPTBN1 results in a post-entry block (Dai et al., 2013), suggesting a role in 
promotion of cell entry and cytoskeleton access. The early activation at CD4 receptor 
engagement might be essential to establish the post-entry progression, once the viral 
membrane fused with the host cell membrane. Extensive phosphorylation of this 
protein, that covered all HIV and cell types, indicates the high regulatory function. 
Highlighted is this by the close proximity of all phosphorylation sites which seems to 
confirm a highly accessed, specific function, potentially involved in the regulation of 
subsequent cytoplasmic movements towards the nucleus. Since this protein is the 
linkage of the cellular membrane to the cytoskeleton, it might also regulate proteins 
involved in actin and tubulin polymerization and reorganization, such as FNBP1 
(Wong et al., 2013).  
 
FNBP1’s function in the enhancement of actin polymerization and 
cytoskeleton reorganization, suggests the importance for HIV to ensure movement 
within the cell from the membrane to the nucleus. Activation of FNBP1 might be 
 ϭϰϰ
possible via its phosphorylation which was extensively seen in numerous HIV types, 
independent of the cell type. This may be in correspondence to the detected 
upregulation in HIV infection (Shrivastava et al., 2016), suggesting the dependency 
of HIV on the actin filament network to progress in the replication cycle, potentially 
by directed movement along the cytoskeleton towards the nucleus to deliver the viral 
genome (McDonald et al., 2002). These 5 entry-related phosphoproteins seem to be 
involved in either the same signaling pathway or in close related pathways with 
potential cross-overs.  
 
A previous study by Wojcechowskyj et al. demonstrated that short after entry 
(1 min into HIV infection), there were host cell proteins revealed that are involved in 
multiple steps of viral replication. In fact, it is well known that cellular alternative 
splicing is altered during T cell activation (Martinez et al., 2012). Indeed, splicing 
factors were identified in the early steps of HIV entry (Wojcechowskyj et al., 2013) 
and investigations showed that silencing of the involved phosphoproteins, SRRM1 
and SRRM2, had an impact on viral replication (SRRM2 indicated a stronger effect 
on viral replication than SRRM1). Our results showed also phosphorylation of 
SRRM1 and SRRM2 at early entry, but we detected them in cell-free HIV at CD4 
engagement, so also linked to resting T cell activation events. Since, other groups 
determined splicing factors to be important in HIV infection and that they are 
modified very early, indicates that these cellular factors seem to play a key role in 
infection. SRRM1 and SRRM2 could be linked to the alteration in alternative 
splicing and therefore associated with HIV-induced modification of T cell activation. 
Our study also associates these two proteins to T cell activation in resting cells but it 
was demonstrated that HIV cannot proceed to the splicing events in those cells 
 ϭϰϱ
(Stevenson et al., 1990, Han et al., 2004). The multiple phosphorylation sites 
detected in both proteins, suggest multiple functions. One of those functions could 
involve the poly(A)-tail binding property of SRRM2 to the HIV genomic RNA (Shan 
et al., 2013) which can promote the RNA stability within the HIV core until 
completion of reverse transcription and cDNA production. As it is unknown how 
rapid this process occurs but there is a prompt and partial CA core disassembly short 
after fusion (Francis et al., 2016), genomic viral RNA might require stabilization 
during this period. Furthermore, either SRRM1 alone or both together could be 
transported into the nucleus where they are waiting for the incoming viral transcripts 
to assist with alternative splicing, once cellular T cell activation commences. Here, 
SRRM1 and SRRM2 may modulate HIV splicing in overlapping and/or distinct 
protein complexes.     
 
 The MVB family was associated to the ESCRT machinery that is utilized by 
HIV for facilitating assembly and release of virions. In particular, the MVB12A and 
MVB12B proteins are mainly involved in these processes and their depletion and 
overexpression inhibit HIV infection and induce unusual viral assembly defects 
(Morita et al., 2007). In this context, it is surprising that MVB12B was 
phosphorylated at the CD4 receptor engagement, whereas the assembly event 
commences further downstream in the replication cycle of HIV. Moreover, the 
assembly and budding inaugurate beyond the integration of viral genome which is 
the termination point until cellular activation. This suggests that MVB12B might 
have to be rapidly associated with its target, the ESCRT machinery, or has an 
extended function. The proteins of the MVB family are involved in multivesicular 
body biogenesis which usually recycles and sorts cargo proteins (Fader CM and MI., 
 ϭϰϲ
2009). Since it is unclear what the exact function of these proteins might be and how 
they contribute to the biogenesis event, they potentially could assist with protein 
reorganization in the HIV particle at early entry or further past the cell membrane 
fusion. This might be linked to the observed expansion (Chapter 3) that seems to 
require a possible movement of proteins together with the rearrangement of lipid 
molecules in the viral membrane. However, this linkage to the protein rearrangement 
in the expanding HIV particle has to be examined in more detail. How sensitive the 
identified phosphorylation regions are, has to be determined via mutation 
experiments in individual positions and their combinations to access the effects of 
these modifications on HIV infection efficiency. 
   
Our data show that HIV is capable of extensive regulation of proteins by 
phosphorylation of packaged cellular factors, triggered by CD4 engagement. We also 
demonstrate that these phosphoproteins seem to be selected and involved in a global 
signaling pathway, potentially required in the activation of HIV entry to resting T 
cells. This includes the facilitation of early access to the cell and preparing for 
subsequent replication steps, such as alternative splicing and potential assembly 
processes (Figure 4.9). In context with global screens on cellular factors that are vital 
for HIV infection, this indicates that there is a broad opportunity to interfere in the 
HIV-induced modification process and interaction with these proteins. Since, it is 
unknown whether, when or how HIV activates pre-packaged cellular factor to gains 
access to resting T cells and promote its entry, this study might contribute to a 
potential mechanism. The knowledge of those cellular proteins and the 
reprogramming mechanisms, HIV uses to access activated and resting cells, will 
assist with the development of novel therapeutics.   
 ϭϰϳ
 
The presented models with the selected phosphoproteins represents 
hypothesized involvements during HIV infection since additional experiments have 
to be undertaken in order to study their functions in detail. Based on the preliminary 
data here, we currently conduct experiments to investigate these and other 
phosphorylated proteins regarding their involvement in HIV infection. These 
experiments and future studies include whether the prevention of phosphorylation of 
intra-viral host proteins inhibit infection, with a focus on how the host proteins are 
phosphorylated within the HIV virions and what kinases are involved. Especially, the 
role of infection-derived down-regulated host factors (phosphorylated or not), such 
as SPN and SLC38A1, are investigated closely regarding their function for HIV 
infection.   
 
 
 
 
 
     
 
 
 
 
 
 
 
 ϭϰϴ
 
 
 
 
Figure 4.9: Schematic model overview of the activation and the involvement of identified 
phosphoproteins during infection of T cells. Early entry of HIV into the cell seems to be mediated 
by different proteins that are inter-related either in one or multiple pathways. Pre-packaged proteins 
are phosphorylated upon CD4 engagement to rapidly facilitating unimpaired entry. It seems likely that 
SPN is the first protein necessary to get access to the cell which usually is attached to the outer 
surface of the cell. The transmembrane proteins SLC38A1 and LAT are potentially the following 
targets of HIV to manipulate T cell activation and TCR signaling to ensure unimpaired entry into the 
cell. Once in the cell, the modification of the SPTBN1 seems to regulate the transmembrane proteins, 
allowing outside-in access and binding to the cytoskeleton for viral movement towards the nucleus. 
Supported is the association of HIV with the cytoskeleton by FNBP1 which enhances actin 
polymerization and reorganizes the cytoskeleton. This ensures the uncompromised entry of HIV and 
prepares for subsequent replication steps. Imaginable is also that splicing proteins, such as SRRM1 
and SRRM2, are either phosphorylated to mediate RNA stability during entry processes or needed as 
preparation for subsequent rapid splicing within the nucleus, once cellular T cell activation occurs. 
The phosphorylation of MVB12B, as essential protein for the later process of assembly, may be in 
preparation for protein reorganization purposes, early ESCRT machinery association or rapid 
assembly initiation, once the viral plasma membrane fusion for budding has started.    
 
 
 
 
 
 
DĂƚƵƌĞ,/s
ϰƌĞĐĞƉƚŽƌ
ĐŽƌĞĐĞƉƚŽƌ
ŶƚƌǇ
ƵĚĚŝŶŐ
,ŽƐƚĐĞůů
dƌĂŶƐŵĞŵďƌĂŶĞƉƌŽƚĞŝŶƐ
EƵĐůĞƵƐ
^ZZDϭ W
^ZZDϮ W
DsϭϮ W
&EWϭ W
ǇƚŽƐŬĞůĞƚŽŶ
^WdEϭ W
ƐƐĞŵďůǇ
ŶƚƌǇ
^ƉůŝĐŝŶŐ
 ϭϰϵ
5 Development of fluorescent imaging tools that can be used 
to dissect sub-particle architecture of HIV  
 
5.1 Abstract 
 
 One of the heavily involved proteins in multiple steps during HIV replication 
is the capsid protein (CA) whereas the interaction between these molecules forms 
into a cone-shaped core during maturation. The core lattice structure is highly 
organized which assures the stability of this compartment and seems to be easily 
compromised by interfering agents, in contrast to other structures, such as the matrix 
(MA) lattice. Imaging viral structures is challenging when attempting to preserve the 
protein functionality and HIV infectivity. Using the biarsenical tetracysteine (TC tag 
attachment) system, allows the labelling of numerous HIV proteins, including MA, 
integrase (IN), and nucleocapsid (NC), and the attachment of the fluorescent dye 
FlAsH. However, this labelling system was unsuitable for CA core labelling as 
previous attempts led to the abolishment of viral infectivity. Since it appears to be 
caused by an extensive TC attachment, a reduction might solve the problem. For the 
first time, we show that it is possible to label the CA proteins with the TC tag at the 
N-terminal region and that these HIV particles lead to a wild type-comparable 
protein processing and formation of virions with wild type-comparable infectivity. 
Together with the MA and NC, the newly acquired CA fluorescent labelling will 
assist with the visualization of HIV particle-internal structures and components. 
Hereby, the biarsenical tetracysteine system was successfully used in confocal 
microscopy. Additionally, the FlAsH-PALM super-resolution microscopy analyses 
was used to examine NC protein cluster distribution within the HIV virion. We 
 ϭϱϬ
demonstrate that the NC proteins are evenly distributed within the HIV particle 
whereas NC clusters seem to spread in a similar distribution range as the MA 
proteins. This and other imaging tools will assist with further examination and 
visualization of particle-internal characteristics.           
 
5.2 Introduction 
 
 Fluorescence microscopy techniques for imaging the internal features of 
HIV-1 and dynamic events during viral infections provide elegant and powerful tools 
in understanding virus-internal and virus-host cell interactions. With recent advances 
in enhanced resolution in the low nanoscale range, super-resolution fluorescence 
microscopy is becoming a prominently used imaging tool with high accuracy and 
specificity. These techniques are now contributing as a comprehensive and 
paramount addition to electron microscopy and becoming stand-alone techniques for 
virology. The combination of these microscopic methods enable new insights in 
understanding both intracellular and intraviral events, as well as their synergy during 
viral infection.  
 
 The most interesting major compartments of HIV are the viral membrane, 
containing envelope (Env) and matrix (MA), the capsid (CA) which forms a core that 
shields internal components, and nucleocapsid (NC) and viral RNA (vRNA), which 
are the most difficult to access. Imaging these structures is challenging, especially 
when viral complexes ranging from 100 – 200 nm (Briggs et al., 2003) and internal 
components are even smaller. While fluorescent viral fusion proteins such as GFP, 
have a potential impact on viral protein function and infectivity (Panchal et al., 2003, 
 ϭϱϭ
Muller et al., 2004, Lanman et al., 2008, Das et al., 2009), this problem has been 
partially overcome with the biarsenical tetracysteine labelling system (Griffin et al., 
1998). Here, the protein of interest is fused to a small, six amino acids tetracysteine 
motif (TC tag) which is less likely to interfere with the structure or biology of 
proteins. This TC tag can then be labelled with membrane-permeable biarsenical 
dyes, such as FlAsH and ReAsH (Adams et al., 2002, Martin et al., 2005). 
Successfully attached was this TC tag at the carboxy- or amino-terminus of HIV MA 
(Gousset et al., 2008, Turville et al., 2008), HIV integrase (IN) (Arhel et al., 2006), 
vesicular stomatitis virus (VSV) MA protein (Das et al., 2009, Mire et al., 2009) and 
HIV Env and NC (Pereira et al., 2011) without compromising virus infectivity. 
However, the TC tag could not be integated into HIV CA core, potentially due to the 
interference with the stability of the highly ordered CA lattice. The HIV CA core is a 
key component because of its multiple levels of involvement in various replication 
steps. Therefore, the visualization of CA is dependent on studying the core-related 
features by density differentiation in electron microscopy (EM) (Welker et al., 2000, 
Briggs et al., 2003, Benjamin et al., 2005). This and other techniques revealed that 
the HIV CA is made up of approximately 1,500 CA monomers, which assemble into 
a hexameric lattice (Ganser-Pornillos et al., 2007, Pornillos et al., 2009). The curved 
cone-shape of the CA core is achieved by capping pentameric rings that are 
integrated into the hexamers at the wide and narrow end (Ganser et al., 1999). 
Disturbing this chemically tightly ordered structure with TC tags might lead to the 
loss of CA lattice stability during assembly, resulting in compromised HIV 
infectivity. Previous studies have not resorted to balancing the TC rate attachment to 
a tolerated level for maintaining structural properties (Pereira et al., 2011), which 
might have been more suitable for this system.  
 ϭϱϮ
 
 HIV entry by membrane fusion releases the viral CA containing the genomic 
RNA and viral structural and replication proteins into the cellular cytoplasm. To 
integrate the viral genome into the cell genome within the nucleus, timely restricted 
reverse transcription commences, which seems to be interdependent from the 
dissociation of the core (uncoating) in a multi-stepwise manner (Xu et al., 2013, 
Francis et al., 2016). Since the uncoating event has various phases, it is likely that the 
reverse transcription process also is executed in several stages. However, it is 
unknown how or when the reverse transcription is initiated and it is also unclear 
whether there is a specific positioning of the RNA required in preparation for this 
event. The accessibility of vRNA is difficult and there are limitations in the 
availability of RNA labelling, therefore studying the NC is an attractive option to 
indirectly investigate RNA. HIV NC is a chaperone protein that catalyzes the 
rearrangement of nucleic acids into thermodynamically more stable structures and 
this activity is critical for RT (Levin et al., 2014). It has been shown that NC binds to 
vRNA (Damgaard et al., 1998) and potentially co-localizes in a complex with the 
genome. Due to NC’s own chaperone activity and the aforementioned reverse 
transcription involvement of HIV NC, the location and position of NC within the CA 
core, may reflect on the location and position of vRNA. Hereby, more accurate 
studies on direct vRNA locations can be made with HIV sequence-specific in situ 
hybridization analyses using the newly developed viewRNA technique (Chin et al., 
2015). Electron microscopic bubblegrams showed that the NC-vRNA complex is 
situated in a concentrated spot at the wide end of the core whereas the results were 
based on density differences and irradiation damage (Fontana et al., 2015). However, 
further investigations are necessary, particularly when taking into account that the 
 ϭϱϯ
vRNA has a length of 9 kb, packaged into the core as dimer (Moore and Hu, 2009), 
with a length of almost 6 μm (estimated from the human genome length) (Lehninger, 
1975, Campbell et al., 1997) and the CA core having a length of barely 100 – 200 nm 
(Briggs et al., 2003) and a width of 50 – 60 nm (Höglund et al., 1992). Furthermore, 
a recent study showed by Atomic Force microscopy that HIV particle size dispersion 
and the characterization of CA core structure is dependent on the availability of the 
“larger” vRNA or the replacement of it with the “smaller” cellular RNA (Faivre-
Moskalenko et al., 2014). This can play a role in the above observation of specific 
positioning of RNA within the CA core. 
 
 Extensive progress has been made on early entry stages of HIV infection. In 
particular, the CD4 receptor attachment to HIV Env is one of the more well 
characterized parts with relatively broad coverage. However, as presented in Chapter 
3, there are still unknown events in HIV entry that have not been explored to the full 
extend. HIV Env binding to the CD4 receptor on the target cell results in a series of 
structural reorganizations of the viral Env proteins and the cellular receptor to 
facilitate subsequent membrane fusion and viral entry (Wilen et al., 2012). It is 
believed that the HIV particle has a static structure and that it only remodels after 
fusion and entry into the cellular cytoplasm. As seen in Chapter 3, HIV is able to 
undergo pre-entry expansion (Pham et al., 2015) and since the entire virion has this 
ability, HIV Env seems also to rearrange, even prior to cellular attachment, namely 
during maturation. It was demonstrated that specific positioning of the HIV Env 
proteins in a locus on the viral surface occurred during maturation and that this event 
was essential for the establishment of successful viral infection (Chojnacki et al., 
2012). This is likely when taking into account that HIV displays only approximately 
 ϭϱϰ
7 – 14 glycoprotein trimers per virion (Chertova et al., 2002, Zhu et al., 2006) and 
there are neutralizing antibodies that can interfere and bind to the Env to avoid its 
attachment (Steimer et al., 1991, Mascola and Haynes, 2013). Therefore, this 
localization of HIV Env might enhance the affinity to the CD4 receptor, promote 
successful association and support the establishment of subsequent replication steps. 
Since this seems to be necessary for subsequent replication steps, an ‘outside-in’ 
signal might prepare particle internal compartments. This has been seen for other 
viruses, such as herpes simplex virus, where cellular receptor engagement resulted in 
the internal release of the viral tegument proteins from the viral capsid complex 
(Meckes and Wills, 2008). Such signaling cascade would be possible for HIV CA 
core which might lead to its position in a specific location to the Env clusters on the 
viral membrane. The imaging of the Env to CA core positioning is challenging due 
to the close proximity of the HIV Env and the inner CA core, with an approximate 
distance of 11 nm between them at the broad base of the core (Benjamin et al., 2005) 
and a closer contact at the narrow end (Briggs et al., 2006b). 
 
 The overall aim of this Chapter is to present tools for super-resolution 
microscopy in order to study HIV internal features. For the first time, we show that it 
is possible to attach a TC tag at the N-terminal end of the CA protein by maintaining 
the infectivity of HIV and that CA-TC can be sufficiently labelled with the 
fluorescent FlAsH dye. This tool enables us to study the inner core compartments 
and will allow the investigation of interactions between viral and cellular proteins. 
Preliminary FlAsH-PALM super-resolution data indicated that the NC within cell-
free HIV virions is distributed throughout the entire CA core, as it showed 
comparable protein cluster distributions to the MA. We are still assessing the 
 ϭϱϱ
viewRNA tool to investigate the positioning of vRNA within the CA core to answer 
the question whether it is occupying the entire core space, as seen for the RNA 
associated NC, or whether it is limited to a specific region. Furthermore, antibody 
labelling is still being assessed to study potential positional characteristics of the CA 
core to the Env clusters on the viral membrane in mature HIV particles.  
    
5.3 Results 
 
5.3.1 Biarsenical tetracysteine labelling of HIVCA-TC with FlAsH 
 
 It is debatable if conventionally used fluorescent labelling might have an 
impact on viral protein function and infectivity and consequently do not correctly 
mirror in vivo infections. The biarsenical tetracysteine (TC) labelling system, that 
was originally developed to study live cell events (Griffin et al., 1998), can be of 
assistance with overcoming this problem. For numerous HIV proteins, such as MA 
and NC, this system was successfully utilized and resulted in infectious particles 
(Pereira et al., 2011). However, the CA labeling always compromised HIV 
infectivity. Therefore, the aim of this part of the study was to investigate whether it is 
possible to label the CA and maintain the functionality of the proteins and 
subsequent HIV infection. Hereby, the non-protruding six amino acids (TC tag) 
motif was directly attached to the N-terminal region of the CA gene (Figure 5.1 A). 
This allows the recognition of the motif and attachment of the FlAsH dye, used in 
fluorescence microscopy, to image the HIV capsid core. Aimed at preserving CA 
functionality and normal replication progression, the attachment of a TC tag also 
allows to maintain normal structural features.  
 ϭϱϲ
 
 We have previously reported that attachment of the TC tag at high levels at 
either the N- or C-terminus of the CA protein compromises its functionality and 
leads to complete abolishment of the infectivity in those particles (Pereira et al., 
2011). To verify the possibility of structural deterioration of the CA lattice caused by 
excessive TC attachments, the challenge was to: (1) reduce the TC tag integration 
into the CA core to an acceptable ratio in order to obtain optimal conditions for 
retaining protein functionality and thereby maintaining viral infectivity and (2) 
accommodate fluorescence labelling at a tolerable level for visualization. With prior 
investigations into the matter in mind, the question was raised whether it is possible 
to overcome the inherited structural difficulties of labelling, affecting CA-CA 
interactions. Therefore, previously developed tactics were assessed and utilized to 
establish a system to harness capsid labelled fluorescence microscopy. In particular, 
we concentrated on exploring the more potent N-terminal tag to the capsid. It 
revealed to be more permissive to the attachment of the TC tag with minimal viral 
activity response (approximately 10%) in prior experiments (Pereira et al., 2011).  
 
In this study, we mixed labelled and unlabelled proviral DNA in a co-
transfection system. As the natural ratio of Gag to Gag-Pol synthesis is 20:1 (Welker 
et al., 1996; Wilk et al., 2001), two different plasmid constructs were used in order to 
change the TC tag attachment at specific ratios. The constructs for the co-
transfections were HIVCA-N-TC and HIVΔRev. HIVCA-N-TC contains the coding genes to 
obtain the labelled CA proteins. HIVΔRev has an introduction of an early termination 
codon and a frameshift in the exon 2 of the Rev sequence, which was removed to 
inactivate the Rev function. Virions, that contain the Rev inactivation in the sequence 
 ϭϱϳ
show a defect in the intron-containing HIV RNA export from the cellular nucleus. 
This construct carries the coding genes to obtain the unlabelled CA proteins. During 
virus production in the producer cell, a mixture of labelled and unlabelled CA 
proteins are incorporated into the HIV core at a specific ratio. The tested ratios were 
4 HIVCA-N-TC to 1 HIV¨Rev, 1 HIVCA-N-TC to 1 HIV¨Rev or 1 HIVCA-N-TC to 5 HIV¨Rev 
to generate theoretical TC tag attachments of 80%, 50% or 16.7% respectively (see 
also Table 2.1).  
 
We subsequently tested the infectivity of the aforementioned TC attachments to the 
N-terminal end of CA to differentiate functional to non-functional labelled CA-
derived viral particles using a HeLa cell line-derived TZM-bl Tat-regulated 
luciferase reporter assay. High TC attachments at CA (above 20%) led to non-
infectious HIV particles, with less than 10% infection capacity as compared to wild 
type HIV. When the labelling ratio was reduced to 16.7%, this resulted in labelled 
capsid proteins in infectious particles with an infectivity rescue of up to 80% of the 
wild type virus (Figure 5.1 B). This specific TC tag attachment was able to retain the 
structural architecture of the capsid core and accounts for the maximum amount of 
TC tag possible, while maintaining the CA protein functionality. Thus, these results 
demonstrate that only small amounts of structural modifications are tolerable in the 
highly ordered CA core when preserving viral infectivity. For the benefit of studying 
internal HIV structures in the natural environment, these modifications are necessary.  
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Figure 5.1 Effects of tetracysteine labelling modification of HIV CA-TC proteins on virus 
infectivity and protein processing. Viruses were produced by transfection in HEK293T cells and 
particle pellets were collected via ultracentrifugation. A. Schematic representation of proviral DNA 
constructs, including TC tag sequences and positions of CA. B. Virions were normalised to their p24 
CA value, indicator TZM-bl cells were infected and the capacity of the particular HIVTC was assessed 
by measuring luciferase activity. Error bars show 4 independent experiments with standard deviations. 
C. Viral proteins were resolved in 10% SDS-PAGE. Protein expression profiles were visualized by 
Western blotting using mouse anti-CA primary and anti-mouse horseradish peroxidase conjugated 
secondary antibodies. 
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 Since there are changes in the CA structure, with a six amino acid 
tetracysteine motif introduced, an important aspect was to monitor the preservation 
of the structural profile of viral CA, which seems to be critical for the functionality. 
Protein analysis using an anti-CA antibody, determined similar capsid characteristics 
of the TC labelled CA compared to that found in wild type HIV (Figure 5.1 C). Due 
to the harvesting procedure which obtained a population of virions at different 
maturation states, a mixture of 55 kDa immature (p55-Gag) and 24 kDa mature (p24-
CA) HIV particles was detected for all, the wild type HIV as well as the TC tagged 
mutants. This implies that the protein production in all tested viruses were not 
essentially different from wild type HIV, and there is no indication of significant 
alterations in the proteolytic processing of HIV CA caused by the TC modifications 
that compromise infectivity.  
  
 Overall, the presented results show that the TC tag can be attached at the N-
terminus of the CA protein without affecting virus infectivity or strongly impairing 
CA functionality.  
   
5.3.2 FlAsH imaging of HIV-1 variants 
 
 Visualization of CA core internal components, such as RNA and proteins, is 
challenging because mainly cluster distributions are measureable within the possibly 
tightly packed compartment. Another disadvantage is, that it is difficult to access 
them for staining purposes. Using the aforementioned TC labelling with its property 
to preserve HIV protein functionality and viral infectivity, allows the study of such 
small cluster distributions. By utilizing the three major HIV proteins MA, CA and 
 ϭϲϬ
NC with the TC system will ensure a comprehensive insight in internal structural 
characteristics of the HIV particle. This will broaden our knowledge about viral 
protein behavior and interactions within the virion, not only valuable for HIV 
research. It has been previously reported that MA can be labelled with 100% TC tags 
(Gousset et al., 2008; Turville et al., 2008) whereas NC requires adjustments in the 
labelling system to accommodate protein functionality by reducing the TC 
attachments to 80% (Pereira et al., 2011). As established in the section above 
(Section 5.3.1), CA only permits TC tags at less than 20% attached to the N-terminal 
region of the protein to maintain functionality. In order to examine whether TC 
labelled MA, CA and NC are appropriate candidates to achieve a comprehensive 
insight into the major intraviral structures non-invasively, a comparison was 
performed regarding their imaging capacity and their intensity levels. We further 
determined whether these major compartments and protein distributions possess the 
claimed characteristics of infectivity at equal levels to wild type HIV. Furthermore, 
we tested imaging properties and evaluated the possibility to combine this imaging 
technique with other imaging methods. In order to examine this, all three constructs 
were used to infect target cells (TZM-bl) to monitor the FlAsH labelling stability 
over a period of time. 
 
 The HIV proviral DNA constructs used in this study are depicted in Figures 
5.1 A and 5.2 A. These constructs were transfected or co-transfected into HEK293T 
cells according the TC system requirements as previously described (Section 
5.3.1)(Pereira et al., 2011). For the purpose of improving imaging quality, 
modifications to the original labelling system were essential to preserve a 
representative signal to noise ratio. Those essential adjustments included the 
 ϭϲϭ
reduction of the FlAsH-EDT2 to half the original concentration (from 1 μM to 500 
nM) during transfection, tight HIV concentration (200 ng) during TZM-bl infection 
and stringent PBS washes (5 times each step) during slide preparation for 
fluorescence microscopy.   
 
 To assess the capacity of the infectivity level obtained from the new CA 
virus, as compared to the available virus systems for MA and NC, TZM-bl cells were 
infected with equal amounts of HIV of the respective viruses as normalized using 
p24 CA protein values, established by ELISA. All TC labelled viruses showed 
similar luciferase activity compared to HIVWT, with ranges of above 100% for 
HIVMA-TC and approximately 70-80% for HIVCA-TC and HIVNC-TC (Figure 5.2 B). 
This demonstrated that the least effect of TC labelling is seen for the HIVMA-TC virus, 
while adjusting the TC tag attachment system, as in the case of HIVCA-TC and HIVNC-
TC
, only slightly affects the infectivity of those viruses. Nonetheless, all tested viruses 
preserve the ability to infect cells efficiently and therefore imaging those viruses 
might reveal a result of what is happening in the virus close to its natural state. Since 
HIVCA-TC exhibits similar infection levels to HIVNC-TC, and the comparison between 
these viruses is essential for further imaging studies to visualize internal core 
structures, the equally high infectivity will potentially help with data integrity. This 
also suggests that, despite differences in the labelling systems, equal virus properties 
are achieved for the different HIV constructs. 
 
 In addition to the infectivity rates, the protein profiles of the different HIV 
virions were examined and compared to wild type HIV, lacking the TC tag, in order 
to differentiate any potential protein processing changes. This determines whether 
 ϭϲϮ
the labelling technique is altering the expression of viral proteins upstream or 
downstream of the target genes, which might invalidate subsequent imaging results. 
The protein profiles were assessed using pelleted virions in protein analyses by SDS 
PAGE and Western blotting with HIV-positive patient sera. All four HIV viruses 
examined, HIVWT, HIVMA-TC, HIVCA-TC and HIVNC-TC, showed similar protein 
processing profiles and therefore confirmed that only minor modifications occur in 
the particles produced in the TC labelling system (Figure 5.2 C). HIVWT revealed 
bands for Env (gp120 with 120 kDa), reverse transcriptase with RNaseH (p66 with 
66 kDa), Reverse Transcriptase alone (p51 with 51 kDa), Gag polyprotein (p55 with 
55 kDa) and the CA (p24 with 24 kDa). These bands were also found in the HIVTC 
mutants but showing different expression levels of the proteins. As the MA permits 
complete TC attachment, the protein processing and expression is equivalent to the 
wild type profile which is also reflected in the infectivity data of approximately 
100% (Figure 5.2 B). However, the protein profiles of HIVCA-TC and HIVNC-TC 
slightly differ from the wild type HIV profile, with the appearance of an additional 
band at approximately 40 kDA. Extra bands for HIVCA-TC and HIVNC-TC might 
suggest that some particles contain partially cleaved proteins with potential MA-CA 
hybrids (17 kDa and 24 kDa) for HIVCA-TC as well as CA-NC hybrid proteins (24 
kDa, 7 kDa plus spacers) for HIVNC-TC. This slight change in the protein expression 
profile may correspond with the previously observed reduction in the infection to 
approximately 70-80% (Figure 5.2 B). This suggests that the attachment of small 
additions to the protein structures are tolerated by the virus only when kept within 
certain boundaries. The high similarity between the protein profiles and infectivity 
rates mean that these constructs can be used in imaging studies.  
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Figure 5.2 Labelling of tetracysteine tagged HIV TC variants and its impact on infectivity and 
protein processing. HIVTC were transfected or co-transfected according the appropriate labelling 
system requirements and compared for their infectivity levels and protein expression profiles. A. 
Schematic representation of proviral DNA constructs, including TC tag sequences and positions of 
MA and NC. B. Infectivity levels, normalized to HIVWT by measuring the luciferase activity in 
reporter TZM-bl cells that have been infected with the appropriate viruses. Error bars with standard 
deviations obtained from 3 independent experiments and 3 batches of virus. C. Virion samples were 
separated by SDS-PAGE and protein profiles were detected by Western blot using pooled HIV-1 
positive patient sera and an anti-human horseradish peroxidase conjugated secondary antibody. 
Positions of viral proteins are indicated on the right.  
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 Before we will be able to analyze protein cluster distributions of the FlAsH 
labelled viruses by PALM super-resolution microscopy, we examined the FlAsH 
labelling stability and accessibility at the early HIV entry stages with confocal 
fluorescence microscopy. This way, we were able to assess the FlAsH signal 
intensity and specificity across the viruses, the excess FlAsH background properties 
and the virus distribution, which are important parameter for super-resolution 
analyses. The best way to analyse these parameters in confocal fluorescence 
microscopy is to use cells as reference. Therefore, we infected TZM-bl cells with 
HIVMA-TC, HIVCA-TC and HIVNC-TC viruses and followed their progress over a period 
of 1 hour. Due to the fact that the MA fuses with the cell membrane at the early 
phases of infection and remains integrated, the one-hour time point was the 
maximum selection in order to compare the imaging quality between all used 
viruses. For referencing purposes all viruses contained red fluorescent mCherry 
attached to the nuclear import regulating viral protein R (Vpr) which is thought to be 
embedded within HIV capsid cores during assembly (Wang et al., 1994). Although it 
was demonstrated that the Vpr is rapidly moving to the nucleus short after CA core 
internalization (Desai et al., 2015) and therefore does not represent an effective post-
fusion infection reference, our study does not proceed further into infection than the 
fusion state. Therefore, the Vpr reference can be used here. This co-transfection 
assists with the identification of viral particles from background fluorescence by 
allowing for co-localization of two fluorescent labels. All virus concentrations were 
normalized to their p24 CA value as described above and equivalent amounts were 
used to infect TZM-bl cells which were spinoculated for 10 min followed by a 
further incubation according the selected time points of 0.5 h and 1 h. The infections 
were terminated with 4% paraformaldehyde (PFA) at 0.5 h or 1 h post infection, the 
 ϭϲϱ
fixed cells were DAPI stained for referencing DNA within the nucleus and mounted 
onto slides for imaging. Generally, the confocal imaging of all virus infections 
revealed the successful attachment via co-localization of the green FlAsH and the red 
mCherry fluorescence at the outskirts of the cell membrane for both time points 
(Figure 5.3 A – D), as described in detail below.  
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Figure 5.3 Confocal fluorescent microscopy of tetracysteine tagged infectious HIV TC variants. 
HIVTC were transfected or co-transfected according the appropriate labelling system requirements and 
compared for imaging efficiency. A – D. The virions were normalized according their p24 CA value 
and target TZM-bl cells were infected with the indicated viruses for 0.5 h or 1 h, before fixation in 4% 
PFA and staining cellular DNA with DAPI. Qualitative confocal microscopy was performed to 
examine dual fluorescence efficiency for the indicated viruses. FlAsH is shown in green (528 nm), 
mCherry in red (610 nm) and nuclei in blue (461 nm). Images are representatives of 3 independent 
experiments. Scale bar is 75 μm.   
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 Firstly, we determined the specificity levels of the FlAsH labelling in HIV 
infections. It was previously reported that fluorescent labelling can result in cell-
associated background, due to the interactions between cellular components and 
residual FlAsH (Arhel et al., 2006). To assess excess FlAsH, we used HIVWT that 
lacked the TC motif and examined the co-localization pattern with particles 
containing the mCherry-Vpr reference. By lowering the FlAsH-EDT2 concentration, 
adjusting the virus amounts and stringent washes during slide preparation, we tried to 
keep the residual FlAsH phenomenon to a minimum (Figure 5.3 A) which was 
achieved, resulting in only nominal co-localization of FlAsH signals with the 
mCherry signal of the viral particles. Hereby, the majority of the viruses were 
localized to the outskirts of the cells with occasional entry of wild type HIV into the 
host at 1 h post infection and mainly lacking the green fluorescent FlAsH. The 0.5 h 
post infection time point revealed nominal virions containing mCherry-Vpr (red 
mCherry channel) and low levels of excess FlAsH (green FlAsH channel) whereas 
there is almost no co-localization between them. However, the 1 h time point showed 
extensive particles containing the mCherry-Vpr (red mCherry channel) compared to 
the low levels of residual FlAsH (green FlAsH channel) with only occasional co-
localization. This gave us confidence to detect primarily true FlAsH labelling on 
mCherry-Vpr containing HIV virions. 
  
 Next, we examined the FlAsH labelling on mCherry-Vpr containing HIV with 
attached TC tags and FlAsH labelling, targeting this motif. We reasoned, by 
comparing HIVMA-TC, HIVCA-TC and HIVNC-TC, the signal intensity between them will 
reveal whether all three viruses are appropriate candidates to examine their cluster 
distributions in super-resolution imaging. MA protein, carrying the TC tag associated 
 ϭϲϴ
with FlAsH showed a strong intensity of the dual fluorescent co-localization with 
mCherry-Vpr in the virion. This virus has the highest possible concentration of 
FlAsH due to the ability to attach the TC tag on 100% of proteins and it showed the 
greatest distinctive signal intensity. Furthermore, an important parameter is that the 
infection did not harm the cells (as seen in the DIC and DAPI channels) and 
therefore assign for uncompromised HIV invasion. This also indicated that high TC 
tagged HIV containing FlAsH dye had no cytotoxic effects on the host cell. The 
extracellular HIVMA-TC virions at 0.5 h post infection, showed no specific 
attachments, displayed nominal signal intensity and showed substantial co-
localization accuracy. The lack of specificity is most likely the result of limited 
attachment affinity in the limited timeframe. On the contrary, at 1 h post infection, 
HIVMA-TC manifested consistently in specific regions around the cell membranes, 
showing similar patterns in the red (mCherry-Vpr) and green fluorescent (FlAsH) 
channels at high levels, almost reaching a co-localization rate of 90 – 95% (Figure 
5.3 B). This suggests that the FlAsH signal is specific for HIVMA-TC viral particles 
containing the mCherry-Vpr reference. Conclusively, the HIVMA-TC virus is an 
appropriate candidate for protein cluster distribution analysis in PALM super-
resolution microscopy.  
 
 Then, we tested our newly developed TC labelling system for HIVCA-TC 
regarding its performance properties to determine whether this labelling system 
would be usable for protein cluster distribution analyses in the planned super-
resolution microscopy. Despite the necessity to change the TC system, the cells 
showed no cytotoxic effects with clear cell borders and distinctive nuclei. As seen for 
the HIVMA-TC virus, HIVCA-TC also showed reduced attachment of viral particles to 
 ϭϲϵ
the cell membrane at 0.5 h which increased at the 1 h time point. Noticeable is that 
the majority of mCherry-Vpr containing viruses (red mCherry channel) and the 
FlAsH signal (green FlAsH channel) reveal similar pattern, appearing to be in the 
same spots. The 0.5 h timepoint showed clear virus particles around the outskirts of 
the cells (red mCherry channel) that was matching with the FlAsH staining of CA 
protein, also located around the cell borders. There was stronger evidence for this 
pattern in the 1 h time point with a higher amount of viral HIVCA-TC particles present 
around the cell membranes which matched the CA protein-derived FlAsH labelling 
pattern. This was indicated in the merged channel with a co-localization rate of 
approximately 75 – 80%. In particular, the zoomed-in panel showed overlapping of a 
large amount of signals (yellow color) (Figure 5.3 C). Therefore, this suggests that 
almost all HIVCA-TC particles contained the FlAsH labelling attached whereas only 
occasionally particles lacked the FlAsH labelling by only showing the incorporated 
mCherry-Vpr. As the laser settings were conserved across all three HIVTC particle 
sets, the HIVCA-TC signal intensity appears reduced, when compared to HIVMA-TC. 
However, this decrease was expected due to the low TC attachment which has to be 
taken into consideration when performing super-resolution microscopy analyses of 
the cluster distributions later on. With this result, we were confident to use the 
HIVCA-TC virus, labelled with FlAsH, for our studies on protein cluster distribution in 
the planned PALM super-resolution microscopy.  
  
 Lastly, we determined whether the core-internal protein TC labelling set, the 
HIVNC-TC virus containing FlAsH fluorescence attached to the NC protein, showed 
sufficient signaling in confocal microscopy, to be used in cluster distribution 
analyses via PALM super-resolution microscopy. The results revealed that the TC 
 ϭϳϬ
labelling did not interfere with the cell conditions again by demonstrating healthy 
TZM-bl cells with distinctive intact cell membranes and nuclei. The HIVNC-TC virus, 
containing mCherry-Vpr (red mCherry channel) as well as the FlAsH labelling 
(green FlAsH channel), at 0.5 h post infection, showed similar pattern in their 
attachment around the cell membrane. 1 h post infection showed a stronger 
attachment to the cells than the 0.5 h timepoint, with co-localized mCherry and 
FlAsH signals at a rate of approximately 85 – 90% (Figure 5.3 D). As expected, the 
fluorescence intensity of HIVNC-TC virus showed a slightly decreased level, 
suggesting this might be linked to the reduced TC labelling that was achievable in 
this virus mutant. This result demonstrates that HIVNC-TC is an appropriate candidate 
for protein cluster distribution investigations in PALM super-resolution microscopy.      
 
 Consequently, this study shows that the three major components of HIVMA-TC, 
HIVCA-TC and HIVNC-TC, can be successfully labelled with FlAsH and that they are 
able to be visualized while undergoing viral cell entry. This determines that the 
technique can be used to further study these compartments and proteins in detail via 
super-resolution microscopy to broaden our understanding of intra-viral and core 
internal features. Since we have limited knowledge about virus internal structures, an 
interesting aspect is to study their protein cluster distribution at different 
development stages, especially what occurs inside the core, and learn more about 
their localizations and positions.   
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5.3.3 Extensive removal of residual FlAsH requires OptiPrep 
density gradient 
 
 In order to visualize HIV particle internal structures and proteins via super-
resolution microscopy by simultaneously enhancing accuracy of protein cluster 
distribution measurements, the best approach is imaging cell-free virions. Here, we 
used sucrose gradient-derived HIV, that previously showed appropriate properties in 
confocal fluorescence imaging, to assess the conditions for cell-free virus attachment 
onto slides, usable for fluorescence microscopy. Firstly, we used Poly-L-Lysine 
coated slides for the direct attachment of the cell-free virus particles and tested their 
binding affinity via confocal fluorescence microscopy. Imaging these particles in a 
confocal set up revealed that the particle-associated FlAsH to excess FlAsH ratio 
indicated a substantial imbalance towards the excess FlAsH. We found co-
localization between HIVWT containing mCherry-Vpr and FlAsH, suggesting 
insufficient removal of residual FlAsH (Figure 5.4 A). The estimated co-localization 
between viral protein attached FlAsH to HIV, containing mCherry-Vpr ranged 
between 30% co-localization for HIVMA-TC and about 70% free FlAsH (Figure 5.4 
C). The HIVCA-TC showed only 10% co-localization for mCherry-Vpr containing the 
FlAsH attachment to the CA protein with approximately 90% excess FlAsH on the 
slide (Figure 5.5 A). Similar to HIVMA-TC, the HIVNC-TC revealed approximately 30% 
co-localization in particles containing FlAsH attached to mCherry-Vpr and about 
70% residual FlAsH (Figure 5.5 C). 
 
Despite achieving clean results for HIV infections using the TC-FlAsH 
labelling technique, the images, described above, demonstrated that visualizing cell-
 ϭϳϮ
free virus is more sensitive for residual FlAsH molecules. Due to the utilization of 
direct harvested virus particles, the preparation to obtain clean HIV virions seems to 
be insufficient for imaging in a cell-free environment. Previously it has been shown 
that the sucrose gradient method removed a significant amount of FlAsH from the 
virus samples (Pereira et al., 2011). However, as seen in this study, it is true for HIV 
infections but requires adjustments for cell-free particles. It became clear that the 
sucrose gradient during particle harvesting is the source of insufficient removal of 
residual FlAsH. Therefore, we had to assess other methods to further clean the 
samples. Although, the primarily used method is the sucrose gradient, higher 
purification can be achieved with the OptiPrep gradient technique which was 
successfully used on HIV beforehand (Dettenhofer and Yu, 1999). With the goal to 
highly purify the viruses from residual FlAsH, we replaced the sucrose gradient with 
the OptiPrep gradient method. The retrieved HIV was then compared to previously 
harvested virions, regarding the residual FlAsH levels.  
 
 The OptiPrep technique follows the same principle as the sucrose gradient by 
separating the heavy virus particles in a pellet from the lighter virus un-associated 
FlAsH molecules in suspension but to a higher purification degree. Confocal imaging 
of these HIV particles exhibited a significantly improved virus-associated FlAsH to 
free FlAsH ratio, showing much higher co-localization which signifies true HIV TC 
tagged particles. HIVWT revealed a high concentration of FlAsH-free particles 
containing the mCherry-Vpr with almost eradicated residual FlAsH of less than 5%, 
(Figure 5.4 B). The co-localization level for HIVMA-TC was upregulated to 
approximately 90 – 95% (Figure 5.4 D) and HIVCA-TC reached a co-localization of 
FlAsH-containing mCherry-Vpr particles of 60 – 70% (Figure 5.5 B). HIVNC-TC also 
 ϭϳϯ
revealed high co-localization of FlAsH attachment to mCherry-Vpr-containing HIV 
particles with values of estimated 70 – 80% (Figure 5.5 D).  
 
 These results demonstrated that we were able to remove the majority of 
residual FlAsH which would have given problems during super-resolution analyses 
on cell-free HIV particles. Therefore, we are confident to use these particles in the 
cluster distribution investigations to learn about particle internal structures.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ϭϳϰ
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Figure 5.4 Residual FlAsH removal is sufficiently achieved by OptiPrep density gradient. Virus 
production was performed by transfection of HEK293T cells and collected through 
ultracentrifugation, followed by density gradient concentration. Qualitative confocal analysis was 
conducted for co-localisation between the green fluorescent channel at 528 nm for FlAsH-viral 
proteins and red fluorescent channel at 610 nm for mCherry-Vpr. Images are representatives of 2 
independent experiments using different virus batches. Scale bar is 75 μm. A and C. Virus production 
using Sucrose density gradient on the appropriate viruses. B and D. Excess FlAsH removal and virion 
collection by OptiPrep density gradient.   
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Figure 5.5 Residual FlAsH removal is sufficiently achieved by OptiPrep density gradient. Virus 
production was performed by transfection of HEK293T cells and collected through 
ultracentrifugation, followed by density gradient concentration. Qualitative confocal analysis was 
conducted for co-localisation between the green fluorescent channel at 528 nm for FlAsH-viral 
proteins and red fluorescent channel at 610 nm for mCherry-Vpr. Images are representatives of 2 
independent experiments using different virus batches. Scale bar is 75 μm. A and C. Virus production 
using Sucrose density gradient on the appropriate viruses. B and D. Excess FlAsH removal and virion 
collection by OptiPrep density gradient.   
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5.3.4 HIV-1 NC protein cluster distribution is equivalent to MA 
 
The least explored region of HIV are the core-internal components where we 
only starting to understand the structure of these features and their interactions. 
Stepping further into the HIV intraviral microenvironment, the following part of the 
project will attempt to visualize structures that are mostly difficult to access with the 
purpose of broadening our understanding of HIV morphology. Having solved the 
intrinsic difficulties of preparing cell-free virions for super-resolution imaging 
(Section 5.3.3), it was possible to use FlAsH labelling to study protein cluster 
distributions of internal HIV structures and gain insights into particle internal 
arrangements. Here, the virus samples were prepared, FlAsH and mCherry-Vpr 
labelled in-house and then send to our collaborator for analyses. The dSTORM 
imaging using the PALM technique and protein cluster distribution analyses were 
performed by Yui Yamamoto (UNSW, Sydney). By gathering cluster distribution 
data for the different structures, internal positioning of the CA and NC within the 
virion can be determined with the reference to MA, which can assist with our 
understanding of structural arrangements within the HIV virion. 
  
Confocal fluorescence imaging on HIV infections (Section 5.3.2) as well as 
cell-free virion visualization (Section 5.3.3), showed best results with HIVMA-TC and 
HIVNC-TC. Therefore, our first experiments were performed using these two viruses 
in super-resolution FlAsH-PALM, in order to set up the conditions for the PALM 
imaging. Little is known about the NC compound within the CA core and the field is 
mainly reliant on density-derived studies of its structure, which makes it difficult to 
distinguish from other core-internal elements. TEM and bubblegram analyses 
 ϭϳϳ
recently demonstrated that NC appears to concentrate in a specific region within the 
capsid core of HIV virions (Fontana et al., 2015). However, this technique relied on 
density variations and irradiation damage and therefore more robust techniques are 
desired to address this issue and get conclusive results. A more appropriate method 
might be provided by combining super-resolution microscopy with FlAsH labelling, 
which would give distinct insights into the specific positioning of NC in the HIV 
virion. Since the position in the virion of MA and CA have previously been 
established, the size and location of NC and RNA, particularly in relation to MA and 
CA, is the primary focus to add information to broaden our understanding of HIV 
internal structures. Firstly, the protein cluster distributions of FlAsH-mediated 
HIVMA-TC and HIVNC-TC at CD4 engagement (Chapter 3) were essential foundations 
to determine (1) fluorescence levels and imaging limitations of the FlAsH labelling 
system, (2) possible differences in the image quality and quantity due to the 
resolution diversity of confocal microscopy and (3) potential complicating factors of 
the analyses. Following the FlAsH labelling of MA and NC was the visualization in 
confocal microscopy. Once adequate viral load and fluorescence levels were attained 
(Figures 5.4 D and 5.5 D), the samples were prepared and sent for PALM imaging. 
This enabled us to generate clear images which can be analyzed to give accurate data 
on the size of MA and NC. The result for HIVMA-TC virus showed a mean cluster 
diameter distribution of approximately 100 nm, when measuring the longest 
perpendicular axes (Figure 5.6 A). The NC mean adjusted only slightly under the 
100 nm value of HIVMA-TC at approximately 90 – 95 nm which might re-regulate 
when reaching higher counts. These close values for HIVMA-TC and HIVNC-TC suggest 
that the NC proteins are evenly distributed within the MA lattice. This result showed 
a discrepancy to the previously proposed restriction of the NC proteins in a specific 
 ϭϳϴ
region within the core, however, this finding has to be explored in more detail. By 
virtue of particle amount limitations, these are preliminary datasets and require 
extended particle numbers for statistical relevance.   
 
   A 
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Figure 5.6 NC labelling reveals similar protein cluster distributions to MA in FlAsH-PALM 
super-resolution microscopy analyses. The diameters were estimated based on the average length of 
the two longest perpendicular axes of the virus particles. Binary images were taken and examined by 
applying a FWHM threshold for MA and NC diameters, followed by Gaussian distribution 
calculations. Statistical analyses were carried out by Mann Whitney tests. A. FlAsH-PALM data 
analyses, using a 528 nm laser line. B. HIV particle distribution of MA exhibit approximately 90 – 
95% co-localization between MA-FlAsH (green fluorescent) and virion reference mCherry-Vpr (red 
fluorescent) in FlAsH-PALM. C. NC-FlAsH distribution in FlAsH-PALM showed about 50 – 60% 
co-localization with mCherry-Vpr. 
 
 ϭϳϵ
The aforementioned particle number is highly dependent on the percentages 
of co-localization pattern between mCherry-Vpr containing particles and their viral 
protein FlAsH labelling. Despite mCherry being unsuitable for the PALM imaging, 
its importance for referencing is valuable. In this case, the HIVMA-TC co-localization 
reached 90 – 95% (Figure 5.6 B) compared to the HIVNC-TC co-localization of 
approximately 50 – 60% (Figure 5.6 C) which influences the protein cluster 
distribution analyses substantially. By means of higher resolution used in the PALM 
imaging technique, the co-localization revealed a higher sensitivity for signals being 
either in close proximity or completely overlapping. Subsequently, detection 
differences between confocal and super-resolution microscopy assigned for the 
differentiation in co-localization percentages (70 – 80% in confocal and only 50 – 
60% in PALM imaging for HIVNC-TC). Therefore, the completely overlapping signals 
accounted for true HIV particles and were selected for protein cluster distribution 
analyses in FlAsH-PALM imaging. In order to accurately determine the positioning 
of the NC proteins within the CA core, our successfully FlAsH labelled infectious 
HIVCA-TC virus will assist with the distribution analyses. By comparing the 
measurements of CA protein cluster distributions to NC cluster distributions, we will 
be able to determine whether the NC truly spreads within the core. Due to the 
successful measurement of the FlAsH-containing NC distribution, we are confident 
to pursue with the CA cluster distribution in FlAsH-PALM super-resolution 
microscopy.  
 
 
 
 ϭϴϬ
5.3.5 Labelling of HIV RNA with fluorescent probes against Gag 
and Env regions 
 
Due to interesting observations on NC protein cluster distributions (Section 
5.3.4) within the MA lattice, and that in viruses NC presumably is tightly associated 
with viral RNA, the next step was to investigate RNA location and positioning 
within the HIV virion. With the recent advances in imaging techniques, a variety of 
viral structures can now be visualized clearly. However, visual information about 
viral RNA is still challenging to obtain. Recent successes in direct visualization of 
RNA during HIV replication events has been achieved using a new technique, 
known as viewRNA (Chin et al., 2015). This technique provides a novel way for 
labelling sequence-specific nucleic acids and combines this with highly amplified 
fluorescent visualization. ViewRNA has been successfully used to visualize 
reasonably stable cell-associated viral DNA (Chin et al., 2015). To study core-
internal elements, such as vRNA, we attempted to adapt the method to image the 
more fragile RNA in cell-free virions. However, the tight timeframe only enables the 
setting up of the viewRNA technique. We focused on viral RNA within virions (as 
opposed to within cells) and combined this with confocal microscopy. Our ultimate 
goal is to develop a solid method by attempting to achieve high specificity and 
accuracy, which could potentially be used for further studies, such as dSTORM 
analyses of RNA internal packaging. Here, we present preliminary preparation steps 
to use this method in a HIV RNA set up. 
 
Hereby, the HIV particles were anchored to Poly-L-Lysine coated slides and 
subjected to viewRNA treatment. An important phase in the viewRNA technique is 
 ϭϴϭ
the permeabilisation of the virions to adequately penetrate the Env membrane and 
CA core with the RNA probes for sequence-specific attachment. This is challenging 
as the barriers are difficult to permeabilise and deliver the probes to its destination. 
Therefore, we added a 60oC heating step for 35 minutes at the probe hybridization 
stage to further assist with the viral membrane and capsid core permeabilisation and 
overall RNA probe penetration. Confocal imaging results revealed co-localization 
between the red fluorescently labelled Gag-RNA probe and the green fluorescence 
on Env-RNA probe (Figure 5.7 A). It appears that we obtained some recognition and 
binding to RNA and that it produced efficient fluorescence intensity for the less 
sensitive confocal microscopic detection. 
  
To determine whether the RNA probes were targeting HIV, mCherry-Vpr 
was co-transfected and used as reference for detection purposes. Using another red 
fluorescent signal was possible because of the far red property inherited by the AF 
647 conjugated to the Gag-RNA probe. Thus, the green, red and far red (re-colored 
with cyan for easier differentiation) channels were overlayed, leading to viral targets 
which featured all three fluorescence signals appearing white in color (Figure 5.7 B). 
Some, but not all co-localized Gag and Env probes overlapped with the mCherry 
engulfed particles (Figure 5.7 B). However, the quantity of particles with all three 
fluorophores present would be adequate for sampling in super-resolution imaging, by 
selecting only co-localized particles for analysis. One potential reason that there is so 
little overlap of mCherry with the viewRNA probes would be non-specific binding of 
viewRNA probes, such as the attachment to Poly-L-Lysine. To test this theory, we 
plan to adjust the permeabilisation step with the goal to enhance specific binding of 
 ϭϴϮ
the probes to the HIV core internal RNA as well as adding a blocking step to 
decrease the non-specific attachment to the Poly-L-Lysine layer on the slide. 
 
The ViewRNA technique used probes specific to regions on the HIV RNA. 
However, potential plasmid contaminations, that remained from the harvesting 
process might be problematic and can lead to false positive attachments. Therefore, 
the procedure required the addition of Benzonase treatment to remove such residual 
plasmid DNA. In order to test the level of removal of HIV plasmid DNA, we 
performed a quantitative PCR on those HIV samples that were equalized according 
their p24 CA levels and samples were separated into Benzonase treated and untreated 
HIV. The samples were then divided into extracted cDNA samples and the 
remaining virions were used to extract RNA that was then reverse transcribed into 
cDNA, followed by qPCR analyses. Specific gag primers were used to detect cDNA 
levels in real-time with the SYBR Green-based PCR. The results revealed that 
residual nucleic acid was 10-fold decreased with the Benzonase treatment (Figure 5.8 
A) but still showed a substantial proportion present. This suggests that either cDNA 
was produced during maturation with packaged dNTPs, residual plasmid DNA was 
present on the harvested virions or other DNA contaminations from laboratory cell 
line-derived harvesting remained. We also tested the levels of RNA in the virions by 
using a proportion of HIV RNA to reverse transcribe them into cDNA. The results 
revealed that a lower cDNA level was present as compared to the complete cDNA 
obtained from DNA extraction of the HIV virions. Since we obtained a 5-fold 
reduction in cDNA transcripts with the Benzonase treatment (Figure 5.8 B), this 
indicates that residual Benzonase might have digested newly synthesized cDNA 
transcripts. Nonetheless, the DNA level in HIV virions is 10-fold higher than the 
 ϭϴϯ
reverse transcribed cDNA level. Although these results are preliminary, they suggest 
that further removal of plasmid DNA is required to ensure specific RNA probes 
binding within HIV particles.             
 
A            B   
                        
 
Figure 5.7 ViewRNA system set up to assess its potential for sequence-specific HIV RNA 
targeting. Cell-free HIV particles were fixed and mounted onto cover slides and detergent treated, 
followed by simultaneous administration of Gag RNA probe sets conjugated with AF647 (red 
fluorescence) and Env RNA probe sets conjugated with AF488 (green fluorescence) for 3 h at 40oC. 
Before the probe addition a 35 min heating step at 60oC was included. A. Fluorescence confocal 
signals were detected by dual-fluorescence localization between Gag and Env probes via overlaying 
red and green fluorescent channels. Scale bar is 5 μm. B. Triple-fluorescence was perceived by 
merging far red fluorescent Gag and green fluorescent Env signals with mCherry reference 
fluorescence for viral particles. For ease, the red fluorescence obtained from the red mCherry channel 
was re-colored with cyan; overlaying the channels therefore shows a white signal. Scale bar is 25 μm.  
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Figure 5.8 HIV DNA levels in untreated and Benzonase treated virions. Cell-free untreated and 
Benzonase treated HIV particles were lysed and the extracted DNA and RNA was prepared for qPCR 
analyses of DNA levels using gag-specific primers. The data represent the fold change of gag DNA 
copies. A. Preliminary data of cDNA levels obtained from DNA extractions in untreated and 
Benzonase treated HIV samples. B. Preliminary data from RNA extracted and reverse transcribed 
cDNA levels in untreated and Benzonase treated HIV samples.  
                
5.3.6 Imaging of CA and Env localization via antibody labelling  
 
It is believed that virus external and internal compartments are interdependent 
and that there are changes in external and internal structures to prepare subsequent 
replication steps, once activated through virus-host interaction. In particular, 
Chojnacki et al. demonstrated in their 2012 report that efficient HIV entry requires 
Env clustering in a specific region (Chojnacki et al., 2012). We wanted to study 
whether this clustering of the Env has an effect on CA core positioning. The 
following part of the study pursues this phenomenon further in order to understand 
the preferential position of the Env on the particle surface in comparison to the 
internal capsid core localization. To visually explore Env simultaneously with CA, it 
is essential to develop a functional system for the standard of imaging complex 
structures at nanoscale resolution. Antibodies against the targeted viral proteins are 
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specific but may be detrimental as their size exceeds the nanoscale requirements to 
image Env and CA in such close proximity. A resolution of approximately 20 nm 
can be reached with super-resolution dSTORM, which will be necessary to visualize 
extra- to intra-viral properties of the cone shaped capsid core and compare this to the 
Env clusters on the viral outskirts. Consequently, reducing the antibody size to the 
smallest possible, will result in lifting the imaging quality and will assist with the 
detection of the precise positioning of Env against CA.  
 
To attain small antibody sizes, anti-Env as well as anti-CA were digested 
with papain by Dr Hanumat Tanwar (Deakin University/ CSIRO, Australia) to obtain 
Fab fragments for further processing. However, fragmentation was only successfully 
achieved with the anti-Env antibody. The full antibody for Env as well as the Fab 
fragment were then conjugated with the Alexa Fluor dye AF647 (red fluorescent) 
and the full length antibody for CA was conjugated with the Alexa Fluor dye AF488 
(green fluorescent). HIV particles were attached onto Poly-L-Lysine coated slides, 
permeabilised with 1% Triton X-100, labelled with the appropriate antibodies and 
imaged for attachment affinity. The results indicated differences in the co-
localization pattern of full CA and Env antibodies compared to the full CA antibody 
plus Env Fab fragment antibodies. While there is a stronger association to the target 
proteins in the full CA and Env antibody with higher co-localization levels (Figure 
5.9 A), the Fab fragment-derived anti-Env seems to sparsely co-localize with its 
binding partner (Figure 5.9 B). This observation may indicate that the fragmentation 
of the Env antibody affects its binding affinity. In this case, extensively increased 
sample iterations would be required to acquire statistically relevant particle numbers 
 ϭϴϲ
by dSTORM. Since this technique is in the testing phase, adjustments are ongoing 
and are still being acquired. 
 
 
A                                                                       B 
                   
 
 
 
 
 
Figure 5.9 Confocal analysis of a HIVWT population to assess co-localization of Env and CA by 
anti-Env and anti-CA dual fluorescence. Cell-free virus was placed on Poly-L-Lysine coated 
coverslips and pre-treated with 1% Triton X-100 for 30 minutes. The anti-CA antibody was 
administered for 16 h in 0.1% Triton X-100/PBS solution, followed by a 2 h anti-Env or anti-
Env(Fab)/PBS treatment. Images of viral particles were collected in a Leica confocal microscope, 
using a 488 nm laser line for Env-AF488 or Env(Fab)-AF488 and a 647 nm laser line for CA-AF647, 
and then displayed using the simultaneous dual-channel mode. Images are representatives of 2 
independent experiments. (A) Co-localisation efficiency of complete antibody against Env with anti-
CA. Scale bar is 25 μm. (B) Qualitative coherence of Fab fragmented antibody against Env co-
localising with entire antibody against CA. Scale bar is 50 μm. 
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5.4 Discussion 
   
 The imaging of fluorescently labelled viruses with the biarsenical-
tetracysteine system is an attractive technique to fluorescently label viral proteins 
without compromising virus infectivity. While the TC tag has been successfully used 
to label several viral proteins, such as HIV MA (Gousset et al., 2008, Turville et al., 
2008), HIV IN (Arhel et al., 2006), VSV MA (Das et al., 2009, Mire et al., 2009), 
HIV Env and HIV NC (Pereira et al., 2011), HIV CA did not reveal uncompromised 
infectivity in these labelled particles. Here, we describe for the first time, that it is 
possible to attach a TC tag in the context of a full-length HIV by maintaining virus 
infectivity comparable to wild type HIV. The attachment of the TC tag at the N-
terminal region of CA protein is dependent on the level of integration into the CA 
core (16.7%) which was detrimental for virus infectivity but did not affect the 
proteolytic processing of CA proteins. HIV inherits a highly ordered CA core lattice 
structure (Ganser-Pornillos et al., 2007), forming a distinct morphology during 
assembly (Zhao et al., 2013). Based on this, the results indicate that only a certain 
level of TC tag attachment is achievable in order to maintain this distinctive 
architecture and its functionality.  
 
 We confirm that the TC tag can be attached to the C-terminus of the MA 
protein without affecting virus infectivity (Gousset et al., 2008, Turville et al., 2008) 
and we also show similar results, as seen in previous studies, for the NC protein with 
only nominal effects on viral replication (Pereira et al., 2011). Using a conditional 
co-transfection system, we were able to rescue the infectivity of both HIVNC-TC and 
HIVCA-TC to approximately 80% of the HIVWT. Since HIVMA-TC showed similar 
 ϭϴϴ
infectivity levels at approximately 100% compared to HIVWT, the TC tagging might 
have caused the slight reduction. We also show that there was enough TC tagged NC 
proteins and CA proteins for visualization by fluorescence microscopy. In cell-
derived HIV infections, we observed intermittent background problems that are 
manageable with the appropriate controls. The HIVMA-TC will enable the 
visualization of particle-internal events and HIVNC-TC will allow the imaging of HIV 
genome-NC complexes. With the first infectious HIV containing fluorescently 
labelled CA proteins it will be possible to visualize intracellular trafficking of the CA 
core and its uncoating in live cells. Furthermore, due to the limited number of TC 
labelled CA proteins and subsequent signal intensity reduction, the new generation of 
brighter biarsenical dyes, such as the Alexa Fluor dye range that can be conjugated to 
proteins, may be more suitable for the imaging. The approach in this study can be 
adapted in other virus systems, containing similar complex structures as seen in the 
CA lattice.  
 
   We demonstrated that one application for the FlAsH labelled MA and NC 
proteins can be the visualization of intra-viral structures in super-resolution 
microscopy using FlAsH-PALM. In order to enhance accuracy on particle internal 
features, cell-free virions are detrimental but require strict removal of residual FlAsH 
which can be achieved with an OptiPrep gradient-derived harvesting of HIV. The 
reduction of excess FlAsH to approximately 5 – 40% in HIV, increased the structural 
analyses success for the sensitive super-resolution microscopy which was 
manageable by selecting true HIV containing mCherry-Vpr. In particular, this is 
essential for the small intra-core NC protein with reduced fluorescent labels. Our 
knowledge about core internal structures, such as NC and RNA, is limited partially 
 ϭϴϵ
due to the difficult accessibility and unavailability of appropriate labelling. Electron 
microscopy (EM) can be of assistance when studying these features but with 
limitations that makes it problematic to identify dense structures within the core. It is 
believed that the NC-vRNA complex occupies a specific location within the HIV CA 
core whereas it was demonstrated by EM bubblegram to be located in the wide end 
of the core (Fontana et al., 2015). Here, NC was identified due to its susceptibility to 
radiation damage. In our study, we used the specific FlAsH labelling system for NC 
proteins and demonstrated that NC might spread within the viral particle. According 
to our results, the previously identified dense structure seems not to reflect the true 
result. Since there are numerous structures within the HIV core and it is unclear what 
feature is susceptible to radiation damage, further examinations on RNA and other 
viral proteins are required. It might be likely that the long, 9kb viral RNA (Moore 
and Hu, 2009) is responsible for the dense structure within the CA core but with the 
data from our study, it seems to have either less dense regions or free NC is also 
enclosed.  Furthermore, NC might not be the only source for the radiation sensitivity 
as sugar residues on the nucleic acids are believed to be susceptible to radiation as 
well. NC is presumably tightly associated with HIV RNA, enabling remodeling of 
the RNA structure (Levin et al., 2014). Furthermore, the RNA contains high sugar 
amounts, therefore these sugar residues of RNA or other components within the core 
could also be responsible for the sensitivity to radiation. Whether all NC chaperones 
are bound to vRNA and the HIV RNA is behaving similar as seen in our NC cluster 
distribution has to be determined.  
 
       The location and position of HIV RNA within the CA core is unknown 
which is mainly due to the difficulties in appropriate labelling. The new and effective 
 ϭϵϬ
viewRNA technique uses sequence-specific nucleic acids labelling (Chin et al., 
2015) that will assist with studying the location of HIV RNA. Using regions on the 
HIV genome that are far apart, Gag and Env, and which were labelled with two 
different fluorescent dyes, we were able to show co-localization in confocal 
fluorescence microscopy. This study also revealed that it is detrimental to use a 
reference for true HIV particles (mCherry-Vpr) as unbound fluorescently labelled 
probes were present, indicating that some probes attach to the Poly-L-Lysine coating 
randomly. This has to be solved by adding a blocking step. Our current research aims 
at optimizing the viewRNA technique to HIV RNA whereas preliminary results 
showed nominal success in permeabilisation and therefore minimized levels of 
attachment to viral RNA targets. It could not be ruled out that unspecific binding of 
RNA probes to fragmented plasmid DNA during hybridization (Vuosku et al., 2010) 
led to false positives. Although it is believed that the majority of nucleic acid 
residues are removed through Benzonase treatment (Sastry et al., 2004), a proportion 
was still present in the virions which has to be further reduced. However, whether 
this is due to pre-reverse transcribed cDNA levels (initiated through packaged 
dNTPs) or any contaminations that might have been obtained from the cell-derived 
transfection procedure, such as the previously found Xenotropic Murine Leukemia 
virus-related (XMRV) DNA contamination in human cell lines (Robinson et al., 
2010), is unclear.  
 
    One of the important challenges in retrovirology is to understand the 
organization of the viral proteins externally and internally and how they interact 
during different maturation stages. In the field it is believed that the Env is evenly 
distributed across the surface of the viral membrane and schematic models of the 
 ϭϵϭ
HIV virus often represent this theory. Since we observed recently that HIV is not a 
static structure and is able to expand upon CD4 engagement (Pham et al., 2015), it is 
not surprising that the virus can alter, such as the previously detected HIV Env re-
organization in a specific region on the surface of the viral membrane during 
maturation (Chojnacki et al., 2012). It is unclear, whether there is a signaling cascade 
sent through the HIV particle, that can alter the CA core as a result of the Env 
clustering. HIV Env is located on the viral surface in close proximity to CA core and 
the broad base of the core is estimated at only 11 nm from the viral lipid membrane 
(Benjamin et al., 2005) while the narrow end is in even closer contact with the inner 
viral membranes (Briggs et al., 2006b). These short distances between the enveloped 
membrane, the MA lattice and the CA core might promote such signaling cascade. 
Furthermore, there is an unusually long cytoplasmic tail in HIV whereas it is 
believed that the cytoplasmic tail is involved in signaling to interact with associated 
proteins (Postler and Desrosiers, 2013). This suggests that there could exist a 
signaling between external triggers to internal changes. Further imaging those tight 
distances is challenging. The reason is the size of the cone-shaped core that has an 
estimated length ranging between 100 to 200 nm (Höglund et al., 1992, Briggs et al., 
2003), which stretches almost through the entire particle. The widest end showed an 
estimated size of 50 to 60 nm (Briggs et al., 2006b) which can be visualized easier 
because of the distance to the MA layer. Imaging such close and small features 
requires accurate labelling which can be challenging taking into account the sizes of 
antibodies at approximately 10 to 15 nm. However, it can be achieved with Fab 
fragments that have 9 nm length (Schauen et al., 2013). Since the advances in super-
resolution ensure that it is possible to reach 20 nm resolution (Huang et al., 2009), 
we will be able to detect distances in this range. This study aimed at the optimization 
 ϭϵϮ
of the Fab fragment utilization for Env-CA core positioning and revealed that the 
fragmentation led to decreased conjugation with fluorescent dyes, suggesting loss of 
conjugation affinity. This was supported with full-length antibody conjugation that 
yielded in higher attachment rates of the fluorescent dyes, probably due to enhanced 
affinity. Future outlooks would be the determination of enhancements in fluorescent 
dye labelling of fragmented Env- and CA-specific antibodies as well as the increase 
in amounts of labelled HIV particles.    
 
 This study shows that imaging HIV particle-internal components is 
challenging and numerous obstacles have to be overcome to visualize such small, 
nano-scale elements. This is partially the reason that we know so little what occurs 
inside the virus particle, in particular within the core. Globally, all the presented data 
in this thesis, try to contribute to the understanding of viral behavior by unveiling 
unexpected events, such as CD4 receptor-mediated expansion and cellular protein 
phosphorylation and developments and adaptation of sophisticated tools to further 
examine fundamental questions in this relation. 
 
 
 
 
 
 
 
 
 
 ϭϵϯ
6 General Discussion 
 
 
HIV-1 early entry into host cells is a complex, multi-step process which relies 
on viral but also cellular factors for the successful internalization and viral genome 
delivery. Hereby, signalling events play an important role to prepare the virus but 
also the target cell for subsequent infection steps that seem to be interdependent. It is 
widely believed that viruses are metabolically inert and have a static structure, and 
that they can only remodel after the entry into the host. However, the observations 
presented in this thesis provide evidence that we have to rethink the way HIV 
operates and manipulates cellular entry, starting with the very first contact to the 
target cell. 
 
In the HIV field it is accepted that the virus is pleomorphic in size, with 
diameters ranging between 100 to 200 nm (Briggs et al., 2003), but that the particle 
size does not change prior to the cell membrane fusion. HIV undergoes numerous 
steps before entering the cell, including Env interaction to the CD4 receptor and 
CCR5 or CXCR4 co-receptor binding, followed by entering through fusion between 
viral membrane and cellular membrane (Wilen et al., 2012), but it was not shown 
that the virus particle size is affected by these events prior to fusion. HIV Env is 
heavily involved in the pre-fusion phases which starts with the first contact of CD4 
engagement and therefore it is not unusual that the Env has to undergo structural 
changes to ensure subsequent reactions (Sullivan et al., 1998, Zhang et al., 1999, 
Gallo et al., 2003). Surprisingly, when we engaged the HIV to CD4 and examined 
the size by cryo-EM, cryo-ET and dSTORM, we observed an effect on the virus 
particle which was measurable as expansion of the viral membrane-associated MA 
 ϭϵϰ
layer (example representative in Figure 3.1 C and D). The 3D cryo-ET analyses 
showed that the mean MA diameter of the HIV particles expanded from 124 nm 
(SEM ± 3.2 nm) to 134 nm (SEM ± 2.5 nm). Since the MA lattice is the underlying 
layer that is associated to the viral lipid envelope, it is likely that the surrounding 
lipids and membrane-associated proteins are involved in this process. Viral 
membranes have a limited number of lipids that are tightly packed, therefore raising 
the question how the virus membrane compensates for such estimated increase in 
surface area upon CD4 engagement. The surface area increase might be achieved by 
a repacking of tightly packed lipid molecules in the rafts microdomains (Brügger et 
al., 2006) which could function similar to the rearrangement of cholesterol-
sphingolipid enriched microdomains during cellular signalling events (Simons and 
Gerl, 2010). Supported is the repacking theory by a recent observation of the 
maturation-induced clustering of HIV Env proteins (Chojnacki et al., 2012). This 
was correlated to rearrangements of the inner protein lattice that facilitates the 
alteration of the virus surface in preparation for productive entry. Therefore, this 
result would suggest that the virus lipid membrane is sufficiently fluid for 
movements of proteins and perhaps repacking of lipid molecules. Whether the Env 
clustering is associated with the expansion of the lipid surface area is currently 
unknown. During the selection process of phosphorylated cellular proteins, we also 
identified a lipid-related protein, phosphatidylserine synthase 1 (PTDSS1), that was 
phosphorylated at CD4 engagement in the HIV virion. Generally, PTDSS1 catalyses 
the conversion of phosphatidylcholine in cellular membranes. This protein was 
previously linked to be modulated at early entry of HIV infection whereas the 
knockdown of PTDSS1 by siRNA inhibited the early stages of HIV replication in 
target cells that were infected with VSV-G pseudotyped HIV (Konig et al., 2008). 
 ϭϵϱ
Since it was detected in 3 of our virus groups (but was not considered noticeable to 
our criteria), we did not initially consider PTDSS1 for investigations during this 
thesis. However, in support for its potential relation to lipid and protein pre-entry 
rearrangement in the virion, PTDSS1 is currently further examined in this regard.    
Unexpectedly, the virus particle expansion seems to follow an ‘outside-in’ 
signalling concept whereas it applies to compartments further in the virus particle, 
namely the CA core. It was previously reported that interactions of herpes simplex 
virus with its cellular receptor can lead to internal release of the viral tegument 
proteins from the viral capsid complex (Meckes and Wills, 2008). In agreement with 
these observations, our study showed evidence that cell-free HIV is able to 
structurally reorganize internally upon receiving a trigger by the engagement of the 
CD4 binding site on Env. Here, we observed that the volume of the CA core 
expanded by 26% after incubation with high concentrations of soluble CD4 (example 
representative in Figure 3.2 C and D). Whether there are any CD4 receptor-mediated 
effects on further internal components, such as NC proteins, could not be determined 
so far. There was an elevated tendency of NC protein cluster distribution evident but 
only a higher particle number will verify a true effect. Since the data indicated that 
CD4-Env engagement is the lynchpin of the virus size expansion process, the CD4-
Env interaction-induced changes in internal virus structure appears to be similar to 
cellular signalling processes. However, it is unclear whether such signalling events 
relate to the classical signalling processes in eukaryotic cells and/or involves virus 
co-packaged host derived signalling molecules (Chertova et al., 2006).  
 
HIV is dependent and strongly interacts with host cellular factors during 
infection (Brass et al., 2008, Zhou et al., 2008, Konig et al., 2008, Yeung et al., 2009, 
 ϭϵϲ
Bushman et al., 2009) and also pre-packages a variety of cellular factors during 
assembly (Segura et al., 2008, Raghavendra et al., 2010, Linde et al., 2013). It is also 
known that HIV manipulates a variety of cellular proteins to gain access to the target 
cell and to facilitate replication processes. Whether these factors have additional 
roles in the involvement in signalling events to mediate CD4-Env-induced expansion 
on the virus particle and CA core is unclear. However, signalling protein 
involvement could be likely, as there was an unexpected phosphorylation of 
numerous co-packaged human proteins observed in the HIV virion upon CD4 
engagement. Therefore, it is tempting to speculate that these factors are involved in 
viral priming events prior to fusion with the cell. We found that these 
phosphorylation events affected cellular proteins that are involved in entry processes, 
including the external membrane protein SPN, transmembrane proteins SLC38A1 
and LAT and cytoskeleton-related factors SPTBN1 and FNBP1 (Figure 4.9). These 
modified cellular factors suggest to assist HIV with gaining access to the host cell, 
since they were linked to infection beforehand (Lefebvre et al., 1994, Abraham et al., 
2012, Dai et al., 2013, Matheson et al., 2015, Shrivastava et al., 2016). Furthermore, 
cellular proteins involved in subsequent replication steps post-transcription were 
detected to be pre-entry phosphorylated, such as the splicing factors SRRM1 and 
SRRM2 and the assembly-related MVB12B which were previously linked to HIV as 
well (Morita et al., 2007, Wojcechowskyj et al., 2013). This hints to either a rapid 
necessity after fusion or multiple functionality, potentially in pre-entry processes 
involving protein rearrangements. 
 
One specific cellular protein, the MVB12B, is noticeable to be 
phosphorylated and activated prior to entry. Generally, this protein is related to 
 ϭϵϳ
functions in late stage infection, namely the assembly (Morita et al., 2007). Since 
viruses are unable to synthesise proteins autonomously, it is likely that the expansion 
is associated with protein rearrangements in addition to the potential lipid 
reorganisation. As a member of the cellular ESCRT machinery, that is involved in 
protein sorting during HIV assembly and release (Van Engelenburg et al., 2014, 
Prescher et al., 2015), MVB12B could assist with such pre-entry priming events. 
Other phosphoproteins were identified that are involved in reorganization processes 
within the host cell, such as SPN, LAT, SPTBN1 and FNBP1, that might organize 
membrane-associated proteins in the virus membrane to accommodate fluent entry. 
Some of these cellular factors are located on the outskirts or exist as transmembrane 
proteins of the cellular membrane that is incorporated into the viral membrane during 
assembly. Therefore, HIV infection activation by CD4 engagement, could also 
rearrange those proteins and enhance their exposure to prime entry to the target cell, 
which can contribute to the expansion of the lipid layer. The virion-packaged 
proteins seem to be activated by the phosphorylation at pre-entry and since some 
proteins are generally downregulated during infection, this suggests that the cellular 
factors are involved in the entry process to resting T cells. HIV infects resting cells, 
potentially due to the fact that a majority of the CD4+ T cells are in a profoundly 
quiescent state in vivo (Stevenson et al., 1990, Han et al., 2004). Therefore, HIV is 
dependent on having entry-permissive mechanisms in place which might be achieved 
by co-packaging and pre-entry activation of cellular proteins via phosphorylation.           
 
Most likely the expansion is a precursor for subsequent infection steps. 
Therefore, we examined the influence of CD4 engagement on early entry processes, 
such as the CA core stability by an in vitro core stability assay and reverse 
 ϭϵϴ
transcription events by qPCR upon exogenous dNTP initiation. Low concentrations 
of the external trigger (engagement of the CD4 binding site on Env) did not affect 
either the core stability (Figures 3.9 and 3.10 A and B) or the production of early and 
late reverse transcription products (Figure 3.11). However, when using a higher 
concentration of CD4 receptor mimics, the core stability (Figure 3.10 C and D) and 
the reverse transcripts production (Figure 3.11 C and D) is nominal affected. To 
examine further aspects, we currently conducting experiments that test RNA dimer 
stability by Northern blot analyses. Additionally, we are also in the preparation stage 
to conduct experiments for CA core structural changes using CA core isolations 
(Welker et al., 2000) at the CD4 engagement stage. 
 
  Currently, we do not know how far the ‘outside-in’ signal can be sent 
through the HIV particle. The preliminary data on the trend of the NC protein cluster 
distribution suggests an effect that is capable of reaching core-internally upon CD4 
engagement (Figure 3.6). This potentially involves not only viral but also co-
packaged cellular proteins to establish viral replication-relevant processes. In order 
to facilitate such events, it is tempting to assume that it requires alterations in the 
location, positioning and distribution of core-internal components, such as vRNA 
and/or NC. Presumably, NC proteins are associated with HIV RNA within the CA 
core to mediate chaperone functions (Levin et al., 2014) and it was shown in EM and 
tomo-bubblegram imaging that the vRNA-NC complex is located in a specific region 
within the CA core as demonstrated by radiation susceptibility of NC proteins 
(Fontana et al., 2015). We also used the core-internal NC to examine NC protein 
cluster distributions by our tetracysteine labelling system and PALM super-
resolution microscopy. In contrast to Fontana et al., we observed an evenly spread of 
 ϭϵϵ
NC protein distribution within the HIV particle (Figure 5.6 A) and it seems to alter at 
CD4 engagement (Figure 3.6). Since we used the MA layer for comparison, these 
preliminary data have to be confirmed by using the more appropriate CA core 
fluorescent labelling. So far, it was impossible to obtain a functional and infectious, 
fluorescently labelled CA core (Pereira et al., 2011). Here, for the first time, we 
present a fluorescently labelled CA core that is functional and preserves the viral 
infectivity (Figure 5.1) which can now be used to study the precise NC protein 
distribution within the core and potentially will confirm our preliminary NC protein 
distribution spread. 
 
The binding partner of NC in the complex is presumably the vRNA which 
can be studied by indirect visualization through NC protein distributions. Since the 
accessibility and the labelling of RNA is difficult, the NC protein labelling is an 
attractive way to examine the vRNA-NC complex. If the theory is correct and the 
NC proteins are associated with the RNA, this indirect imaging of the RNA in the 
NC complex might hint to a broad spread within the HIV particle. This seems likely 
when taking into account that the RNA is almost 9 kb in size (Moore and Hu, 2009) 
with almost 6 μm length. This is an estimated calculation from an average single 
human chromosome containing DNA molecule that would be approximately 2 m 
long (Lehninger, 1975, Campbell et al., 1997).  However, the CA core  is only 
approximately 100 – 200 nm long  and 50 – 60 nm wide (Höglund et al., 1992, 
Briggs et al., 2003). This suggests that this small space with tight dimension does not 
allow enough room for such regionally restricted location and the vRNA-NC 
complex more likely uses the entire available space. The previously suggested 
stabilizing properties of NC for HIV RNA dimers supports the observation of a 
 ϮϬϬ
potential localization of NC along the vRNA (Shehu-Xhilaga et al., 2001b). Whether 
there are alterations during maturation or pre-entry events, has to be further 
examined. However, the preliminary trend in elevated NC cluster distribution (Figure 
3.6) could either indicate that CD4 engaged HIV RNA requires a higher activity of 
NC for its dimer stabilization or stronger chaperone functionality for potential RNA 
conformational rearrangements. We did detect splicing involved cellular proteins that 
were phosphorylated in the HIV virion at CD4 engagement, SRRM1, SRRM2 and 
THRAP3, which suggests that there is an early association of these factors to the 
vRNA-NC complex. Therefore, these splicing factors might promote the role of NC 
in the early transcription of viral spliced mRNA in HIV infected cells (Zhang and 
Crumpacker, 2002) which is currently further examined. Assisting with the HIV 
RNA positioning can the recently established and successfully used viewRNA 
technique (Chin et al., 2015) which allows the direct visualization of HIV sequence-
specific fluorescently labelled RNA. Therefore, this method can be used to analyse 
RNA distribution within the HIV particle by dual fluorescence in dSTORM during 
maturation and pre-entry processes which is currently commencing.  
 
To further examine the ‘outside-in’ signalling which was detected through the 
CD4-Env binding and the associated expansion of the viral particle and the CA core, 
we currently conduct experiments on Env clustering and CA core localisation. It has 
been shown that the HIV Env clusters on the lipid membrane during maturation 
(Chojnacki et al., 2012). This clustering could send signalling events inwards to 
prepare subsequent processes, as seen with the expansion of HIV at CD4 
engagement. Recently, it was shown that the uncoating is a multi-step process (Xu et 
al., 2013) and rapidly occurs after fusion (partial disassembly) (Francis et al., 2016). 
 ϮϬϭ
Whether this requires a specific orientation of the core to the Env clusters and 
therefore ensure the rapid internalization or ‘shooting’ towards the nucleus 
(potentially with the narrow capped end forward) has to be examined. 
 
The results of this thesis contribute to our understanding of HIV entry by 
revealing previously unknown events. This phenomenon of multi-levelled pre-entry 
priming upon receptor engagement, including the expansion of the viral particle and 
the virion-internal effects, may be a general principle for viruses to mediate 
subsequent replication steps. Understanding the mechanisms and principles, viruses 
follow for the establishment of successful infection, will assist with fresh 
perspectives to develop novel antiviral therapeutics.       
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